<!DOCTYPE html>

<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <title>WAAMS - Western Australia AntiMicrobial Stewardship</title>
    <link rel="shortcut icon" type="image/ico" href="favicon.ico" />
    <link rel="apple-touch-icon" href="apple-touch-icon-precomposed.png">
    <link rel="apple-touch-icon-precomposed" href="apple-touch-icon-precomposed.png">
    <link rel="stylesheet" href="bootstrap/css/bootstrap.min.css" />
    <link rel="stylesheet" href="bootstrap/css/bootstrap-theme.min.css" />
    <link rel="stylesheet" href="bootstrap/css/basic.css" />
    <link rel="stylesheet" href="bootstrap/css/style.css" />
    <script src="bootstrap/js/jquery-1.11.1.min.js"></script>
    <script type="text/javascript" src="bootstrap/js/codecheckWA.js"></script>
    <!-- Needed for Forms Feature Detection -->
    <script src="polyfill/better-dom.min.js"></script>
    <!-- Needed for Validation -->
    <script src="polyfill/better-dateinput-polyfill.js"></script>
    <script src="polyfill/ie-array-polyfill.js"></script>
    <!-- General helpful functions -->
    <script src="bootstrap/js/kraken.js"></script>
</head>

<body>

    <!-- loading page -->
    <div data-role="page" id="load" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Loading</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Loading</span>
            </h3>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /load -->

    <!-- Ascending Cholangitis Maze Begins -->
    
    <!-- Start of ascending cholangitis page: #intrab6-->
    <div data-role="page" id="intrab6" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Ascending cholangitis</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn15b">Does the patient have a penicillin allergy? <span
                class="font15 color-info">&#40;See below for details on penicillin allergy severity&#41;</span></h3>

        <div data-role="content" class="container-fluid">
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#ascho3">No penicillin allergy</a></li>
                <li><a href="#ascho1">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#ascho2">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr>
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>

        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /ascho -->

    <!-- Start of cholangitis PEN BAD, Gent Q: #ascho2 -->
    <div data-role="page" id="ascho2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Ascending cholangitis</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn15b">Is gentamicin contraindicated in this patient? <span
                class="color-info font15">&#40;See below for contraindications&#41;</span></h3>

        <div data-role="content" class="container-fluid">
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#ascho2b">Gentamicin not contraindicated</a></li>
                <li><a href="#ascho2a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b text-center">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /ascho2 -->

    <!-- Start of cholangitis PEN OK, Gent Q: #ascho3 -->
    <div data-role="page" id="ascho3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Ascending Cholangitis</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn15b">Is gentamicin contraindicated in this patient? <span
                class="color-info font15">&#40;See below for contraindications&#41;</span></h3>

        <div data-role="content" class="container-fluid">
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#ascho3b">Gentamicin not contraindicated</a></li>
                <li><a href="#ascho3a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b text-center">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /ascho3 -->

    <!-- Start of cholangitis PEN MILD, Gent OK: #ascho1 -->
    <div data-role="page" id="ascho1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Ascending cholangitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h4 class="color-primary mrgn15b">For ascending cholangitis in a patient with non-life threatening
                penicillin hypersensitivity:</h4>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g &#40;child 1 month or older: 50 mg/kg up to 2 g&#41; IV,
                        daily</span>
                </h4>
                <div class="font15 mrgn20b"><b>PLUS</b> if the patient has a history of biliary obstruction <b>ADD:</b>
                </div>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child 1 month or older: 12.5 mg/kg up to 500
                        mg&#41; IV, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is: </span>
                <span class="font15 bold">3<script> document.write(getCode())</script>asc</span>
                <div class="font15 mrgn20b text-left">This code is valid for THREE days only, starting from the first
                    day of treatment for this condition. Infectious diseases must be contacted if IV treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <ul class="line20">
                <li>If patient appears septic, treat as per severe sepsis protocol &#40;see homepage&#41;</li>
                <li>Ascending cholangitis is usually caused by enteric gram negative bacilli such as <i>Eschericia.coli,
                        Klebsiella spp and Enterobacter spp</i>. Gram positive bacteria such as <i>Enterococcus</i> may
                    also be implicated. Infrequently it is caused by anaerobic bacteria</li>
                <li>Consider an early switch to oral within 48 hours as with all abdominal infections</li>
                <li>Total antibiotic therapy &#40;IV and PO&#41; should not usually exceed 7 days treatment. Antibiotic
                    therapy should be ceased within 24 hours of uncomplicated cholecystectomy</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on ascending cholangitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /ascho1 -->

    <!-- Start of cholangitis PEN BAD, Gent OK: #ascho2a -->
    <div data-role="page" id="ascho2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Ascending Cholangitis Treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h4 class="color-primary mrgn15b">For ascending cholangitis in a patient with life threatening penicillin
                hypersensitivity intolerant of gentamicin:</h4>
            <h4 class="color-danger mrgn15b">Please contact infectious diseases for advice</h4>
            <hr>
            <ul class="line30">
                <li>If patient appears septic, treat as per severe sepsis protocol &#40;see homepage&#41;</li>
                <li>Ascending cholangitis is usually caused by enteric gram negative bacilli such as <i>Eschericia.coli,
                        Klebsiella spp and Enterobacter spp</i>. Gram positive bacteria such as <i>Enterococcus</i> may
                    also be implicated. Infrequently it is caused by anaerobic bacteria</li>
                <li>Consider an early switch to oral within 48 hours as with all abdominal infections</li>
                <li>Total antibiotic therapy &#40;IV and PO&#41; should not usually exceed 7 days treatment. Antibiotic
                    therapy should be ceased within 24 hours of uncomplicated cholecystectomy</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on ascending cholangitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /ascho2a -->

    <!-- Start of cholangitis PEN BAD, Gent OK: #ascho2b -->
    <div data-role="page" id="ascho2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Ascending cholangitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h4 class="color-primary mrgn15b">For ascending cholangitis in a patient with life threatening penicillin
                hypersensitivity use:</h4>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV,</span>
                    <span class="color-purple"> dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND</b> if the patient has a history of biliary obstruction <b>ADD</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child 1 month or older: 12.5 mg/kg up to 500
                        mg&#41; IV, 12-hourly</span>
                </h4>
                <p class="mrgn20b">Please contact infectious diseases for advice for ongoing therapy past 72 hours</p>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>asc</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>If patient appears septic, treat as per severe sepsis protocol &#40;see homepage&#41;</li>
                <li>Ascending cholangitis is usually caused by enteric gram negative bacilli such as <i>Eschericia.coli,
                        Klebsiella spp and Enterobacter spp</i>. Gram positive bacteria such as <i>Enterococcus</i> may
                    also be implicated. Infrequently it is caused by anaerobic bacteria</li>
                <li>Consider an early switch to oral within 48 hours as with all abdominal infections</li>
                <li>Total antibiotic therapy &#40;IV and PO&#41; should not usually exceed 7 days treatment. Antibiotic
                    therapy should be ceased within 24 hours of uncomplicated cholecystectomy</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b text-center">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12
                years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <h4 class="color-primary mrgn20b text-center">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12
                years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on ascending cholangitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /ascho2b -->

    <!-- Start of cholangitis PEN OK, Gent OK: #ascho3b -->
    <div data-role="page" id="ascho3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Ascending Cholangitis Treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For ascending cholangitis in a patient who can tolerate penicillin and
                gentamicin:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 2 g &#40;child: 50 mg/kg up to 2 g&#41; IV, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, </span>
                    <span class="color-purple"> dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND</b> if the patient has a history of biliary obstruction <b>ADD</b>
                </p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child 1 month or older: 12.5 mg/kg up to 500
                        mg&#41; IV, 12-hourly</span>
                </h4>
                <p class="mrgn20b">If IV treatment is required after 72 hours change to ceftriaxone 1 g daily +/-
                    metronidazole if biliary obstruction present, or use piperacillin 4 g and tazobactam 500 mg 8-hourly
                    &#40;Please contact infectious diseases for advice&#41;</p>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>asc</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>If patient appears septic, treat as per severe sepsis protocol &#40;see homepage&#41;</li>
                <li>Ascending cholangitis is usually caused by enteric gram negative bacilli such as <i>Eschericia.coli,
                        Klebsiella spp and Enterobacter spp</i>. Gram positive bacteria such as <i>Enterococcus</i> may
                    also be implicated. Infrequently it is caused by anaerobic bacteria</li>
                <li>Consider an early switch to oral within 48 hours as with all abdominal infections</li>
                <li>Total antibiotic therapy &#40;IV and PO&#41; should not usually exceed 7 days treatment. Antibiotic
                    therapy should be ceased within 24 hours of uncomplicated cholecystectomy</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b text-center">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12
                years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on ascending cholangitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /ascho3b -->

    <!-- Start of cholangitis PEN OK, Gent BAD: #ascho3a -->
    <div data-role="page" id="ascho3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Ascending Cholangitis Treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For ascending cholangitis in a patient tolerant of penicillin but
                intolerant of gentamicin:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ceftriaxone 2 g &#40;child 1 month or
                        older: 50 mg/kg up to 2 g&#41; IV, daily</span>
                </h4>
                <p class="font15 mrgn20b"><b>AND</b> if the patient has a history of biliary obstruction <b>ADD</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child 1 month or older: 12.5 mg/kg up to 500
                        mg&#41; IV, 12-hourly</span>
                </h4>
                <p class="font15 mrgn20b"><b>OR</b> as a single agent (without metronidazole)</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Piperacillin+tazobactam 4+0.5 g
                        &#40;child: 100+12.5 mg/kg up to 4+0.5 g&#41; IV, 8-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin or ceftriaxone is: </span>
                <span class="font15 bold">3<script> document.write(getCode())</script>asc</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>If patient appears septic, treat as per severe sepsis protocol &#40;see homepage&#41;</li>
                <li>Consider an early switch to oral within 48 hours as with all abdominal infections</li>
                <li>Total antibiotic therapy &#40;IV and PO&#41; should not usually exceed 7 days treatment. Antibiotic
                    therapy should be ceased within 24 hours of uncomplicated cholecystectomy</li>
                <li>Ascending cholangitis is usually caused by enteric gram negative bacilli such as <i>Eschericia.coli,
                        Klebsiella spp and Enterobacter spp</i>. Gram positive bacteria such as <i>Enterococcus</i> may
                    also be implicated. Infrequently it is caused by anaerobic bacteria</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on ascending cholangitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /ascho3a -->
    <!-- END OF Ascending Cholangitis Maze -->


    <!--START OF LIVER ABSCESS MAZE-->

    <!-- Start of LIVER ABSCESS ?Pen allergy -->
    <div data-role="page" id="liver" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Liver Abscess</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">&#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#liver1">No penicillin allergy</a></li>
                <li><a href="#liver2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#liverx">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /liver -->

<!-- Start of LIVER ABSCESS, NO PEN ALL -->
    <div data-role="page" id="liver1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical liver abscess treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient tolerates penicillin treat with:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 2 g IV, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 750 mg IV, 8-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>liv</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>In children, liver abscesses are rare and most commonly caused by Staphylococcus aureus. Seek expert paediatric advice for management—it may be necessary to involve a multidisciplinary team, including a paediatric infectious diseases physician</li>
                <li>Drainage is the mainstay of therapy for the treatment of bacterial liver abscess. For abscesses less than 5 cm in diameter, closed-needle drainage is usually sufficient. For abscesses more than 5 cm in diameter, radiologically guided catheter drainage is recommended. Surgical drainage is needed in more complicated situations, including multiple or loculated abscesses, and for cases with inadequate response to catheter drainage and antibiotics after 7 days</li>
                <li>Drainage is rarely necessary for the treatment of amoebic liver abscess</li>
                <li>Modify therapy based on the results of culture and susceptibility testing, if available. If the results of susceptibility testing are not available by 72 hours and empirical intravenous therapy is still required</li>
                <li>The total duration of therapy is usually 4 to 6 weeks (intravenous + oral). If response to initial drainage is good, switch to directed oral therapy after 2 weeks. If results of culture and susceptibility testing are not available, a reasonable oral option is amoxicillin+clavulanate. If drainage was incomplete, 4 to 6 weeks of intravenous antibiotic therapy may be required</li>
                <li>The presentation of bacterial and amoebic liver abscess can be identical, so in all cases, take blood samples for culture and susceptibility testing (for bacterial causes) and serological testing (for E. histolytica). Ultrasound- or computed tomography (CT)–guided needle aspiration of the abscess, together with microbiological examination of the aspirate, is usually necessary for diagnosis. If radiological imaging suggests hydatid disease, needle aspiration should be delayed to avoid intraperitoneal spillage of hydatid contents—seek expert advice</li>
                <li>See the <a href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on liver abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /liver1 -->

    <!-- Start of LIVER ABSCESS, MILD PEN ALL -->
    <div data-role="page" id="liver2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical liver abscess treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient has a non-severe penicillin allergy treat with:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ceftriaxone 2 g IV, daily</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefotaxime 2 g IV, daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 750 mg intravenously, 8-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone or cefotaxime is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>liv</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>In children, liver abscesses are rare and most commonly caused by Staphylococcus aureus. Seek expert paediatric advice for management—it may be necessary to involve a multidisciplinary team, including a paediatric infectious diseases physician</li>
                <li>Drainage is the mainstay of therapy for the treatment of bacterial liver abscess. For abscesses less than 5 cm in diameter, closed-needle drainage is usually sufficient. For abscesses more than 5 cm in diameter, radiologically guided catheter drainage is recommended. Surgical drainage is needed in more complicated situations, including multiple or loculated abscesses, and for cases with inadequate response to catheter drainage and antibiotics after 7 days</li>
                <li>Drainage is rarely necessary for the treatment of amoebic liver abscess</li>
                <li>Modify therapy based on the results of culture and susceptibility testing, if available. If the results of susceptibility testing are not available by 72 hours and empirical intravenous therapy is still required</li>
                <li>The total duration of therapy is usually 4 to 6 weeks (intravenous + oral). If response to initial drainage is good, switch to directed oral therapy after 2 weeks. If drainage was incomplete, 4 to 6 weeks of intravenous antibiotic therapy may be required</li>
                <li>The presentation of bacterial and amoebic liver abscess can be identical, so in all cases, take blood samples for culture and susceptibility testing (for bacterial causes) and serological testing (for E. histolytica). Ultrasound- or computed tomography (CT)–guided needle aspiration of the abscess, together with microbiological examination of the aspirate, is usually necessary for diagnosis. If radiological imaging suggests hydatid disease, needle aspiration should be delayed to avoid intraperitoneal spillage of hydatid contents—seek expert advice</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on liver abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /liver2 -->

    <!-- Start of LIVER ABSCESS bail out page -->
    <div data-role="page" id="liverx" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Liver abscess treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h4 class="color-primary mrgn15b">If the patient has a severe penicillin allergy:</h4>
            <h4 class="color-danger mrgn15b">Treatment options are limited. Treatment options include metronidazole in combination with either gentamicin, ciprofloxacin or aztreonam. Please contact infectious diseases for advice</h4>
            <hr>
            <ul class="line30">
                <li>In children, liver abscesses are rare and most commonly caused by Staphylococcus aureus. Seek expert paediatric advice for management—it may be necessary to involve a multidisciplinary team, including a paediatric infectious diseases physician</li>
                <li>Drainage is the mainstay of therapy for the treatment of bacterial liver abscess. For abscesses less than 5 cm in diameter, closed-needle drainage is usually sufficient. For abscesses more than 5 cm in diameter, radiologically guided catheter drainage is recommended. Surgical drainage is needed in more complicated situations, including multiple or loculated abscesses, and for cases with inadequate response to catheter drainage and antibiotics after 7 days</li>
                <li>Drainage is rarely necessary for the treatment of amoebic liver abscess</li>
                <li>Modify therapy based on the results of culture and susceptibility testing, if available. If the results of susceptibility testing are not available by 72 hours and empirical intravenous therapy is still required</li>
                <li>The total duration of therapy is usually 4 to 6 weeks (intravenous + oral). If response to initial drainage is good, switch to directed oral therapy after 2 weeks. If drainage was incomplete, 4 to 6 weeks of intravenous antibiotic therapy may be required</li>
                <li>The presentation of bacterial and amoebic liver abscess can be identical, so in all cases, take blood samples for culture and susceptibility testing (for bacterial causes) and serological testing (for E. histolytica). Ultrasound- or computed tomography (CT)–guided needle aspiration of the abscess, together with microbiological examination of the aspirate, is usually necessary for diagnosis. If radiological imaging suggests hydatid disease, needle aspiration should be delayed to avoid intraperitoneal spillage of hydatid contents—seek expert advice</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on liver abscess</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /liverx -->




    









    <!--END OF LIVER ABSCESS MAZE-->


    <!--START OF POSTPARTUM ENDOMETRITIS MAZE-->

    <!-- Start of POSTPARTUM ENDOMETRITIS ?Pen allergy -->
    <div data-role="page" id="postendo" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Postpartum Endometritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">&#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#postendo1">No penicillin allergy</a></li>
                <li><a href="#postendo2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#postendo3">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /postendo -->

    <!-- Start of POSTPARTUM ENDOMETRITIS NO Pen allergy, ?severe: -->
    <div data-role="page" id="postendo1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Postpartum Endometritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the postpartum endometritis severe or non-severe?</span>
                <span class="font15">Postpartum endometritis is considered nonsevere if the infection is localised and the patient does not have fever or other systemic features. If the patient has any systemic features treat as severe.</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#postendo1a">Non-severe infection</a></li>
                <li><a href="#postendo1b">Severe infection</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /postendo1 -->

    <!-- Start of POSTPARTUM ENDOMETRITIS MILD Pen allergy, ?severe: -->
    <div data-role="page" id="postendo2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Postpartum Endometritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the postpartum endometritis severe or non-severe?</span>
                <span class="font15">Postpartum endometritis is considered nonsevere if the infection is localised and the patient does not have fever or other systemic features. If the patient has any systemic features treat as severe.</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#postendo2a">Non-severe infection</a></li>
                <li><a href="#postendo2b">Severe infection</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /postendo2 -->

    <!-- Start of POSTPARTUM ENDOMETRITIS BAD Pen allergy, ?severe: -->
    <div data-role="page" id="postendo3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Postpartum Endometritis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the postpartum endometritis severe or non-severe?</span>
                <span class="font15">Postpartum endometritis is considered nonsevere if the infection is localised and the patient does not have fever or other systemic features. If the patient has any systemic features treat as severe.</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#postendo2a">Non-severe infection</a></li>
                <li><a href="#postendo3b">Severe infection</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /postendo3 -->



    <!-- Start of POSTPARTUM ENDOMETRITIS NO Pen allergy, NOT severe -->
    <div data-role="page" id="postendo1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Postpartum Endometritis Treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For non-severe endometritis with no penicillin allergy give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg orally, 12-hourly for 7 days</span>
                </h4>
            </div>
            <hr>
            <ul class="line30">
                <li>Postpartum endometritis typically presents with fever (38°C or more), lower abdominal pain and uterine tenderness. Purulent vaginal discharge may be present.</li>
                <li>The majority of endometritis cases present within the first week after delivery, but approximately 15% of cases present between 1 and 6 weeks postpartum. Late presentations are often less severe and may present as late postpartum haemorrhage. If postpartum endometritis is suspected, refer to an obstetrician for appropriate assessment and management.</li>
                <li>Modify therapy based on the results of culture and susceptibility testing (if possible), and clinical response.</li>
                <li>Postpartum endometritis is usually a polymicrobial infection, most commonly involving ascending cervicovaginal organisms. Rarely, patients who are critically ill with sepsis or septic shock may have infection caused by Clostridium species or Streptococcus pyogenes (group A Streptococcus). Late-onset endometritis (occurring more than 7 days after delivery) suggests Chlamydia trachomatis infection.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on postpartum endometritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /postendo1a -->


    <!-- Start of POSTPARTUM ENDOMETRITIS MILD OR BAD Pen allergy, NOT severe -->
    <div data-role="page" id="postendo2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Postpartum Endometritis Treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For non-severe endometritis with a penicillin allergy give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+sulfamethoxazole 160+800 mg orally, 12-hourly for 7 days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg orally, 12-hourly for 7 days</span>
                </h4>
            </div>
            <hr>
            <ul class="line30">
                <li>Postpartum endometritis typically presents with fever (38°C or more), lower abdominal pain and uterine tenderness. Purulent vaginal discharge may be present.</li>
                <li>The majority of endometritis cases present within the first week after delivery, but approximately 15% of cases present between 1 and 6 weeks postpartum. Late presentations are often less severe and may present as late postpartum haemorrhage. If postpartum endometritis is suspected, refer to an obstetrician for appropriate assessment and management.</li>
                <li>Modify therapy based on the results of culture and susceptibility testing (if possible), and clinical response.</li>
                <li>Postpartum endometritis is usually a polymicrobial infection, most commonly involving ascending cervicovaginal organisms. Rarely, patients who are critically ill with sepsis or septic shock may have infection caused by Clostridium species or Streptococcus pyogenes (group A Streptococcus). Late-onset endometritis (occurring more than 7 days after delivery) suggests Chlamydia trachomatis infection.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on postpartum endometritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /postendo2a -->

<!-- Start of POSTPARTUM ENDOMETRITIS NO Pen allergy, SEVERE, ?Gent : -->
<div data-role="page" id="postendo1b" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
        <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Postpartum Endometritis</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">
        <h3 class="mrgn20b">
            <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
            <span class="font15"> &#40;See below&#41;</span>
        </h3>
        <ul data-role="listview" data-inset="true" class="listview">
            <li><a href="#postendo1b1">No gentamicin contraindications</a></li>
            <li><a href="#postendox">Gentamicin contraindicated</a></li>
        </ul>
        <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
        <div class="table-responsive">
            <table class="table table-bordered table-striped">
                <tr>
                    <th>Contraindications</th>
                    <th>Precautions</th>
                </tr>
                <tr>
                    <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                    <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                </tr>
                <tr>
                    <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                    <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                </tr>
                <tr>
                    <td>Myasthenia gravis</td>
                    <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                </tr>
                <tr>
                    <td></td>
                    <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                        renal function</td>
                </tr>
                <tr>
                    <td></td>
                    <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                </tr>
            </table>
        </div>
        <hr />
        <ul class="line30">
            <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                diseases</li>
        </ul>
    </div>
    <!-- /content -->
    <div class="footer">
        <a href="index.html" class="btn btn-lg btn-success"><span
                class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
</div>
<!-- /postendo1b -->

<!-- Start of POSTPARTUM ENDOMETRITIS MILD Pen allergy, SEVERE, ?Gent : -->
<div data-role="page" id="postendo2b" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
        <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Postpartum Endometritis</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">
        <h3 class="mrgn20b">
            <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
            <span class="font15"> &#40;See below&#41;</span>
        </h3>
        <ul data-role="listview" data-inset="true" class="listview">
            <li><a href="#postendo2b1">No gentamicin contraindications</a></li>
            <li><a href="#postendox">Gentamicin contraindicated</a></li>
        </ul>
        <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
        <div class="table-responsive">
            <table class="table table-bordered table-striped">
                <tr>
                    <th>Contraindications</th>
                    <th>Precautions</th>
                </tr>
                <tr>
                    <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                    <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                </tr>
                <tr>
                    <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                    <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                </tr>
                <tr>
                    <td>Myasthenia gravis</td>
                    <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                </tr>
                <tr>
                    <td></td>
                    <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                        renal function</td>
                </tr>
                <tr>
                    <td></td>
                    <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                </tr>
            </table>
        </div>
        <hr />
        <ul class="line30">
            <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                diseases</li>
        </ul>
    </div>
    <!-- /content -->
    <div class="footer">
        <a href="index.html" class="btn btn-lg btn-success"><span
                class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
</div>
<!-- /postendo2b -->

<!-- Start of POSTPARTUM ENDOMETRITIS BAD Pen allergy, SEVERE, ?Gent : -->
<div data-role="page" id="postendo3b" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
        <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Postpartum Endometritis</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">
        <h3 class="mrgn20b">
            <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
            <span class="font15"> &#40;See below&#41;</span>
        </h3>
        <ul data-role="listview" data-inset="true" class="listview">
            <li><a href="#postendo3b1">No gentamicin contraindications</a></li>
            <li><a href="#postendo3b2">Gentamicin contraindicated</a></li>
        </ul>
        <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
        <div class="table-responsive">
            <table class="table table-bordered table-striped">
                <tr>
                    <th>Contraindications</th>
                    <th>Precautions</th>
                </tr>
                <tr>
                    <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                    <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                </tr>
                <tr>
                    <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                    <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                </tr>
                <tr>
                    <td>Myasthenia gravis</td>
                    <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                </tr>
                <tr>
                    <td></td>
                    <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                        renal function</td>
                </tr>
                <tr>
                    <td></td>
                    <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                </tr>
            </table>
        </div>
        <hr />
        <ul class="line30">
            <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                diseases</li>
        </ul>
    </div>
    <!-- /content -->
    <div class="footer">
        <a href="index.html" class="btn btn-lg btn-success"><span
                class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
</div>
<!-- /postendo3b -->

<!-- Start of POSTPARTUM ENDOMETRITIS BAD Pen allergy, SEVERE, Gent OK, ?GBS sensitive : -->
<div data-role="page" id="postendo3b1" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
        <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Postpartum Endometritis</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">
        <h3 class="mrgn20b">
            <span class="color-primary">Is the patient's Group B <i>Streptococcus</i> isolate susceptible to clindamycin?</span>
        </h3>
        <ul data-role="listview" data-inset="true" class="listview">
            <li><a href="#postendo3b2">Group B <i>Streptococcus</i> status unknown</a></li>
            <li><a href="#postendo3b1a">Group B <i>Streptococcus</i> clindamycin sensitive</a></li>
            <li><a href="#postendo3b2">Group B <i>Streptococcus</i> clindamycin resistant</a></li>
        </ul>
        <hr />
        <ul class="line30">
            <li>If the patient Group B <i>Streptococcus</i> sensitivity is pending then treat as 'status unknown'</li>
        </ul>
    </div>
    <!-- /content -->
    <div class="footer">
        <a href="index.html" class="btn btn-lg btn-success"><span
                class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
</div>
<!-- /postendo3b1 -->

    <!-- Start of POSTPARTUM ENDOMETRITIS NO Pen allergy, SEVERE, GENT OK -->
    <div data-role="page" id="postendo1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Postpartum Endometritis Treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For severe endometritis with no penicillin allergy give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17"><span class="color-purple">Gentamicin given over 3-5 minutes
                            intravenously</span></span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">Septic shock or requiring intensive care support, but without
                                        known or likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Septic shock or requiring intensive care support, with known or
                                        likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Without septic shock and not requiring intensive care
                                        support:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 2 g intravenously, 6-hourly (see below for duration)</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>end</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>Modify therapy based on the results of culture and susceptibility testing (if possible), and clinical response. If results of susceptibility testing are not available by 72 hours and empirical intravenous therapy is still required, stop the gentamicin-containing regimen and seek expert advice.</li>
                <li>For uncomplicated infections, continue intravenous antibiotic therapy for at least 24 to 48 hours after the resolution of leucocytosis and clinical signs and symptoms (ie fever, uterine tenderness, purulent vaginal discharge), and then stop antibiotic therapy. Oral antibiotic therapy is not required.</li>
                <li>For complicated infection (eg abscess, bacteraemia), a longer course of intravenous therapy may be required followed by a switch to oral therapy once the patient is clinically stable (see Therapeutic Guidelines for Guidance for antimicrobial intravenous to oral switch). If the results of susceptibility testing are not available and oral continuation therapy is appropriate, use oral therapy as for nonsevere postpartum endometritis</li>
                <li>Postpartum endometritis typically presents with fever (38°C or more), lower abdominal pain and uterine tenderness. Purulent vaginal discharge may be present.</li>
                <li>The majority of endometritis cases present within the first week after delivery, but approximately 15% of cases present between 1 and 6 weeks postpartum. Late presentations are often less severe and may present as late postpartum haemorrhage. If postpartum endometritis is suspected, refer to an obstetrician for appropriate assessment and management.</li>
                <li>Postpartum endometritis is usually a polymicrobial infection, most commonly involving ascending cervicovaginal organisms. Rarely, patients who are critically ill with sepsis or septic shock may have infection caused by Clostridium species or Streptococcus pyogenes (group A Streptococcus). Late-onset endometritis (occurring more than 7 days after delivery) suggests Chlamydia trachomatis infection.</li>
            </ul>
            <hr>
        <h4 class="color-primary mrgn20b text-center">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12
            years&#41;</h4>
        <div class="table-responsive">
            <table class="table table-bordered table-striped">
                <tr>
                    <th>Creatinine clearance<br> (mL/min)</th>
                    <th>Initial<br> dose</th>
                    <th>Dosing<br> frequency</th>
                    <th>Maximum number <br>of empirical doses</th>
                </tr>

                <tr>
                    <td>More than<br> 60 mL/min</td>
                    <td>4 to 5 mg/kg</td>
                    <td>24-hourly</td>
                    <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                </tr>

                <tr>
                    <td>40 to 60 mL/min</td>
                    <td>4 to 5 mg/kg</td>
                    <td>36-hourly</td>
                    <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                </tr>

                <tr>
                    <td>less than <br>40 mL/min</td>
                    <td>4mg/kg</td>
                    <td colspan="2">Single dose, then seek expert advice</td>
                </tr>
            </table>
        </div>
        <hr />
        <ul class="line30">
            <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                calculate the dose. For morbidly obese patients, seek expert advice.</li>
            <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                dose of 7mg/kg may be appropriate</li>
            <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                    dose calculator</a></li>
        </ul>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on postpartum endometritis</a> - Antibiotic Expert Groups. Therapeutic
                guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /postendo1b1 -->

    <!-- Start of POSTPARTUM ENDOMETRITIS MILD Pen allergy, SEVERE, GENT OK -->
    <div data-role="page" id="postendo2b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Postpartum Endometritis Treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For severe endometritis with non-severe penicillin allergy give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17"><span class="color-purple">Gentamicin given over 3-5 minutes
                            intravenously</span></span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">Septic shock or requiring intensive care support, but without
                                        known or likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Septic shock or requiring intensive care support, with known or
                                        likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Without septic shock and not requiring intensive care
                                        support:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin 2 g intravenously, 8-hourly (see below for duration)</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>end</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>Modify therapy based on the results of culture and susceptibility testing (if possible), and clinical response. If results of susceptibility testing are not available by 72 hours and empirical intravenous therapy is still required, stop the gentamicin-containing regimen and seek expert advice.</li>
                <li>For uncomplicated infections, continue intravenous antibiotic therapy for at least 24 to 48 hours after the resolution of leucocytosis and clinical signs and symptoms (ie fever, uterine tenderness, purulent vaginal discharge), and then stop antibiotic therapy. Oral antibiotic therapy is not required.</li>
                <li>For complicated infection (eg abscess, bacteraemia), a longer course of intravenous therapy may be required followed by a switch to oral therapy once the patient is clinically stable (see Therapeutic Guidelines for Guidance for antimicrobial intravenous to oral switch). If the results of susceptibility testing are not available and oral continuation therapy is appropriate, use oral therapy as for nonsevere postpartum endometritis</li>
                <li>Postpartum endometritis typically presents with fever (38°C or more), lower abdominal pain and uterine tenderness. Purulent vaginal discharge may be present.</li>
                <li>The majority of endometritis cases present within the first week after delivery, but approximately 15% of cases present between 1 and 6 weeks postpartum. Late presentations are often less severe and may present as late postpartum haemorrhage. If postpartum endometritis is suspected, refer to an obstetrician for appropriate assessment and management.</li>
                <li>Postpartum endometritis is usually a polymicrobial infection, most commonly involving ascending cervicovaginal organisms. Rarely, patients who are critically ill with sepsis or septic shock may have infection caused by Clostridium species or Streptococcus pyogenes (group A Streptococcus). Late-onset endometritis (occurring more than 7 days after delivery) suggests Chlamydia trachomatis infection.</li>
            </ul>
            <hr>
        <h4 class="color-primary mrgn20b text-center">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12
            years&#41;</h4>
        <div class="table-responsive">
            <table class="table table-bordered table-striped">
                <tr>
                    <th>Creatinine clearance<br> (mL/min)</th>
                    <th>Initial<br> dose</th>
                    <th>Dosing<br> frequency</th>
                    <th>Maximum number <br>of empirical doses</th>
                </tr>

                <tr>
                    <td>More than<br> 60 mL/min</td>
                    <td>4 to 5 mg/kg</td>
                    <td>24-hourly</td>
                    <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                </tr>

                <tr>
                    <td>40 to 60 mL/min</td>
                    <td>4 to 5 mg/kg</td>
                    <td>36-hourly</td>
                    <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                </tr>

                <tr>
                    <td>less than <br>40 mL/min</td>
                    <td>4mg/kg</td>
                    <td colspan="2">Single dose, then seek expert advice</td>
                </tr>
            </table>
        </div>
        <hr />
        <ul class="line30">
            <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                calculate the dose. For morbidly obese patients, seek expert advice.</li>
            <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                dose of 7mg/kg may be appropriate</li>
            <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                    dose calculator</a></li>
        </ul>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on postpartum endometritis</a> - Antibiotic Expert Groups. Therapeutic
                guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /postendo2b1 -->

    <!-- Start of POSTPARTUM ENDOMETRITIS MILD Pen allergy, SEVERE, GENT BAD -->
    <div data-role="page" id="postendox" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Postpartum Endometritis Treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If gentamicin is contraindicated:</h3>
            <div id="backcolour">
                <h4 class="color-danger mrgn15b">Please contact infectious diseases for advice.</h4>
            </div>
            <hr>
            <ul class="line30">
                <li>Modify therapy based on the results of culture and susceptibility testing (if possible), and clinical response.</li>
                <li>For uncomplicated infections, continue intravenous antibiotic therapy for at least 24 to 48 hours after the resolution of leucocytosis and clinical signs and symptoms (ie fever, uterine tenderness, purulent vaginal discharge), and then stop antibiotic therapy. Oral antibiotic therapy is not required.</li>
                <li>For complicated infection (eg abscess, bacteraemia), a longer course of intravenous therapy may be required followed by a switch to oral therapy once the patient is clinically stable (see Therapeutic Guidelines for Guidance for antimicrobial intravenous to oral switch). If the results of susceptibility testing are not available and oral continuation therapy is appropriate, use oral therapy as for nonsevere postpartum endometritis</li>
                <li>Postpartum endometritis typically presents with fever (38°C or more), lower abdominal pain and uterine tenderness. Purulent vaginal discharge may be present.</li>
                <li>The majority of endometritis cases present within the first week after delivery, but approximately 15% of cases present between 1 and 6 weeks postpartum. Late presentations are often less severe and may present as late postpartum haemorrhage. If postpartum endometritis is suspected, refer to an obstetrician for appropriate assessment and management.</li>
                <li>Postpartum endometritis is usually a polymicrobial infection, most commonly involving ascending cervicovaginal organisms. Rarely, patients who are critically ill with sepsis or septic shock may have infection caused by Clostridium species or Streptococcus pyogenes (group A Streptococcus). Late-onset endometritis (occurring more than 7 days after delivery) suggests Chlamydia trachomatis infection.</li>
            </ul>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on postpartum endometritis</a> - Antibiotic Expert Groups. Therapeutic
                guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /postendox -->

        <!-- Start of POSTPARTUM ENDOMETRITIS BAD Pen allergy, SEVERE, GENT BAD OR GBS Resistant-->
        <div data-role="page" id="postendo3b2" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
                <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                        Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Postpartum Endometritis Treatment</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="color-primary mrgn15b">For severe endometritis with severe penicillin allergy and either resistant Group B <i>Streptococcus</i> or unable to tolerate gentamicin give:</h3>
                <div id="backcolour">
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple"> Vancomycin IV, consider a loading dose of
                            25-30 mg/Kg then as per nomogram below or use the <a href="dosecalcs.html#dose6">vancomycin
                                empiric dose calculator for adults</a></span>
                    </h4>
                    <p class="mrgn20b"><b>AND</b></p>
                    <h4 class="medicine mrgn20b">
                        <span class="color-purple">Metronidazole 500 mg intravenously, 12-hourly</span>
                    </h4>
                </div>
                <hr />
                <h4 class="mrgn20b text-center codefor">
                    <span class="color-success">Code for vancomycin is:</span>
                    <span class="font15 bold"> 3<script> document.write(getCode())</script>end</span>
                    <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only. Starting from the
                        first day of treatment for this condition. Infectious diseases must be contacted within 72 hours.
                        Please annotate this code on the medication chart and document when infectious diseases are to be
                        contacted in the patient notes.</div>
                </h4>
                <hr>
                <ul class="line30">
                    <li>Modify therapy based on the results of culture and susceptibility testing (if possible), and clinical response.</li>
                    <li>For uncomplicated infections, continue intravenous antibiotic therapy for at least 24 to 48 hours after the resolution of leucocytosis and clinical signs and symptoms (ie fever, uterine tenderness, purulent vaginal discharge), and then stop antibiotic therapy. Oral antibiotic therapy is not required.</li>
                    <li>For complicated infection (eg abscess, bacteraemia), a longer course of intravenous therapy may be required followed by a switch to oral therapy once the patient is clinically stable (see Therapeutic Guidelines for Guidance for antimicrobial intravenous to oral switch). If the results of susceptibility testing are not available and oral continuation therapy is appropriate, use oral therapy as for nonsevere postpartum endometritis</li>
                    <li>Postpartum endometritis typically presents with fever (38°C or more), lower abdominal pain and uterine tenderness. Purulent vaginal discharge may be present.</li>
                    <li>The majority of endometritis cases present within the first week after delivery, but approximately 15% of cases present between 1 and 6 weeks postpartum. Late presentations are often less severe and may present as late postpartum haemorrhage. If postpartum endometritis is suspected, refer to an obstetrician for appropriate assessment and management.</li>
                    <li>Postpartum endometritis is usually a polymicrobial infection, most commonly involving ascending cervicovaginal organisms. Rarely, patients who are critically ill with sepsis or septic shock may have infection caused by Clostridium species or Streptococcus pyogenes (group A Streptococcus). Late-onset endometritis (occurring more than 7 days after delivery) suggests Chlamydia trachomatis infection.</li>
                </ul>
                <hr>
    <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
    <div class="table-responsive">
        <table class="table table-bordered table-striped">
            <tr>
                <td>Actual body<br> weight &#40;kg&#41;</td>
                <td>CrClr <br>&lt; 20 mL/min</td>
                <td>CrClr <br>20-60 mL/min</td>
                <td>CrClr <br>&gt; 60 mL/min</td>
                <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
            </tr>
            <tr>
                <td>&lt; 40</td>
                <td>Call infectious diseases</td>
                <td>Call infectious diseases</td>
                <td>Call infectious diseases</td>
                <td class="bg-success">---</td>
            </tr>
            <tr>
                <td>40-49</td>
                <td>750 mg<br />48 hly</td>
                <td>750 mg<br />24 hly</td>
                <td>750 mg<br />12 hly</td>
                <td class="bg-success">1 hr<br />15 min</td>
            </tr>
            <tr>
                <td>50-64</td>
                <td>1000 mg<br />48 hly</td>
                <td>1000 mg<br />24 hly</td>
                <td>1000 mg<br />12 hly</td>
                <td class="bg-success">1 hr<br />40 min</td>
            </tr>
            <tr>
                <td>65-79</td>
                <td>1250 mg<br />48 hly</td>
                <td>1250 mg<br />24 hly</td>
                <td>1250 mg<br />12 hly</td>
                <td class="bg-success">2 hrs<br />5 min</td>
            </tr>
            <tr>
                <td>80-94</td>
                <td>1500 mg<br />48 hly</td>
                <td>1500 mg<br />24 hly</td>
                <td>1500 mg<br />12 hly</td>
                <td class="bg-success">2 hrs<br />30 min</td>
            </tr>
            <tr>
                <td>95-110</td>
                <td>1750 mg<br />48 hly</td>
                <td>1750 mg<br />24 hly</td>
                <td>1750 mg<br />12 hly</td>
                <td class="bg-success">3 hrs</td>
            </tr>
            <tr>
                <td>&gt; 110</td>
                <td>Call infectious diseases</td>
                <td>Call infectious diseases</td>
                <td>Call infectious diseases</td>
                <td class="bg-success">---</td>
            </tr>
            <tr>
                <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                <td class="bg-success">---</td>
            </tr>
        </table>
    </div>
    <ul class="line30">
        <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                class="color-danger bold">Red Man</span> Syndrome</li>
        <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
            considered the first dose</li>
        <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
            the next dose is given before the trough concentration is available or withheld until the result is
            known</li>
        <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
        <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
            baseline creatinine will almost always result in an increase in vancomycin concentration as
            vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
            an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
            available.</li>
        <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
            interpretation of trough levels as vancomycin will not have reached steady state</li>
    </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on postpartum endometritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html" class="btn btn-lg btn-success"><span
                        class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /postendo3b2 -->

        <!-- Start of POSTPARTUM ENDOMETRITIS BAD Pen allergy, SEVERE, GENT OK, GBS sensitive -->
    <div data-role="page" id="postendo3b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Postpartum Endometritis Treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For severe endometritis with severe penicillin allergy tolerant of gentamicin with Group B <i>Streptococcus</i> sensitive to clindamycin give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17"><span class="color-purple">Gentamicin given over 3-5 minutes
                            intravenously</span></span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">Septic shock or requiring intensive care support, but without
                                        known or likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Septic shock or requiring intensive care support, with known or
                                        likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Without septic shock and not requiring intensive care
                                        support:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg intravenously, 8-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin and clindamycin IV is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>end</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>Modify therapy based on the results of culture and susceptibility testing (if possible), and clinical response. If results of susceptibility testing are not available by 72 hours and empirical intravenous therapy is still required, stop the gentamicin-containing regimen and seek expert advice.</li>
                <li>For uncomplicated infections, continue intravenous antibiotic therapy for at least 24 to 48 hours after the resolution of leucocytosis and clinical signs and symptoms (ie fever, uterine tenderness, purulent vaginal discharge), and then stop antibiotic therapy. Oral antibiotic therapy is not required.</li>
                <li>For complicated infection (eg abscess, bacteraemia), a longer course of intravenous therapy may be required followed by a switch to oral therapy once the patient is clinically stable (see Therapeutic Guidelines for Guidance for antimicrobial intravenous to oral switch). If the results of susceptibility testing are not available and oral continuation therapy is appropriate, use oral therapy as for nonsevere postpartum endometritis</li>
                <li>Postpartum endometritis typically presents with fever (38°C or more), lower abdominal pain and uterine tenderness. Purulent vaginal discharge may be present.</li>
                <li>The majority of endometritis cases present within the first week after delivery, but approximately 15% of cases present between 1 and 6 weeks postpartum. Late presentations are often less severe and may present as late postpartum haemorrhage. If postpartum endometritis is suspected, refer to an obstetrician for appropriate assessment and management.</li>
                <li>Postpartum endometritis is usually a polymicrobial infection, most commonly involving ascending cervicovaginal organisms. Rarely, patients who are critically ill with sepsis or septic shock may have infection caused by Clostridium species or Streptococcus pyogenes (group A Streptococcus). Late-onset endometritis (occurring more than 7 days after delivery) suggests Chlamydia trachomatis infection.</li>
            </ul>
            <hr>
        <h4 class="color-primary mrgn20b text-center">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12
            years&#41;</h4>
        <div class="table-responsive">
            <table class="table table-bordered table-striped">
                <tr>
                    <th>Creatinine clearance<br> (mL/min)</th>
                    <th>Initial<br> dose</th>
                    <th>Dosing<br> frequency</th>
                    <th>Maximum number <br>of empirical doses</th>
                </tr>

                <tr>
                    <td>More than<br> 60 mL/min</td>
                    <td>4 to 5 mg/kg</td>
                    <td>24-hourly</td>
                    <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                </tr>

                <tr>
                    <td>40 to 60 mL/min</td>
                    <td>4 to 5 mg/kg</td>
                    <td>36-hourly</td>
                    <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                </tr>

                <tr>
                    <td>less than <br>40 mL/min</td>
                    <td>4mg/kg</td>
                    <td colspan="2">Single dose, then seek expert advice</td>
                </tr>
            </table>
        </div>
        <hr />
        <ul class="line30">
            <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                calculate the dose. For morbidly obese patients, seek expert advice.</li>
            <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                dose of 7mg/kg may be appropriate</li>
            <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                    dose calculator</a></li>
        </ul>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on postpartum endometritis</a> - Antibiotic Expert Groups. Therapeutic
                guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /postendo3b1a -->

    <!--POSTPARTUM ENDOMETRITIS COMPLETE-->


    <!--START OF CHORIOAMNIONITIS MAZE-->

        <!-- Start of chorioamnionitis ?Pen allergy -->
        <div data-role="page" id="chor" data-theme="a">
            <div data-role="header" class="frontpage">
                <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
                <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                        Stewardship</a></h1>
            </div>
            <!-- /header -->
            <div data-role="header" class="secondpage">
                <h1>Chorioamnionitis</h1>
            </div>
            <!-- /header -->
            <div data-role="content" class="container-fluid">
                <h3 class="mrgn20b">
                    <span class="color-primary">Does the patient have a penicillin allergy?</span>
                    <span class="font15">&#40;See below for details on penicillin allergy severity&#41;</span>
                </h3>
                <ul data-role="listview" data-inset="true" class="listview">
                    <li><a href="#chor1">No penicillin allergy</a></li>
                    <li><a href="#chor2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                    <li><a href="#chor3">Severe immediate or delayed penicillin hypersensitivity</a></li>
                </ul>
                <hr />
                <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
                <p class="bold">No penicillin allergy</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                    <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                        prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                        strategies for symptom control such as metoclopramide</li>
                </ul>
                <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes non-severe reactions such as isolated rash.</li>
                    <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                        allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                        to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                    </li>
                </ul>
                <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
                <ul class="line30">
                    <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                        such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                        reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                        patient has a history of these, contact infectious diseases for advice</li>
                </ul>
                <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
                <div id="allergycolour">
                    <div class="row">
                        <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                            involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                            swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                        <div class="col-sm-9">
                            <ul class="line30">
                                <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                    expiratory flow, hypoxemia&#41;.</li>
                                <b>OR</b>
                                <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                    malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                            </ul>
                        </div>
                    </div>
                </div>
                <p class="bold">OR </p>
                <div id="allergycolour">
                    <div class="row">
                        <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                            <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                        </div>
                        <div class="col-sm-9">
                            <ul class="line30">
                                <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                    lips-tongue-uvula&#41;.</li>
                                <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                    expiratory flow, hypoxemia&#41;.</li>
                                <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                    incontinence&#41;.</li>
                                <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                    vomiting&#41;.</li>
                            </ul>
                        </div>
                    </div>
                </div>
                <p class="bold">OR </p>
                <div id="allergycolour">
                    <div class="row">
                        <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                            with known penicillin allergy &#40;within minutes to several hours&#41;
                        </div>
                        <div class="col-sm-9">
                            <ul class="line30">
                                <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                    percent decrease from that person's baseline</li>
                                <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                    or greater than 30 percent decrease in systolic BP</li>
                                <ul class="circle">
                                    <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                    <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                    <li>Less than 90 mmHg from 11 to 17 years</li>
                                </ul>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>
            <!-- /content -->
            <div class="footer">
                <a href="index.html" class="btn btn-lg btn-success"><span
                        class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
            </div>
            <!-- /footer -->
        </div>
        <!-- /chori -->

        <!-- Start of chorio NO Pen ALLERGY, ?Sepsis -->
    <div data-role="page" id="chor1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Chorioamnionitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have severe infection or are they showing signs of severe sepsis?</span>
                <span class="font15"> &#40;See below&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="sepsisNsimilar.html#sepsis1a7">Yes</a></li>
                <li><a href="#chor1b">No</a></li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Signs of Sepsis:</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>SIRS response: &ge;2 of:</th>
                        <th>AND presence of refractory hypotension or hypoperfusion</th>
                    </tr>
                    <tr>
                        <td>
                            <p>Temp &lt;36 <b>or</b> &gt;38</p>
                            <p>Heart rate &gt; 90</p>
                            <p>Resp Rate &gt; 20</p>
                            <p>WCC &gt; 12.0 <b>or</b> &lt; 4.0</p>
                        </td>
                        <td>
                            <p align="left"><b>Hypotension:</b></p>
                            <ul type=circle>
                                <li>systolic BP&lt; 90 mmHg <b>OR</b> 40 mmHg below premorbid BP <b> AFTER</b> at least
                                    500 mL fluid challenge.</li>
                            </ul>
                            <p align="left"><b>Hypoperfusion:</b></p>
                            <ul type=circle>
                                <li>Lactate &ge;4 mmol/L <b>OR</b> Bicarbonate &lt;16mmol/L</li>
                            </ul>
                        </td>
                    </tr>
                </table>
            </div>
            <ul class="line30">
                <li>See the Therapeutic Guidelines for more advice on managing a septic patient</li>
                <li>If yes to the above contact an ID physician for review of this patient</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /chori1-->


    <!-- Start of chorio NO Pen ALLERGY, ?Sepsis -->
    <div data-role="page" id="chor2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Chorioamnionitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have severe infection or are they showing signs of severe sepsis?</span>
                <span class="font15"> &#40;See below&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="sepsisNsimilar.html#sepsis1b7">Yes</a></li>
                <li><a href="#chor2b">No</a></li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Signs of Sepsis:</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>SIRS response: &ge;2 of:</th>
                        <th>AND presence of refractory hypotension or hypoperfusion</th>
                    </tr>
                    <tr>
                        <td>
                            <p>Temp &lt;36 <b>or</b> &gt;38</p>
                            <p>Heart rate &gt; 90</p>
                            <p>Resp Rate &gt; 20</p>
                            <p>WCC &gt; 12.0 <b>or</b> &lt; 4.0</p>
                        </td>
                        <td>
                            <p align="left"><b>Hypotension:</b></p>
                            <ul type=circle>
                                <li>systolic BP&lt; 90 mmHg <b>OR</b> 40 mmHg below premorbid BP <b> AFTER</b> at least
                                    500 mL fluid challenge.</li>
                            </ul>
                            <p align="left"><b>Hypoperfusion:</b></p>
                            <ul type=circle>
                                <li>Lactate &ge;4 mmol/L <b>OR</b> Bicarbonate &lt;16mmol/L</li>
                            </ul>
                        </td>
                    </tr>
                </table>
            </div>
            <ul class="line30">
                <li>See the Therapeutic Guidelines for more advice on managing a septic patient</li>
                <li>If yes to the above contact an ID physician for review of this patient</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /chori2 -->

<!-- Start of chorio NO Pen ALLERGY, ?Sepsis -->
<div data-role="page" id="chor3" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
        <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Chorioamnionitis</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">
        <h3 class="mrgn20b">
            <span class="color-primary">Does the patient have severe infection or are they showing signs of severe sepsis?</span>
            <span class="font15"> &#40;See below&#41;</span>
        </h3>
        <ul data-role="listview" data-inset="true" class="listview">
            <li><a href="sepsisNsimilar.html#sepsis1c7">Yes</a></li>
            <li><a href="#chor3b">No</a></li>
        </ul>
        <hr>
        <h4 class="color-primary mrgn20b">Signs of Sepsis:</h4>
        <div class="table-responsive">
            <table class="table table-bordered table-striped">
                <tr>
                    <th>SIRS response: &ge;2 of:</th>
                    <th>AND presence of refractory hypotension or hypoperfusion</th>
                </tr>
                <tr>
                    <td>
                        <p>Temp &lt;36 <b>or</b> &gt;38</p>
                        <p>Heart rate &gt; 90</p>
                        <p>Resp Rate &gt; 20</p>
                        <p>WCC &gt; 12.0 <b>or</b> &lt; 4.0</p>
                    </td>
                    <td>
                        <p align="left"><b>Hypotension:</b></p>
                        <ul type=circle>
                            <li>systolic BP&lt; 90 mmHg <b>OR</b> 40 mmHg below premorbid BP <b> AFTER</b> at least
                                500 mL fluid challenge.</li>
                        </ul>
                        <p align="left"><b>Hypoperfusion:</b></p>
                        <ul type=circle>
                            <li>Lactate &ge;4 mmol/L <b>OR</b> Bicarbonate &lt;16mmol/L</li>
                        </ul>
                    </td>
                </tr>
            </table>
        </div>
        <ul class="line30">
            <li>See the Therapeutic Guidelines for more advice on managing a septic patient</li>
            <li>If yes to the above contact an ID physician for review of this patient</li>
        </ul>
    </div>
    <!-- /content -->
    <div class="footer">
        <a href="index.html" class="btn btn-lg btn-success"><span
                class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
</div>
<!-- /chori3 -->

<!-- Start of CHORIO, pen OK, gent question: -->
<div data-role="page" id="chor1b" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
        <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Chorioamnionitis</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">
        <h3 class="mrgn20b">
            <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
            <span class="font15"> &#40;See below&#41;</span>
        </h3>
        <ul data-role="listview" data-inset="true" class="listview">
            <li><a href="#chor1b1">No gentamicin contraindications</a></li>
            <li><a href="#chor1b2">Gentamicin contraindicated</a></li>
        </ul>
        <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
        <div class="table-responsive">
            <table class="table table-bordered table-striped">
                <tr>
                    <th>Contraindications</th>
                    <th>Precautions</th>
                </tr>
                <tr>
                    <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                    <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                </tr>
                <tr>
                    <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                    <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                </tr>
                <tr>
                    <td>Myasthenia gravis</td>
                    <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                </tr>
                <tr>
                    <td></td>
                    <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                        renal function</td>
                </tr>
                <tr>
                    <td></td>
                    <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                </tr>
            </table>
        </div>
        <hr />
        <ul class="line30">
            <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                diseases</li>
        </ul>
    </div>
    <!-- /content -->
    <div class="footer">
        <a href="index.html" class="btn btn-lg btn-success"><span
                class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
</div>
<!-- /chorio1b -->

<!-- Start of CHORIO, pen MILD, gent question: -->
<div data-role="page" id="chor2b" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
        <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Chorioamnionitis</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">
        <h3 class="mrgn20b">
            <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
            <span class="font15"> &#40;See below&#41;</span>
        </h3>
        <ul data-role="listview" data-inset="true" class="listview">
            <li><a href="#chor2b1">No gentamicin contraindications</a></li>
            <li><a href="#chor2b2">Gentamicin contraindicated</a></li>
        </ul>
        <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
        <div class="table-responsive">
            <table class="table table-bordered table-striped">
                <tr>
                    <th>Contraindications</th>
                    <th>Precautions</th>
                </tr>
                <tr>
                    <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                    <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                </tr>
                <tr>
                    <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                    <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                </tr>
                <tr>
                    <td>Myasthenia gravis</td>
                    <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                </tr>
                <tr>
                    <td></td>
                    <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                        renal function</td>
                </tr>
                <tr>
                    <td></td>
                    <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                </tr>
            </table>
        </div>
        <hr />
        <ul class="line30">
            <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                diseases</li>
        </ul>
    </div>
    <!-- /content -->
    <div class="footer">
        <a href="index.html" class="btn btn-lg btn-success"><span
                class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
</div>
<!-- /chorio2b -->

<!-- Start of CHORIO, pen BAD, gent question: -->
<div data-role="page" id="chor3b" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
        <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Chorioamnionitis</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">
        <h3 class="mrgn20b">
            <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
            <span class="font15"> &#40;See below&#41;</span>
        </h3>
        <ul data-role="listview" data-inset="true" class="listview">
            <li><a href="#chor3b1">No gentamicin contraindications</a></li>
            <li><a href="#chor3b2">Gentamicin contraindicated</a></li>
        </ul>
        <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
        <div class="table-responsive">
            <table class="table table-bordered table-striped">
                <tr>
                    <th>Contraindications</th>
                    <th>Precautions</th>
                </tr>
                <tr>
                    <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                    <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                </tr>
                <tr>
                    <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                    <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                </tr>
                <tr>
                    <td>Myasthenia gravis</td>
                    <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                </tr>
                <tr>
                    <td></td>
                    <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                        renal function</td>
                </tr>
                <tr>
                    <td></td>
                    <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                </tr>
            </table>
        </div>
        <hr />
        <ul class="line30">
            <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                diseases</li>
        </ul>
    </div>
    <!-- /content -->
    <div class="footer">
        <a href="index.html" class="btn btn-lg btn-success"><span
                class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
</div>
<!-- /chorio3b -->

<!-- Start of chorioamnionitis, pen OK, Gent BAD-->
<div data-role="page" id="chor1b2" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
        <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Chorioamnionitis treatment</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">
        <h3 class="mrgn20b">
            <span class="color-primary">For chorioamnionitis treatment with no penicillin allergy but with gentamicin contraindications:</span>
        </h3>
        <div id="backcolour">
            <h4 class="color-danger mrgn15b">Please contact infectious diseases for advice. Possible treatments may
                include:</h4>
            <h4 class="medicine mrgn20b">
                <span class="font17">&#9312;</span><span class="color-purple"> Ceftriaxone 1 g IV, daily</span>
            </h4>
            <p class="mrgn20b"><b>AND</b></p>
            <h4 class="medicine mrgn20b">
                &nbsp;&nbsp;<span class="color-purple"> Amoxicillin 2 g IV, 6-hourly</span>
            </h4>
            <p class="mrgn20b"><b>OR</b> &#40;as a single agent&#41;</p>
            <h4 class="medicine mrgn20b">
                <span class="font17">&#9312;</span><span class="color-purple"> Piperacillin+tazobactam 4+0.5 g IV,
                    8-hourly until clinical condition improves</span>
            </h4>
            <p class="mrgn20b"><b>OR</b> &#40;as a single agent&#41;</p>
            <h4 class="medicine mrgn20b">
                <span class="font17">&#9312;</span><span class="color-purple"> Amoxicillin + clavulanate
                    intravenously</span>
                <br><br>
                <div class="table-responsive">
                    <table class="table-blank">
                        <tr>
                            <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                            <td><span class="color-purple">1 + 0.2 g 8-hourly, </span></td>
                        </tr>
                    </table>
                </div>
            </h4>
        </div>
        <hr />
        <h4 class="mrgn20b text-center codefor">
            <span class="color-success">Code for Amoxicillin IV & clavulanate, piperacillin+tazobactam or
                ceftriaxone is:</span>
            <span class="font15 bold"> 3<script> document.write(getCode())</script>chr</span>
            <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only. Starting from the
                first day of treatment for this condition. Infectious diseases must be contacted within 72 hours.
                Please annotate this code on the medication chart and document when infectious diseases are to be
                contacted in the patient notes.</div>
        </h4>
        <hr />
        <ul class="line30">
            <li>Women with intra-amniotic infections often present with nonspecific signs of infection. Suspect intra-amniotic infection in a pregnant woman with any of the following features:
                <ul>
                    <li>fever (38°C or more) and ruptured membranes</li>
                    <li>fever during labour (intrapartum fever), even if membranes are intact</li>
                    <li>uterine tenderness</li>
                    <li>purulent amniotic fluid</li>
                </ul>
            </li>
            <li>If intra-amniotic infection is suspected, early consultation with an obstetrician is required for appropriate assessment and management</li>
            <li>Patients undergoing caesarean section require surgical prophylaxis (see <a href="SurgProNmiscInfections.html#surgpro">here</a> for regimens). If the intra-amniotic infection treatment regimen has an appropriate spectrum of activity for prophylaxis, additional surgical prophylaxis is not required. However, adjust the timing of the dose to achieve adequate plasma and tissue concentrations at the time of surgical incision and for the duration of the procedure</li>
            <li>If the results of culture and susceptibility testing are not available by 72 hours and empirical therapy is still required seek specialist advice</li>
            <li>Neonates born to mothers with intra-amniotic infection are at increased risk of early-onset sepsis. Following birth, closely observe neonates born to mothers with intrapartum fever (ie 38°C or more during labour), or suspected or confirmed intra-amniotic infection</li>
        </ul>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on sepsis</a> - Antibiotic Expert Groups. Therapeutic guidelines:
                antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
    </div>
    <!-- /content -->

    <div class="footer">
        <a href="index.html" class="btn btn-lg btn-success"><span
                class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
</div>
<!-- /chori1b2-->


<!-- Start of chorioamnionitis, pen OK, Gent OK-->
<div data-role="page" id="chor1b1" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
        <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Chorioamnionitis treatment</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">
        <h3 class="mrgn20b">
            <span class="color-primary">For chorioamnionitis treatment with no penicillin allergy or gentamicin contraindications:</span>
        </h3>
        <div id="backcolour">
            <h4 class="medicine mrgn20b">
                <span class="font17"><span class="color-purple">Gentamicin given over 3-5 minutes
                        intravenously</span></span>
                <br><br>
                <div class="table-responsive">
                    <table class="table-blank">
                        <tr>
                            <td><span class="font17">Septic shock or requiring intensive care support, but without
                                    known or likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                            <td><span class="color-purple">7 mg/kg for the first dose, then use the nomogram below
                                    for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                        empiric dose calculator</a></span><br><br></td>
                        </tr>
                        <tr>
                            <td><span class="font17">Septic shock or requiring intensive care support, with known or
                                    likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                            <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                    for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                        empiric dose calculator</a></span><br><br></td>
                        </tr>
                        <tr>
                            <td><span class="font17">Without septic shock and not requiring intensive care
                                    support:&nbsp;&nbsp;</span></td>
                            <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                    for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                        empiric dose calculator</a></span><br><br></td>
                        </tr>
                    </table>
                </div>
            </h4>
            <p class="mrgn20b"><b>AND</b></p>
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Amoxicillin 2 g IV, 6-hourly</span>
            </h4>
        </div>
        <hr />
        <h4 class="mrgn20b text-center codefor">
            <span class="color-success">Code for gentamicin is:</span>
            <span class="font15 bold"> 2<script> document.write(getCode())</script>chr</span>
            <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only. Starting from the
                first day of treatment for this condition. Infectious diseases must be contacted within 48 hours.
                Please annotate this code on the medication chart and document when infectious diseases are to be
                contacted in the patient notes.</div>
        </h4>
        <hr />
        <ul class="line30">
            <li>Women with intra-amniotic infections often present with nonspecific signs of infection. Suspect intra-amniotic infection in a pregnant woman with any of the following features:
                <ul>
                    <li>fever (38°C or more) and ruptured membranes</li>
                    <li>fever during labour (intrapartum fever), even if membranes are intact</li>
                    <li>uterine tenderness</li>
                    <li>purulent amniotic fluid</li>
                </ul>
            </li>
            <li>If intra-amniotic infection is suspected, early consultation with an obstetrician is required for appropriate assessment and management</li>
            <li>Patients undergoing caesarean section require surgical prophylaxis (see <a href="SurgProNmiscInfections.html#surgpro">here</a> for regimens). If the intra-amniotic infection treatment regimen has an appropriate spectrum of activity for prophylaxis, additional surgical prophylaxis is not required. However, adjust the timing of the dose to achieve adequate plasma and tissue concentrations at the time of surgical incision and for the duration of the procedure</li>
            <li>If the results of culture and susceptibility testing are not available by 72 hours and empirical therapy is still required seek specialist advice</li>
            <li>Neonates born to mothers with intra-amniotic infection are at increased risk of early-onset sepsis. Following birth, closely observe neonates born to mothers with intrapartum fever (ie 38°C or more during labour), or suspected or confirmed intra-amniotic infection</li>
        </ul>
        <hr>
        <h4 class="color-primary mrgn20b text-center">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12
            years&#41;</h4>
        <div class="table-responsive">
            <table class="table table-bordered table-striped">
                <tr>
                    <th>Creatinine clearance<br> (mL/min)</th>
                    <th>Initial<br> dose</th>
                    <th>Dosing<br> frequency</th>
                    <th>Maximum number <br>of empirical doses</th>
                </tr>

                <tr>
                    <td>More than<br> 60 mL/min</td>
                    <td>4 to 5 mg/kg</td>
                    <td>24-hourly</td>
                    <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                </tr>

                <tr>
                    <td>40 to 60 mL/min</td>
                    <td>4 to 5 mg/kg</td>
                    <td>36-hourly</td>
                    <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                </tr>

                <tr>
                    <td>less than <br>40 mL/min</td>
                    <td>4mg/kg</td>
                    <td colspan="2">Single dose, then seek expert advice</td>
                </tr>
            </table>
        </div>
        <hr />
        <ul class="line30">
            <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                calculate the dose. For morbidly obese patients, seek expert advice.</li>
            <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                dose of 7mg/kg may be appropriate</li>
            <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                    dose calculator</a></li>
        </ul>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on chorioamnionitis</a> - Antibiotic Expert Groups. Therapeutic guidelines:
                antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
    </div>
    <!-- /content -->

    <div class="footer">
        <a href="index.html" class="btn btn-lg btn-success"><span
                class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
</div>
<!-- /chori1b1-->


<!-- Start of chorioamnionitis, pen MILD, Gent BAD-->
<div data-role="page" id="chor2b2" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
        <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Sepsis treatment</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">
        <h3 class="mrgn20b">
            <span class="color-primary">For chorioamnionitis with non-severe penicillin allergy and gentamicin contraindications give:</span>
        </h3>
        <div id="backcolour">
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Ceftriaxone 1 g IV, daily</span>
            </h4>
            <p class="mrgn20b"><b>AND</b></p>
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Metronidazole 500 mg IV, 12-hourly</span>
            </h4>
        </div>
        <hr />
        <h4 class="mrgn20b text-center codefor">
            <span class="color-success">Code for ceftriaxone is:</span>
            <span class="font15 bold"> 3<script> document.write(getCode())</script>chr</span>
            <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only. Starting from the
                first day of treatment for this condition. Infectious diseases must be contacted within 72 hours.
                Please annotate this code on the medication chart and document when infectious diseases are to be
                contacted in the patient notes.</div>
        </h4>
        <hr />
        <ul class="line30">
            <li>Women with intra-amniotic infections often present with nonspecific signs of infection. Suspect intra-amniotic infection in a pregnant woman with any of the following features:
                <ul>
                    <li>fever (38°C or more) and ruptured membranes</li>
                    <li>fever during labour (intrapartum fever), even if membranes are intact</li>
                    <li>uterine tenderness</li>
                    <li>purulent amniotic fluid</li>
                </ul>
            </li>
            <li>If intra-amniotic infection is suspected, early consultation with an obstetrician is required for appropriate assessment and management</li>
            <li>Patients undergoing caesarean section require surgical prophylaxis (see <a href="SurgProNmiscInfections.html#surgpro">here</a> for regimens). If the intra-amniotic infection treatment regimen has an appropriate spectrum of activity for prophylaxis, additional surgical prophylaxis is not required. However, adjust the timing of the dose to achieve adequate plasma and tissue concentrations at the time of surgical incision and for the duration of the procedure</li>
            <li>If the results of culture and susceptibility testing are not available by 72 hours and empirical therapy is still required seek specialist advice</li>
            <li>Neonates born to mothers with intra-amniotic infection are at increased risk of early-onset sepsis. Following birth, closely observe neonates born to mothers with intrapartum fever (ie 38°C or more during labour), or suspected or confirmed intra-amniotic infection</li>
        </ul>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on chorioamnionitis</a> - Antibiotic Expert Groups. Therapeutic guidelines:
                antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
    </div>
    <!-- /content -->

    <div class="footer">
        <a href="index.html" class="btn btn-lg btn-success"><span
                class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
</div>
<!-- /chori2b2-->

<!-- Start of chorio pen MILD, Gent OK -->
<div data-role="page" id="chor2b1" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
        <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Chorioamnionitis treatment</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">
        <h3 class="mrgn20b">
            <span class="color-primary">For chorioamnionitis with non-severe immediate or
                delayed penicillin hypersensitivity give:</span>
        </h3>
        <div id="backcolour">
            <h4 class="medicine mrgn20b">
                <span class="font17"><span class="color-purple">Gentamicin given over 3-5 minutes
                        intravenously</span></span>
                <br><br>
                <div class="table-responsive">
                    <table class="table-blank">
                        <tr>
                            <td><span class="font17">Septic shock or requiring intensive care support, but without
                                    known or likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                            <td><span class="color-purple">7 mg/kg for the first dose, then use the nomogram below
                                    for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                        empiric dose calculator</a></span><br><br></td>
                        </tr>
                        <tr>
                            <td><span class="font17">Septic shock or requiring intensive care support, with known or
                                    likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                            <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                    for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                        empiric dose calculator</a></span><br><br></td>
                        </tr>
                        <tr>
                            <td><span class="font17">Without septic shock and not requiring intensive care
                                    support:&nbsp;&nbsp;</span></td>
                            <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                    for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                        empiric dose calculator</a></span><br><br></td>
                        </tr>
                    </table>
                </div>
            </h4>
            <p class="mrgn20b"><b>AND</b></p>
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Cefazolin 2 g IV, 8-hourly</span>
            </h4>
            <p class="mrgn20b"><b>AND</b></p>
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Metronidazole 500 mg IV, 12-hourly</span>
            </h4>
        </div>
        <hr />
        <h4 class="mrgn20b text-center codefor">
            <span class="color-success">Code for gentamicin is:</span>
            <span class="font15 bold"> 2<script> document.write(getCode())</script>chr</span>
            <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only. Starting from the
                first day of treatment for this condition. Infectious diseases must be contacted within 48 hours.
                Please annotate this code on the medication chart and document when infectious diseases are to be
                contacted in the patient notes.</div>
        </h4>
        <hr />
        <ul class="line30">
            <li>Women with intra-amniotic infections often present with nonspecific signs of infection. Suspect intra-amniotic infection in a pregnant woman with any of the following features:
                <ul>
                    <li>fever (38°C or more) and ruptured membranes</li>
                    <li>fever during labour (intrapartum fever), even if membranes are intact</li>
                    <li>uterine tenderness</li>
                    <li>purulent amniotic fluid</li>
                </ul>
            </li>
            <li>If intra-amniotic infection is suspected, early consultation with an obstetrician is required for appropriate assessment and management</li>
            <li>Patients undergoing caesarean section require surgical prophylaxis (see <a href="SurgProNmiscInfections.html#surgpro">here</a> for regimens). If the intra-amniotic infection treatment regimen has an appropriate spectrum of activity for prophylaxis, additional surgical prophylaxis is not required. However, adjust the timing of the dose to achieve adequate plasma and tissue concentrations at the time of surgical incision and for the duration of the procedure</li>
            <li>If the results of culture and susceptibility testing are not available by 72 hours and empirical therapy is still required seek specialist advice</li>
            <li>Neonates born to mothers with intra-amniotic infection are at increased risk of early-onset sepsis. Following birth, closely observe neonates born to mothers with intrapartum fever (ie 38°C or more during labour), or suspected or confirmed intra-amniotic infection</li>
        </ul>
        <hr>
        <h4 class="color-primary mrgn20b text-center">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12
            years&#41;</h4>
        <div class="table-responsive">
            <table class="table table-bordered table-striped">
                <tr>
                    <th>Creatinine clearance<br> (mL/min)</th>
                    <th>Initial<br> dose</th>
                    <th>Dosing<br> frequency</th>
                    <th>Maximum number <br>of empirical doses</th>
                </tr>

                <tr>
                    <td>More than<br> 60 mL/min</td>
                    <td>4 to 5 mg/kg</td>
                    <td>24-hourly</td>
                    <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                </tr>

                <tr>
                    <td>40 to 60 mL/min</td>
                    <td>4 to 5 mg/kg</td>
                    <td>36-hourly</td>
                    <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                </tr>

                <tr>
                    <td>less than <br>40 mL/min</td>
                    <td>4mg/kg</td>
                    <td colspan="2">Single dose, then seek expert advice</td>
                </tr>
            </table>
        </div>
        <hr />
        <ul class="line30">
            <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                calculate the dose. For morbidly obese patients, seek expert advice.</li>
            <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                dose of 7mg/kg may be appropriate</li>
            <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                    dose calculator</a></li>
        </ul>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on chorioamnionitis</a> - Antibiotic Expert Groups. Therapeutic guidelines:
                antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
    </div>
    <!-- /content -->

    <div class="footer">
        <a href="index.html" class="btn btn-lg btn-success"><span
                class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
</div>
<!-- /chori2b1-->

<!-- Start of chorio pen BAD, Gent OK, Chorio: #sepsis1c7b-->
<div data-role="page" id="chor3b1" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
        <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Chorioamnionitis treatment</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">
        <h3 class="mrgn20b">
            <span class="color-primary">For chorioamnionitis with severe immediate or delayed
                penicillin hypersensitivity give:</span>
        </h3>
        <div id="backcolour">
            <h4 class="medicine mrgn20b">
                <span class="font17"><span class="color-purple">Gentamicin given over 3-5 minutes
                        intravenously</span></span>
                <br><br>
                <div class="table-responsive">
                    <table class="table-blank">
                        <tr>
                            <td><span class="font17">Septic shock or requiring intensive care support, but without
                                    known or likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                            <td><span class="color-purple">7 mg/kg for the first dose, then use the nomogram below
                                    for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                        empiric dose calculator</a></span><br><br></td>
                        </tr>
                        <tr>
                            <td><span class="font17">Septic shock or requiring intensive care support, with known or
                                    likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                            <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                    for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                        empiric dose calculator</a></span><br><br></td>
                        </tr>
                        <tr>
                            <td><span class="font17">Without septic shock and not requiring intensive care
                                    support:&nbsp;&nbsp;</span></td>
                            <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                    for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                        empiric dose calculator</a></span><br><br></td>
                        </tr>
                    </table>
                </div>
            </h4>
            <p class="mrgn20b"><b>AND</b> if the Group B <i>Streptococcus</i> isolate is sensitive to clindamycin
                <b>ADD</b> to the gentamicin above:</p>
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Clindamycin 600 mg IV, 8-hourly</span>
            </h4>
            <p class="mrgn20b"><b>OR</b> if the Group B Streptococcus isolate is resistant to clindamycin, or the
                sensitivity is unknown, in place of clindamycin <b>ADD</b> both:</p>
            <h4 class="medicine mrgn20b">
                <span class="font17">&#9312;</span><span class="color-purple"> Vancomycin IV, consider a loading dose of
                    25-30 mg/Kg then as per nomogram below or use the <a href="dosecalcs.html#dose6">vancomycin
                        empiric dose calculator for adults</a></span>
            </h4>
            <p class="mrgn20b"><b>AND</b></p>
            <h4 class="medicine mrgn20b">
                <span class="font17">&#9313;</span><span class="color-purple"> Metronidazole 500 mg IV,
                    12-hourly</span>
            </h4>
        </div>
        <hr />
        <h4 class="mrgn20b text-center codefor">
            <span class="color-success">Code for clindamycin, vancomycin and gentamicin is:</span>
            <span class="font15 bold"> 2<script> document.write(getCode())</script>chr</span>
            <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only. Starting from the
                first day of treatment for this condition. Infectious diseases must be contacted within 48 hours.
                Please annotate this code on the medication chart and document when infectious diseases are to be
                contacted in the patient notes.</div>
        </h4>
        <hr />
        <ul class="line30">
            <li>Women with intra-amniotic infections often present with nonspecific signs of infection. Suspect intra-amniotic infection in a pregnant woman with any of the following features:
                <ul>
                    <li>fever (38°C or more) and ruptured membranes</li>
                    <li>fever during labour (intrapartum fever), even if membranes are intact</li>
                    <li>uterine tenderness</li>
                    <li>purulent amniotic fluid</li>
                </ul>
            </li>
            <li>If intra-amniotic infection is suspected, early consultation with an obstetrician is required for appropriate assessment and management</li>
            <li>Patients undergoing caesarean section require surgical prophylaxis (see <a href="SurgProNmiscInfections.html#surgpro">here</a> for regimens). If the intra-amniotic infection treatment regimen has an appropriate spectrum of activity for prophylaxis, additional surgical prophylaxis is not required. However, adjust the timing of the dose to achieve adequate plasma and tissue concentrations at the time of surgical incision and for the duration of the procedure</li>
            <li>If the results of culture and susceptibility testing are not available by 72 hours and empirical therapy is still required seek specialist advice</li>
            <li>Neonates born to mothers with intra-amniotic infection are at increased risk of early-onset sepsis. Following birth, closely observe neonates born to mothers with intrapartum fever (ie 38°C or more during labour), or suspected or confirmed intra-amniotic infection</li>
        </ul>
        <hr>
        <h4 class="color-primary mrgn20b">Vancomycin Dosing in Adults</h4>
        <div class="table-responsive">
            <table class="table table-bordered table-striped">
                <tr>
                    <td>Actual body<br> weight &#40;kg&#41;</td>
                    <td>CrClr <br>&lt; 20 mL/min</td>
                    <td>CrClr <br>20-60 mL/min</td>
                    <td>CrClr <br>&gt; 60 mL/min</td>
                    <td class="bg-success">Administer<br> over<sup>(1)</sup></td>
                </tr>
                <tr>
                    <td>&lt; 40</td>
                    <td>Call infectious diseases</td>
                    <td>Call infectious diseases</td>
                    <td>Call infectious diseases</td>
                    <td class="bg-success">---</td>
                </tr>
                <tr>
                    <td>40-49</td>
                    <td>750 mg<br />48 hly</td>
                    <td>750 mg<br />24 hly</td>
                    <td>750 mg<br />12 hly</td>
                    <td class="bg-success">1 hr<br />15 min</td>
                </tr>
                <tr>
                    <td>50-64</td>
                    <td>1000 mg<br />48 hly</td>
                    <td>1000 mg<br />24 hly</td>
                    <td>1000 mg<br />12 hly</td>
                    <td class="bg-success">1 hr<br />40 min</td>
                </tr>
                <tr>
                    <td>65-79</td>
                    <td>1250 mg<br />48 hly</td>
                    <td>1250 mg<br />24 hly</td>
                    <td>1250 mg<br />12 hly</td>
                    <td class="bg-success">2 hrs<br />5 min</td>
                </tr>
                <tr>
                    <td>80-94</td>
                    <td>1500 mg<br />48 hly</td>
                    <td>1500 mg<br />24 hly</td>
                    <td>1500 mg<br />12 hly</td>
                    <td class="bg-success">2 hrs<br />30 min</td>
                </tr>
                <tr>
                    <td>95-110</td>
                    <td>1750 mg<br />48 hly</td>
                    <td>1750 mg<br />24 hly</td>
                    <td>1750 mg<br />12 hly</td>
                    <td class="bg-success">3 hrs</td>
                </tr>
                <tr>
                    <td>&gt; 110</td>
                    <td>Call infectious diseases</td>
                    <td>Call infectious diseases</td>
                    <td>Call infectious diseases</td>
                    <td class="bg-success">---</td>
                </tr>
                <tr>
                    <td class="bg-success">Timing of 1<sup>st</sup><br> trough level<sup>(2)</sup></td>
                    <td class="bg-success">48 hrs after <br>the 1<sup>st</sup> dose<sup>(3)</sup></td>
                    <td class="bg-success">Before the<br> 3<sup>rd</sup> dose</td>
                    <td class="bg-success">Before the <br />4<sup>th</sup> dose</td>
                    <td class="bg-success">---</td>
                </tr>
            </table>
        </div>
        <ul class="line30">
            <li>Vancomycin should be administered at a maximum rate of 10 mg/min to avoid <span
                    class="color-danger bold">Red Man</span> Syndrome</li>
            <li>"Trough" levels are taken within 60 minutes of the next dose. If a loading dose is given then it is
                considered the first dose</li>
            <li>In patients with CrClr &lt; 20 mL/min, the clinical context (e.g haemodialysis) determines whether
                the next dose is given before the trough concentration is available or withheld until the result is
                known</li>
            <li>Please contact infectious diseases within 48 hours of initiating therapy with vancomycin</li>
            <li>Watch baseline creatinine closely while treating a patient with vancomycin. An increase from
                baseline creatinine will almost always result in an increase in vancomycin concentration as
                vancomycin is 40-100% renally cleared. A sudden dramatic increase in creatinine should always prompt
                an immediate vancomycin level prior to the next dose, witholding the next dose until the level is
                available.</li>
            <li>If a dose is missed or delayed within 48 hours of taking a level please contact pharmacy for
                interpretation of trough levels as vancomycin will not have reached steady state</li>
        </ul>
        <hr>
        <h4 class="color-primary mrgn20b text-center">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12
            years&#41;</h4>
        <div class="table-responsive">
            <table class="table table-bordered table-striped">
                <tr>
                    <th>Creatinine clearance<br> (mL/min)</th>
                    <th>Initial<br> dose</th>
                    <th>Dosing<br> frequency</th>
                    <th>Maximum number <br>of empirical doses</th>
                </tr>

                <tr>
                    <td>More than<br> 60 mL/min</td>
                    <td>4 to 5 mg/kg</td>
                    <td>24-hourly</td>
                    <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                </tr>

                <tr>
                    <td>40 to 60 mL/min</td>
                    <td>4 to 5 mg/kg</td>
                    <td>36-hourly</td>
                    <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                </tr>

                <tr>
                    <td>less than <br>40 mL/min</td>
                    <td>4mg/kg</td>
                    <td colspan="2">Single dose, then seek expert advice</td>
                </tr>
            </table>
        </div>
        <hr />
        <ul class="line30">
            <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                calculate the dose. For morbidly obese patients, seek expert advice.</li>
            <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                dose of 7mg/kg may be appropriate</li>
            <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                    dose calculator</a></li>
        </ul>
        <hr />
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on chorioamnionitis</a> - Antibiotic Expert Groups. Therapeutic guidelines:
                antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
    </div>
    <!-- /content -->

    <div class="footer">
        <a href="index.html" class="btn btn-lg btn-success"><span
                class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
</div>
<!-- /chor3b1-->

<!-- Start of chorio, bad pen, bad gent -->
<div data-role="page" id="chor3b2" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
        <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Chorioamnionitis treatment</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">
        <h3 class="mrgn20b">
            <span class="color-primary">If gentamicin is contraindicated:</span>
        </h3>
        <div id="backcolour">
            <h4 class="color-danger mrgn15b">Please contact infectious diseases for advice.</h4>
        </div>
        <hr />
        <ul class="line30">
            <li>Women with intra-amniotic infections often present with nonspecific signs of infection. Suspect intra-amniotic infection in a pregnant woman with any of the following features:
                <ul>
                    <li>fever (38°C or more) and ruptured membranes</li>
                    <li>fever during labour (intrapartum fever), even if membranes are intact</li>
                    <li>uterine tenderness</li>
                    <li>purulent amniotic fluid</li>
                </ul>
            </li>
            <li>If intra-amniotic infection is suspected, early consultation with an obstetrician is required for appropriate assessment and management</li>
            <li>Patients undergoing caesarean section require surgical prophylaxis (see <a href="SurgProNmiscInfections.html#surgpro">here</a> for regimens). If the intra-amniotic infection treatment regimen has an appropriate spectrum of activity for prophylaxis, additional surgical prophylaxis is not required. However, adjust the timing of the dose to achieve adequate plasma and tissue concentrations at the time of surgical incision and for the duration of the procedure</li>
            <li>If the results of culture and susceptibility testing are not available by 72 hours and empirical therapy is still required seek specialist advice</li>
            <li>Neonates born to mothers with intra-amniotic infection are at increased risk of early-onset sepsis. Following birth, closely observe neonates born to mothers with intrapartum fever (ie 38°C or more during labour), or suspected or confirmed intra-amniotic infection</li>
        </ul>
    </div>
    <!-- /content -->
    <div class="footer">
        <a href="index.html" class="btn btn-lg btn-success"><span
                class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
</div>
<!-- /chor3b2 -->

    <!-- CHORIOAMNIONITIS COMPLETE-->

    <!-- START of GASTROENTERITIS treatment maze -->

    <!-- Start of gastro. Long stayer, ?severe disease: #gastro1 -->
    <div data-role="page" id="gastro1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis and Colitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have features of severe disease? &#40;See below&#41;</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#gastro1a">Yes</a></li>
                <li><a href="#gastro1b">No</a></li>
            </ul>
        </div>
        <hr />
        <ul class="line30">
            <li>Features indicative of severe gastroenteritis may include:</li>
            <ul class="circle">
                <li>High fever</li>
                <li>Tachycardia</li>
                <li>Leukocytosis</li>
                <li>Abdominal tenderness</li>
                <li>Severe abdominal pain</li>
                <li>High volume diarrhoea with hypovolaemia</li>
                <li>Bloody stools</li>
            </ul>
        </ul>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /gastro -->

    <!-- Start of gastro. non severe disease, ?immunocompromised: #gastro1b -->
    <div data-role="page" id="gastro1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis and Colitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient immunocompromised?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#gastro1b1">Yes</a></li>
                <li><a href="#gastro1b2">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /gastro1b -->
    <!-- Start of gastro1. non severe disease, immunocompromised, ?orals OK: #gastro1b -->
    <div data-role="page" id="gastro1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis and Colitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Can the patient tolerate oral antibiotics? &#40;See below&#41;</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#gastro1b1a">Yes</a></li>
                <li><a href="#gastro1b1b">No</a></li>
            </ul>
            <hr>
            <ul class="line30">
                <li>Oral antibiotics are the preferred route of administration for bacterial enteritis due to superior
                    local action within the GI tract versus intravenous therapy</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /gastro1b1 -->
    <!-- Start of gastro. non severe disease, not immunocompromised, ?At risk group: #gastro1b2 -->
    <div data-role="page" id="gastro1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis and Colitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Low risk gastroenteritis:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <h4 class="color-danger mrgn15b">Antimicrobial treatment for gastroenteritis is unlikely to be
                        required</h4>
                    <br>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>Send stool for microscopy, culture and sensitivities in all patients who have features of severe
                    disease &#40;such as high fever, tachycardia, leucocytosis, abdominal tenderness or severe abdominal
                    pain, high-volume diarrhoea with hypovolaemia, blood in the stool&#41;.</li>
                <li>In immunocompromised patients, in addition to sending stool for routine pathogens, request
                    microscopy for ova, cysts and parasites, and consider testing for cytomegalovirus</li>
                <li>In returned travellers from high risk areas, request testing for Salmonella Typhi and Paratyphi and
                    discuss treatment with infectious diseases</li>
                <li>In patients with recent hospitalisation or antibiotic use, request testing for Clostridium difficile
                    and consider empiric treatment for C. difficile</li>
                <li>In infants, bacterial enteritis is treated more aggressively with antibiotics due to the greater
                    risk of developing severe sepsis. Seek expert advice for all infant enteritis cases.</li>
                <li>If the results of microbiological testing are available before the symptoms of diarrhoea have
                    resolved, adjust therapy accordingly.</li>
                <li>The principal aim of treatment of acute infectious diarrhoea is to achieve and maintain adequate
                    hydration. All patients with gastroenteritis should have their hydration status assessed and
                    appropriate fluid resuscitation given</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /gastro1b2 -->

    <!-- Start of gastro1. Severe Disease, long stayer ?Child: #gastro1a -->
    <div data-role="page" id="gastro1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis and Colitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Is the patient an adult or child?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#gastro1a2">Adult</a></li>
                <li><a href="#gastro1a1">Child</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /gastro1a -->

    <!-- Start of gastro1. Severe Disease, long stayer, Child ?entorohaemorragic E.coli risk factors: #gastro1a1 -->
    <div data-role="page" id="gastro1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis and Colitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Does the patient have risk factors for enterohaemorrhagic <i>E.coli</i>?
                &#40;See below&#41;</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#gastro1a1a">Yes, bloody stool without fever</a></li>
                <li><a href="#gastro1a1b">No</a></li>
            </ul>
            <hr>
            <ul class="line30">
                <li>Antibiotic therapy is not recommended in children with bloody diarrhoea without fever, due to the
                    potential for precipitating haemolytic uraemic syndrome if the infection is caused by
                    enterohaemorrhagic Escherichia coli.</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /gastro1a1 -->
    <!-- Start of gastro1. Severe Disease, long stayer, Child, NO entorohaemorragic E.coli risk factors: #gastro1a1b -->
    <div data-role="page" id="gastro1a1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis and Colitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Can the patient tolerate oral antibiotics? &#40;See below&#41;</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#gastro1a1b1">Yes</a></li>
                <li><a href="#gastro1a1b2">No</a></li>
            </ul>
            <hr>
            <ul class="line30">
                <li>Oral antibiotics are the preferred route of administration for bacterial enteritis due to superior
                    local action within the GI tract versus intravenous therapy</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /gastro1a1b -->
    <!-- Start of gastro1. Severe Disease, ADULT: #gastro1a2 -->
    <div data-role="page" id="gastro1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis and Colitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Can the patient tolerate oral antibiotics? &#40;See below&#41;</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#gastro1a2a">Yes</a></li>
                <li><a href="#gastro1a2b">No</a></li>
            </ul>
            <hr>
            <ul class="line30">
                <li>Oral antibiotics are the preferred route of administration for bacterial enteritis due to superior
                    local action within the GI tract versus intravenous therapy</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /gastro1a2 -->
    <!-- Start of gastro1. Severe Disease, long stayer, Child, NO entorohaemorragic E.coli risk factors, NO orals: #gastro1a1b2 -->
    <div data-role="page" id="gastro1a1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis and Colitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Has the patient had a life-threatening reaction or anaphylaxis to a
                    penicillin antibiotic or do they have a cephalosporin allergy?</span>
                <span class="font15"> &#40;See below&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#gastro1b1b1">no allergy, or immediate non-severe or delayed non-severe penicillin
                        hypersensitivity and no cephalosporin allergy</a></li>
                <li><a href="#gastrox">Life-Threatening reaction or anaphylaxis to penicillin or cephalosporin
                        allergy</a></li>
            </ul>
            <hr />
            <h4 class="color-primary">Diagnostic Criteria for Penicillin Allergy:</h4>
            <ul class="line30">
                <li>Non-life threatening reactions such as minor rash, skin irritation, nausea, diarrhoea or vomiting
                    should not usually be considered life threatening and may not be an allergic reaction at all</li>
                <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin.
                    In most cases it is safe to administer a cephalosporin to a patient who has had a non-life
                    threatening reaction to penicillin</li>
                <li>Life-threatening reactions include SJS, DRESS, TENS or any reaction that led to respiratory
                    compromise</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="backcolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="backcolour2">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="backcolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /gastro1a1b -->
    <!-- Start of gastro1. Severe Disease, ADULT, NO orals: #gastro1a2b -->
    <div data-role="page" id="gastro1a2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis and Colitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Has the patient had a life-threatening reaction or anaphylaxis to a
                    penicillin antibiotic or do they have a cephalosporin allergy?</span>
                <span class="font15"> &#40;See below&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#gastro1a2b1">no allergy, or immediate non-severe or delayed non-severe penicillin
                        hypersensitivity and no cephalosporin allergy</a></li>
                <li><a href="#gastrox">Life-Threatening reaction or anaphylaxis to penicillin or cephalosporin
                        allergy</a></li>
            </ul>
            <hr />
            <h4 class="color-primary">Diagnostic Criteria for Penicillin Allergy:</h4>
            <ul class="line30">
                <li>Non-life threatening reactions such as minor rash, skin irritation, nausea, diarrhoea or vomiting
                    should not usually be considered life threatening and may not be an allergic reaction at all</li>
                <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin.
                    In most cases it is safe to administer a cephalosporin to a patient who has had a non-life
                    threatening reaction to penicillin</li>
                <li>Life-threatening reactions include SJS, DRESS, TENS or any reaction that led to respiratory
                    compromise</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="backcolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="backcolour2">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="backcolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /gastro1a2b -->

    <!-- Start of gastro1. non-Severe Disease, immunocompromised, NO orals: #gastro1b1b -->
    <div data-role="page" id="gastro1b1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis and Colitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Has the patient had a life-threatening reaction or anaphylaxis to a
                    penicillin antibiotic or do they have a cephalosporin allergy?</span>
                <span class="font15"> &#40;See below&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#gastro1b1b1">no allergy, or immediate non-severe or delayed non-severe penicillin
                        hypersensitivity and no cephalosporin allergy</a></li>
                <li><a href="#gastrox">Life-Threatening reaction or anaphylaxis to penicillin or cephalosporin
                        allergy</a></li>
            </ul>
            <hr />
            <h4 class="color-primary">Diagnostic Criteria for Penicillin Allergy:</h4>
            <ul class="line30">
                <li>Non-life threatening reactions such as minor rash, skin irritation, nausea, diarrhoea or vomiting
                    should not usually be considered life threatening and may not be an allergic reaction at all</li>
                <li>There is only a 2.5% chance of cephalosporin allergy in a patient previously allergic to penicillin.
                    In most cases it is safe to administer a cephalosporin to a patient who has had a non-life
                    threatening reaction to penicillin</li>
                <li>Life-threatening reactions include SJS, DRESS, TENS or any reaction that led to respiratory
                    compromise</li>
            </ul>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="backcolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="backcolour2">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="backcolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /gastro1b1b -->

    <!-- Start of gastro1. Severe Disease, long stayer, Child, NO entorohaemorragic E.coli risk factors, ORAL OK: #gastro1a1b1 -->
    <div data-role="page" id="gastro1a1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient can tolerate oral therapy give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Azithromycin 10mg/kg &#40;up to 500mg&#41;, daily for 3 days</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for azithromycin orally is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>gas</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>In infants, bacterial enteritis is treated more aggressively with antibiotics due to the greater
                    risk of developing severe sepsis. Seek expert advice for all infant enteritis cases.</li>
                <li>If the results of microbiological testing are available before the symptoms of diarrhoea have
                    resolved, adjust therapy accordingly.</li>
                <li>The principal aim of treatment of acute infectious diarrhoea is to achieve and maintain adequate
                    hydration. All patients with gastroenteritis should have their hydration status assessed so that
                    appropriate rehydration can be given</li>
                <li>The usually self-limiting nature of acute infectious diarrhoea means that there is rarely a need for
                    microbiological testing or antimicrobial therapy.</li>
                <li>Faecal microbiological testing, when performed, rarely provides results during the acute stages of
                    gastroenteritis. Perform testing in all patients who have features of severe disease &#40;such as
                    high fever, tachycardia, leucocytosis, abdominal tenderness or severe abdominal pain, high-volume
                    diarrhoea with hypovolaemia, blood in the stool&#41;.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on gastroenteritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /gastro1a1b1 -->


    <!-- Start of gastro1. Severe Disease, ADULT, ORAL NOT OK, PEN/CEF OK: #gastro1a2b1 -->
    <div data-role="page" id="gastro1a2b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient cannot tolerate oral therapy give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2g IV, daily for 3 days</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>gas</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>Send stool for microscopy, culture and sensitivities in all patients who have features of severe
                    disease &#40;such as high fever, tachycardia, leucocytosis, abdominal tenderness or severe abdominal
                    pain, high-volume diarrhoea with hypovolaemia, blood in the stool&#41;.</li>
                <li>In immunocompromised patients, in addition to sending stool for routine pathogens, request
                    microscopy for ova, cysts and parasites, and consider testing for cytomegalovirus</li>
                <li>In returned travellers from high risk areas, request testing for Salmonella Typhi and Paratyphi and
                    discuss treatment with infectious diseases</li>
                <li>In patients with recent hospitalisation or antibiotic use, request testing for Clostridium difficile
                    and consider empiric treatment for C. difficile</li>
                <li>In infants, bacterial enteritis is treated more aggressively with antibiotics due to the greater
                    risk of developing severe sepsis. Seek expert advice for all infant enteritis cases.</li>
                <li>If the results of microbiological testing are available before the symptoms of diarrhoea have
                    resolved, adjust therapy accordingly.</li>
                <li>The principal aim of treatment of acute infectious diarrhoea is to achieve and maintain adequate
                    hydration. All patients with gastroenteritis should have their hydration status assessed and
                    appropriate fluid resuscitation given</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on gastroenteritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /gastro1a2b1 -->

    <!-- Start of gastro1. Severe Disease, ADULT, ORAL OK: #gastro1a2a -->
    <div data-role="page" id="gastro1a2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient can tolerate oral therapy give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 500mg orally, 12-hourly for 3 days</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Norfloxacin 400mg orally, 12-hourly for 3 days</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> if the infection was likely to be acquired in a region where quinolone
                    resistance is common &#40;eg South or Southeast Asia&#41;</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Azithromycin 500mg orally, daily for 3 days</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ciprofloxacin orally, norfloxacin or azithromycin orally is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>gas</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>Send stool for microscopy, culture and sensitivities in all patients who have features of severe
                    disease &#40;such as high fever, tachycardia, leucocytosis, abdominal tenderness or severe abdominal
                    pain, high-volume diarrhoea with hypovolaemia, blood in the stool&#41;.</li>
                <li>In immunocompromised patients, in addition to sending stool for routine pathogens, request
                    microscopy for ova, cysts and parasites, and consider testing for cytomegalovirus</li>
                <li>In returned travellers from high risk areas, request testing for Salmonella Typhi and Paratyphi and
                    discuss treatment with infectious diseases</li>
                <li>In patients with recent hospitalisation or antibiotic use, request testing for Clostridium difficile
                    and consider empiric treatment for C. difficile</li>
                <li>In infants, bacterial enteritis is treated more aggressively with antibiotics due to the greater
                    risk of developing severe sepsis. Seek expert advice for all infant enteritis cases.</li>
                <li>If the results of microbiological testing are available before the symptoms of diarrhoea have
                    resolved, adjust therapy accordingly.</li>
                <li>The principal aim of treatment of acute infectious diarrhoea is to achieve and maintain adequate
                    hydration. All patients with gastroenteritis should have their hydration status assessed and
                    appropriate fluid resuscitation given</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on gastroenteritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /gastro1a2a -->

    <!-- Start of gastro1. non-severe Disease, immunocompromised ADULT OR CHILD, ORAL OK: #gastro1b1a -->
    <div data-role="page" id="gastro1b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient can tolerate oral therapy and bacterial infection is
                suspected consider giving:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ciprofloxacin 500mg orally, 12-hourly for 3 days
                        &#40;see below if treating a child&#41;</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Norfloxacin 400mg orally, 12-hourly for 3 days &#40;see below if treating
                        a child&#41;</span>
                </h4>
                <p class="mrgn20b"><b>OR,</b> if patient is a child, or the infection was likely to be acquired in a
                    region where quinolone resistance is common &#40;eg South or Southeast Asia&#41;</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Azithromycin 500mg &#40;child: 10mg/kg&#41; orally, daily for 3
                        days</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ciprofloxacin orally, norfloxacin or azithromycin orally is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>gas</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>Send stool for microscopy, culture and sensitivities in all patients who have features of severe
                    disease &#40;such as high fever, tachycardia, leucocytosis, abdominal tenderness or severe abdominal
                    pain, high-volume diarrhoea with hypovolaemia, blood in the stool&#41;.</li>
                <li>In immunocompromised patients, in addition to sending stool for routine pathogens, request
                    microscopy for ova, cysts and parasites, and consider testing for cytomegalovirus</li>
                <li>In returned travellers from high risk areas, request testing for Salmonella Typhi and Paratyphi and
                    discuss treatment with infectious diseases</li>
                <li>In patients with recent hospitalisation or antibiotic use, request testing for Clostridium difficile
                    and consider empiric treatment for C. difficile</li>
                <li>In infants, bacterial enteritis is treated more aggressively with antibiotics due to the greater
                    risk of developing severe sepsis. Seek expert advice for all infant enteritis cases.</li>
                <li>If the results of microbiological testing are available before the symptoms of diarrhoea have
                    resolved, adjust therapy accordingly.</li>
                <li>The principal aim of treatment of acute infectious diarrhoea is to achieve and maintain adequate
                    hydration. All patients with gastroenteritis should have their hydration status assessed and
                    appropriate fluid resuscitation given</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on gastroenteritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /gastro1b1a -->

    <!-- Start of gastro1. non-Severe Disease, immunocompromised, ORAL NOT OK, CEPH'S OK: #gastro1b1b1 -->
    <div data-role="page" id="gastro1b1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient cannot tolerate oral therapy give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <b>ADULT or CHILD &gt;2 months old: </b><span class="color-purple">Ceftriaxone 2g &#40;child 50mg/kg
                        up to 2g&#41;, IV daily for 3 days</span>
                </h4>
                <br>
                <h4 class="medicine mrgn20b">
                    <b>CHILD &lt;2 months old: </b><span class="color-purple">Cefotaxime 50mg/kg, IV 8-hourly for 3
                        days</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone or cefotaxime is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>gas</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>Send stool for microscopy, culture and sensitivities in all patients who have features of severe
                    disease &#40;such as high fever, tachycardia, leucocytosis, abdominal tenderness or severe abdominal
                    pain, high-volume diarrhoea with hypovolaemia, blood in the stool&#41;.</li>
                <li>In immunocompromised patients, in addition to sending stool for routine pathogens, request
                    microscopy for ova, cysts and parasites, and consider testing for cytomegalovirus</li>
                <li>In returned travellers from high risk areas, request testing for Salmonella Typhi and Paratyphi and
                    discuss treatment with infectious diseases</li>
                <li>In patients with recent hospitalisation or antibiotic use, request testing for Clostridium difficile
                    and consider empiric treatment for C. difficile</li>
                <li>In infants, bacterial enteritis is treated more aggressively with antibiotics due to the greater
                    risk of developing severe sepsis. Seek expert advice for all infant enteritis cases.</li>
                <li>If the results of microbiological testing are available before the symptoms of diarrhoea have
                    resolved, adjust therapy accordingly.</li>
                <li>The principal aim of treatment of acute infectious diarrhoea is to achieve and maintain adequate
                    hydration. All patients with gastroenteritis should have their hydration status assessed and
                    appropriate fluid resuscitation given</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on gastroenteritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /gastro1b1b1 -->

    <!-- Start of gastrox. Any gastroenteritis where oral route is compromised and they have penicillin anaphylaxis: #gastrox -->
    <div data-role="page" id="gastrox" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient has a history of penicillin anaphylaxis and cannot tolerate
                oral medications:</h3>
            <hr>
            <div id="backcolour">
                <h4 class="color-danger mrgn15b">Please contact infectious diseases for advice</h4>
            </div>
            <hr>
            <ul class="line30">
                <li>Send stool for microscopy, culture and sensitivities in all patients who have features of severe
                    disease &#40;such as high fever, tachycardia, leucocytosis, abdominal tenderness or severe abdominal
                    pain, high-volume diarrhoea with hypovolaemia, blood in the stool&#41;.</li>
                <li>In immunocompromised patients, in addition to sending stool for routine pathogens, request
                    microscopy for ova, cysts and parasites, and consider testing for cytomegalovirus</li>
                <li>In returned travellers from high risk areas, request testing for Salmonella Typhi and Paratyphi and
                    discuss treatment with infectious diseases</li>
                <li>In patients with recent hospitalisation or antibiotic use, request testing for Clostridium difficile
                    and consider empiric treatment for C. difficile</li>
                <li>In infants, bacterial enteritis is treated more aggressively with antibiotics due to the greater
                    risk of developing severe sepsis. Seek expert advice for all infant enteritis cases.</li>
                <li>If the results of microbiological testing are available before the symptoms of diarrhoea have
                    resolved, adjust therapy accordingly.</li>
                <li>The principal aim of treatment of acute infectious diarrhoea is to achieve and maintain adequate
                    hydration. All patients with gastroenteritis should have their hydration status assessed and
                    appropriate fluid resuscitation given</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on gastroenteritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /gastrox -->

    <!-- Start of gastro1. Severe Disease, long stayer, Child WITH entorohaemorragic E.coli risk factors: #gastro1a1a -->
    <div data-role="page" id="gastro1a1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Gastroenteritis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient has risk factors for enterohaemorrhagic E.coli then
                antibiotic therapy is not recommended:</h3>
            <hr>
            <div id="backcolour">
                <h4 class="color-danger mrgn15b">Please contact infectious diseases for advice</h4>
            </div>
            <hr>
            <ul class="line30">
                <li>In infants, bacterial enteritis is treated more aggressively with antibiotics due to the greater
                    risk of developing severe sepsis. Seek expert advice for all infant enteritis cases.</li>
                <li>If the results of microbiological testing are available before the symptoms of diarrhoea have
                    resolved, adjust therapy accordingly.</li>
                <li>The principal aim of treatment of acute infectious diarrhoea is to achieve and maintain adequate
                    hydration. All patients with gastroenteritis should have their hydration status assessed so that
                    appropriate rehydration can be given</li>
                <li>The usually self-limiting nature of acute infectious diarrhoea means that there is rarely a need for
                    microbiological testing or antimicrobial therapy.</li>
                <li>Faecal microbiological testing, when performed, rarely provides results during the acute stages of
                    gastroenteritis. Perform testing in all patients who have features of severe disease &#40;such as
                    high fever, tachycardia, leucocytosis, abdominal tenderness or severe abdominal pain, high-volume
                    diarrhoea with hypovolaemia, blood in the stool&#41;.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on gastroenteritis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1a1a -->


    <!-- START of INTRA ABDOMINAL treatment maze -->
    <!-- Start of intrab. ?Type: #intrab -->
    <div data-role="page" id="intrab" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Intra-abdominal infection</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">What type of infection is suspected/confirmed?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab1">Appendicitis</a></li>
                <li><a href="#intrab2">Cholecystitis</a></li>
                <li><a href="#intrab3">Diverticulitis</a></li>
                <li><a href="#intrab4">Pancreatitis</a></li>
                <li><a href="#intrab5">Peritonitis</a></li>
                <li><a href="#intrab6">Ascending cholangitis</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1 -->

    <!-- Start of intrab1. ?penicillin: #intrab1-->
    <div data-role="page" id="intrab1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Appendicitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab1c">No penicillin allergy</a></li>
                <li><a href="#intrab1a">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#intrab1b">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->

        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab -->

    <!-- Start of intrab. Pen MILD, Appendix ? surgery: #intrab1a -->
    <div data-role="page" id="intrab1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Appendicitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has an appendicectomy been performed?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab1a1">Yes</a></li>
                <li><a href="#intrab1a2">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1a -->

    <!-- Start of intrab. Pen MILD, Appendix surg YES: #intrab1a1 -->
    <div data-role="page" id="intrab1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Appendicitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Was the appendix ruptured or was there an appendiceal abscess?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab1a1a">Yes</a></li>
                <li><a href="#intrab1a1b">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1a1 -->

    <!-- Start of intrab. Pen MILD, Appendix, surgery NO: #intrab1a2 -->
    <div data-role="page" id="intrab1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical appendicitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient has a mild penicillin allergy cover with:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g &#40;child 1 month or older: 50 mg/kg up to 2 g&#41; IV,
                        daily until surgery</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child: 12.5 mg/kg up to 500 mg&#41; IV,
                        12-hourly until surgery</span>
                </h4>
            </div>
            <hr />
            <p class="mrgn20b"><b>Then,</b> after surgery is performed, if a perforation or abscess was uncovered,
                consider step down to oral after initial improvement:</p>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+Sulfamethoxazole 160+800 mg &#40;child 1 month or older:
                        4+20 mg/kg up to 160+800 mg&#41; orally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; orally,
                        12-hourly</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>int</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Following successful surgery IV therapy can be rapidly switched to oral therapy if patient is
                    improving</li>
                <li>If the appendix was not perforated then antibiotic therapy can be discontinued immediately post
                    appendicectomy</li>
                <li>For patients with a perforated appendix or an appendiceal abscess, the total duration of therapy is
                    5 days (intravenous + oral) after adequate surgical control of the source of infection has been
                    achieved</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on appendicitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1a -->

    <!-- Start of intrab. Pen MILD, Appendix, surgery YES, Rupture YES: #intrab1a1a-->
    <div data-role="page" id="intrab1a1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Appendicitis treatment post surgery</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient has a mild penicillin allergy and the appendix was ruptured
                or an appendiceal abscess was uncovered treat with:</h3>
            <hr>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g &#40;child 1 month or older: 50 mg/kg up to 2 g&#41; IV,
                        daily until patients clinical condition improves</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child: 12.5 mg/kg up to 500 mg&#41; IV,
                        12-hourly until patients clinical condition improves</span>
                </h4>
            </div>
            <hr>
            <p class="mrgn20b"><b>Then,</b> after clinical condition improves, step down to oral:</p>
            <div id="backcolour">

                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+Sulfamethoxazole 160+800 mg &#40;child 1 month or older:
                        4+20 mg/kg up to 160+800 mg&#41; orally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; orally,
                        12-hourly</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>int</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Following successful surgery IV therapy can be rapidly switched to oral therapy if patient is
                    improving. Please see the switch to oral criteria in the Therapeutic Guidelines &#40;below&#41;</li>
                <li>For patients with a perforated appendix or an appendiceal abscess, the total duration of therapy is
                    5 days (intravenous + oral) after adequate surgical control of the source of infection has been
                    achieved</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on appendicitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1a1a -->
    <!-- Start of intrab. Pen MILD, Appendix, surgery YES, Rupture NO: #intrab1a1a-->
    <div data-role="page" id="intrab1a1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Appendicitis treatment post surgery</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the appendix was not perforated and no appendiceal abscess was
                uncovered:</h3>
            <h4 class="medicine mrgn20b">
                <span class="color-purple">No further antibiotic therapy should be necessary</span>

            </h4>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on appendicitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1a1a -->

    <!-- PEN BAD -->
    <!-- Start of intrab. Pen BAD, Appendix ? surgery: #intrab1b -->
    <div data-role="page" id="intrab1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Appendicitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has an appendicectomy been performed?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab1b1">Yes</a></li>
                <li><a href="#intrab1b2">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1b -->

    <!-- Start of intrab. Pen BAD, Appendix surg YES: #intrab1b1 -->
    <div data-role="page" id="intrab1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Appendicitis</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Was the appendix ruptured or was there an appendiceal abscess?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab1b1a">Yes</a></li>
                <li><a href="#intrab1a1b">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1b1 -->

    <!-- Start of intrab. Pen BAD, Appendix surg YES ?GENT: #intrab1b1a -->
    <div data-role="page" id="intrab1b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Appendicitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15">&#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab1b1a2">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab1b2a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1b1a -->

    <!-- Start of intrab. Pen BAD, Appendix surg YES ?GENT: #intrab1b1a -->
    <div data-role="page" id="intrab1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Appendicitis</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15">&#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab1b2b">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab1b2a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1b2 -->

    <!-- Start of intrab. Pen BAD, Appendix, surgery NO, Gent OK: #intrab1b2b -->
    <div data-role="page" id="intrab1b2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical appendicitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient has a severe penicillin allergy cover with:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg &#40;child: 15 mg/kg up to 600 mg&#41; IV, 8-hourly
                        until surgery</span>
                </h4>
            </div>
            <hr />
            <div id="backcolour">
                <p class="mrgn20b"><b>Then,</b> after surgery is performed, if perforation or abscess was uncovered then
                    consider a step down to oral after initial improvement:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+Sulfamethoxazole 160+800 mg &#40;child 1 month or older:
                        4+20 mg/kg up to 160+800 mg&#41; orally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; orally,
                        12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for clindamycin and gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>int</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Following successful surgery IV therapy can be rapidly switched to oral therapy if patient is
                    improving</li>
                <li>If the appendix was not perforated then antibiotic therapy can be discontinued immediately post
                    appendicectomy</li>
                <li>If the appendix was perforated or an appendiceal abscess was uncovered then a total treatment
                    duration &#40;IV and oral&#41; of 5 days is suggested</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>

                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on appendicitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1b -->


    <!-- Start of intrab. Pen BAD, Appendix, surgery YES, Rupture YES, GENT OK: #intrab1b1a-->
    <div data-role="page" id="intrab1b1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Appendicitis treatment post surgery</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient has a severe penicillin allergy and the appendix was
                ruptured or had an appendiceal abscess treat with:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg &#40;child: 15 mg/kg up to 600 mg&#41; IV, 8-hourly
                        until patients clinical condition improves</span>
                </h4>
            </div>
            <hr />
            <p class="mrgn20b"><b>Then,</b> after clinical condition improves, step down to oral:</p>
            <div id="backcolour">
                <br>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+Sulfamethoxazole 160+800 mg &#40;child 1 month or older:
                        4+20 mg/kg up to 160+800 mg&#41; orally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; orally,
                        12-hourly</span>
                </h4>
                <br>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for clindamycin and gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>int</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Please note clindamycin has excellent oral bioavailability (90% orally bioavailable), consider an
                    early switch to oral therapy once patients clinical condition has improved</li>
                <li>Following successful surgery IV therapy can be rapidly switched to oral therapy if patient is
                    improving. Please see the switch to oral criteria in the Therapeutic Guidelines &#40;below&#41;</li>
                <li>If the appendix was perforated or an appendiceal abscess was uncovered then a total treatment
                    duration &#40;IV and oral&#41; of 5 days is suggested</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on appendicitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1b1a2 -->

    <!-- Start of intrab. Pen BAD, Appendix, surgery YES, Rupture NO: #intrab1b2a-->
    <div data-role="page" id="intrab1b2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Appendicitis treatment post surgery</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient has a contraindication to gentamicin and a severe
                penicillin allergy:</h3>
            <h4 class="color-danger mrgn15b">Please contact infectious diseases for advice</h4>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on appendicitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1b2a -->

    <!-- Intrab Pen OK treatment ->
    <!- Start of intrab. Pen OK, Appendix ? surgery: #intrab1c -->
    <div data-role="page" id="intrab1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Appendicitis</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has an appendicectomy been performed?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab1c1">Yes</a></li>
                <li><a href="#intrab1c2">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1c -->

    <!-- Start of intrab. Pen OK, Appendix surg YES: #intrab1c1 -->
    <div data-role="page" id="intrab1c1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Appendicitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Was the appendix ruptured or was there an appendiceal abscess?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab1c1a">Yes</a></li>
                <li><a href="#intrab1a1b">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1c1 -->

    <!-- Start of intrab. Pen OK, Appendix surg YES ?GENT: #intrab1c1a -->
    <div data-role="page" id="intrab1c1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Appendicitis</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15">&#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab1c1a2">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab1c1a1">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1c1a -->

    <!-- Start of intrab. Pen OK, Appendix surg YES ?GENT: #intrab1c2 -->
    <div data-role="page" id="intrab1c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Appendicitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15">&#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab1c2b">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab1c2a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1c2 -->

    <!-- Start of intrab. Pen OK, Appendix, surgery NO, Gent OK: #intrab1c2b -->
    <div data-role="page" id="intrab1c2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical appendicitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient tolerates penicillin cover with:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 2 g &#40;child: 50 mg/kg up to 2 g&#41; IV, 6-hourly until
                        surgery</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child: 12.5 mg/kg up to 500 mg&#41; IV,
                        12-hourly until surgery</span>
                </h4>
            </div>
            <hr />
            <p class="mrgn20b"><b>Then,</b> after surgery is performed, if perforation or abscess was uncovered then
                consider step down to oral after initial improvement:</p>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg &#40;child: 22.5+3.2 mg/kg up to
                        875+125 mg&#41; orally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>int</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Following successful surgery IV therapy can be rapidly switched to oral therapy if patient is
                    improving</li>
                <li>If the appendix was not perforated then antibiotic therapy can be discontinued immediately post
                    appendicectomy</li>
                <li>If the appendix was perforated or an appendiceal abscess was uncovered then a total treatment
                    duration &#40;IV and oral&#41; of 5 days is suggested</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on appendicitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1c -->

    <!-- Start of intrab. Pen OK, Appendix, surgery YES, Rupture YES, GENT BAD: #intrab1c1a-->
    <div data-role="page" id="intrab1c1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Appendicitis treatment post surgery</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient tolerates penicillin but not gentamicin and the appendix
                was ruptured or had an appendiceal abscess treat with:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple"> Amoxicillin + clavulanate intravenously</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">1 + 0.2 g 8-hourly, If the patient has an appendiceal
                                        abscess, use a dose of 1+0.2 g 6-hourly</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and less than 4kg: &nbsp;</span>
                                </td>
                                <td><span class="color-purple"> 25 + 5 mg/kg 12-hourly,</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and 4kg or more, or 3 months or
                                        older: &nbsp;</span></td>
                                <td><span class="color-purple"> 25 + 5 mg/kg (up to 1 + 0.2g) 8-hourly</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <hr />
                <p class="mrgn20b"><b>Then,</b> after clinical condition improves, step down to oral:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg orally, 12-hourly&#40;child: 22.5+3.2
                        mg/kg up to 875+125 mg&#41; orally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for Amoxicillin IV and Clavulanate is:</span>
                <span class="font15 bold"> 5<script> document.write(getCode())</script>int</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Following successful surgery IV therapy can be rapidly switched to oral therapy if patient is
                    improving. Please see the switch to oral criteria in the Therapeutic Guidelines &#40;below&#41;</li>
                <li>If the appendix was perforated or an appendiceal abscess was uncovered then a total treatment
                    duration &#40;IV and oral&#41; of 5 days is suggested</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on appendicitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1c1a1 -->

    <!-- Start of intrab. Pen OK, Appendix, surgery NO: #intrab1c2a -->
    <div data-role="page" id="intrab1c2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical appendicitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient tolerates penicillin but not gentamicin cover with:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple"> Amoxicillin + clavulanate intravenously</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">1 + 0.2 g 8-hourly, If the patient has an appendiceal
                                        abscess, use a dose of 1+0.2 g 6-hourly</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and less than 4kg: &nbsp;</span>
                                </td>
                                <td><span class="color-purple"> 25 + 5 mg/kg 12-hourly,</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and 4kg or more, or 3 months or
                                        older: &nbsp;</span></td>
                                <td><span class="color-purple"> 25 + 5 mg/kg (up to 1 + 0.2g) 8-hourly</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <hr />
                <p class="mrgn20b"><b>Then,</b> after surgery is performed, if perforation or abscess was uncovered then
                    consider step down to oral after initial improvement:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg &#40;child: 22.5+3.2 mg/kg up to
                        875+125 mg&#41; orally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for Amoxicillin IV & Clavulanate is:</span>
                <span class="font15 bold"> 5<script> document.write(getCode())</script>int</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>FIVE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Following successful surgery IV therapy can be rapidly switched to oral therapy if patient is
                    improving</li>
                <li>If the appendix was not perforated then antibiotic therapy can be discontinued immediately post
                    appendicectomy</li>
                <li>If the appendix was perforated or an appendiceal abscess was uncovered then a total treatment
                    duration &#40;IV and oral&#41; of 5 days is suggested</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on appendicitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1c2a -->

    <!-- Start of intrab. Pen OK, Appendix, surgery YES, Gent OK: #intrab1c1a2 -->
    <div data-role="page" id="intrab1c1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical appendicitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">If the patient tolerates penicillin and gentamicin give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 2 g &#40;child: 50 mg/kg up to 2 g&#41; IV, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child: 12.5 mg/kg up to 500 mg&#41; IV,
                        12-hourly until clinical condition improves</span>
                </h4>
            </div>
            <hr />
            <div id="backcolour">
                <p class="mrgn20b"><b>Then,</b> after clinical condition improves switch to oral:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg &#40;child: 22.5+3.2 mg/kg up to
                        875+125 mg&#41; orally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>int</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Following successful surgery IV therapy can be rapidly switched to oral therapy if patient is
                    improving. Please see the switch to oral criteria in the Therapeutic Guidelines &#40;below&#41;</li>
                <li>If the appendix was perforated or an appendiceal abscess was uncovered then a total treatment
                    duration &#40;IV and oral&#41; of 5 days is suggested</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b text-center">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12
                years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on appendicitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab1c1a2 -->










    <!--Start of cholecystitis-->
    <!-- Start of intrab. Pen MILD, CALCULOUS CHOLECYSTITIS?: #intrab2 -->
    <div data-role="page" id="intrab2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cholecystitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Are you treating calculous or acalculous cholecystitis?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2b1">Acalculous cholecystitis</a></li>
                <li><a href="#intrab2a1">Calculous cholecystitis</a></li>
            </ul>
        </div>
        <hr />
        <ul class="line30">
            <li>Acute acalculous cholecystitis is an uncommon variant of cholecystitis and accounts for about 10% of
                cases. Acalculous cholecystitis presents without gall stones and is usually associated with a thickened
                or emphysematous gallbladder wall. It is more likely to occur in patients who are critically ill,
                immunocompromised or those with diabetes.</li>
            <li>Calculous cholecystitis is typically caused by <i>Enterobacteriaceae</i> &#41;eg Escherichia coli and
                Klebsiella species&#41; and, less commonly, <i>Enterococcus faecalis</i>. Infrequently, infection is
                caused by anaerobic bacteria</li>
        </ul>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2 -->





    <!--Start of CALCULOUS CHOLECYSTITIS-->

    <!-- Start of intrab2a1. ?penicillin: #intrab2a1-->
    <div data-role="page" id="intrab2a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Calculous Cholecystitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2a1c">No penicillin allergy</a></li>
                <li><a href="#intrab2a1a">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#intrab2a1b">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2a1 -->

    <!-- Start of intrab. Pen MILD, cholecystectomy ? surgery: #intrab2a1a -->
    <div data-role="page" id="intrab2a1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Calculous Cholecystitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Has a cholecystectomy been performed?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2a1a1">Yes</a></li>
                <li><a href="#intrab2a1a2a">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2a1a -->

    <!-- Start of intrab. Pen MILD, cholecystectomy, surgery NO, Gent NO: #intrab2a1a2a -->
    <div data-role="page" id="intrab2a1a2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical calculous cholecystitis treatment intolerant of gentamicin or penicillin</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient has a mild penicillin allergy or does not tolerate gentamicin
                    treat empirically with:</span>
            </h3>
            <hr>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g &#40;child 1 month or older: 50 mg/kg up to 2 g&#41; IV,
                        daily until surgery or until clinical improvement then switch to oral</span>
                </h4>
            </div>
            <p class="mrgn20b">Once the patient's condition has improved, change to:</p>
            <hr>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+sulfamethoxazole 160+800 mg &#40;child 1 month or older:
                        4+20 mg/kg up to 160+800 mg&#41; orally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold">2<script> document.write(getCode())</script>inb</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Antibiotic therapy should be ceased after uncomplicated cholecystectomy as the source of the
                    infection has been removed</li>
                <li>If surgery is not performed the total treatment duration should not normally exceed 7 days &#40;IV +
                    oral&#41;.</li>
                <li>Metronidazole is not recommended for acute cholecystitis, and is only recommended in cases of
                    ascending cholangitis with biliary obstruction present</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
                <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and
                    Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by
                    anaerobic bacteria.</li>
                <li>Please see the switch to oral criteria in the Therapeutic Guidelines &#40;below&#41;</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2a1a2a -->

    <!-- Start of intrab. Pen MILD, cholecystectomy, surgery YES: #intrab2a1a1-->
    <div data-role="page" id="intrab2a1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Calculous cholecystitis treatment post surgery</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Treatment post cholecystectomy should normally be ceased within 24 hours. If
                    a further dose of surgical prophylaxis is deemed necessary give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g &#40;child 1 month or older: 50 mg/kg up to 2 g&#41; IV,
                        as a single dose</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 1<script> document.write(getCode())</script>ina</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>ONE</b> day only. Starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 24 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>If surgery is complicated in some way then please contact infectious diseases for approval of a
                    longer course of IV antibiotics</li>
                <li>If surgery is not performed the total treatment duration should not normally exceed 7 days &#40;IV +
                    oral&#41;.</li>
                <li>Metronidazole is not recommended for acute cholecystitis, and is only recommended in cases of
                    ascending cholangitis with biliary obstruction present</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
                <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and
                    Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by
                    anaerobic bacteria.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2a1a1a -->

    <!-- PEN BAD -->
    <!-- Start of intrab. Pen BAD, cholecystectomy ? surgery: #intrab2a1b -->
    <div data-role="page" id="intrab2a1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Calculous Cholecystitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Has a cholecystectomy been performed?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2a1b1">Yes</a></li>
                <li><a href="#intrab2a1b2">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2a1b -->

    <!-- Start of intrab. Pen BAD, cholecystectomy surg YES ?GENT: #intrab2a1b1 -->
    <div data-role="page" id="intrab2a1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cholecystitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2a1b1b">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab2a1b2a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2a1b1 -->

    <!-- Start of intrab. Pen BAD, cholecystectomy surg NO ?GENT: #intrab2a1b2 -->
    <div data-role="page" id="intrab2a1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Calculous Cholecystitis</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2a1b2b">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab2a1b2a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2a1b2 -->

    <!-- Start of intrab. Pen BAD, cholecystectomy, surgery NO, Gent OK: #intrab2a1b2b -->
    <div data-role="page" id="intrab2a1b2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical calculous cholecystitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient has a severe penicillin allergy cover with:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>continue for no more than 72 hours</b>. Cease after surgery. If surgery is not
                    performed please contact ID for advice. The total duration of therapy should not normally exceed 7
                    days (IV and Oral)</p>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>int</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Antibiotic therapy should be ceased after uncomplicated cholecystectomy as the source of the
                    infection has been removed</li>
                <li>If surgery is not performed the total treatment duration should not normally exceed 7 days &#40;IV +
                    oral&#41;.</li>
                <li>Metronidazole is not recommended for acute cholecystitis, and is only recommended in cases of
                    ascending cholangitis with biliary obstruction present</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
                <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and
                    Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by
                    anaerobic bacteria.</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2a1b -->

    <!-- Start of intrab. Pen BAD, cholecystectomy, surgery YES, GENT OK: #intrab2a1b1b-->
    <div data-role="page" id="intrab2a1b1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Calculous cholecystitis treatment post surgery</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Following cholecystectomy antibiotic treatment should cease within 24 hours
                    as the source of the infection has been removed. If a further dose of surgical prophylaxis is deemed
                    necessary give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, as a single dose as the per nomogram below</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is: </span>
                <span class="font15 bold">1<script> document.write(getCode())</script>ina</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>ONE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 24 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>When available the results of susceptibility testing should always guide treatment</li>
                <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and
                    Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by
                    anaerobic bacteria.</li>
                <li>Metronidazole is not recommended for acute cholecystitis, and is only recommended in cases of
                    ascending cholangitis with biliary obstruction present</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2a1b1b -->

    <!-- Start of intrab. Pen BAD, cholecystectomy, surgery YES, Rupture NO: #intrab2a1b2a-->
    <div data-role="page" id="intrab2a1b2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical calculous cholecystitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient has a contraindication to gentamicin and a severe penicillin
                    allergy:</span>
            </h3>
            <h4 class="color-danger mrgn15b">Please contact infectious diseases for advice</h4>
            <hr />
            <ul class="line30">
                <li>Please note, following cholecystectomy antibiotic treatment should cease within 24 hours as the
                    source of the infection has been removed.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2a1b2a -->

    <!-- Start of Intrab 3b pen OK treatment -->
    <!-- Start of intrab. Pen OK, Cholecystecomy ? surgery: #intrab2a1c -->
    <div data-role="page" id="intrab2a1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Cholecysitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has a cholecystectomy been performed?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2a1c1b">Yes</a></li>
                <li><a href="#intrab2a1c2">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2a1c -->

    <!-- Start of intrab. Pen MILD, Chole surg NO ?GENT: #intrab2a1c2 -->
    <div data-role="page" id="intrab2a1c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Calculous Cholecystitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2a1c2b">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab2a1c2a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2a1c2 -->

    <!-- Start of intrab. Pen OK, chole surgery YES, Gent OK: #intrab2a1c1b -->
    <div data-role="page" id="intrab2a1c1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical calculous cholecystitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Stop antibiotic therapy post surgery</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>Following successful cholecystectomy all antibiotic therapy should normally be ceased immediately
                    after cholecystectomy as the source of infection has been removed. &#40;If surgery was complicated
                    please see antibiotic <a href="#intrab2a1c2">suggestions here</a>&#41;</li>
                <li>Metronidazole is not recommended for acute cholecystitis, and is only recommended in cases of
                    ascending cholangitis with biliary obstruction present</li>
                <li>When available, the results of susceptibility testing should always guide treatment</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2a1c1b -->

    <!-- Start of intrab. Pen OK, chole surgery NO, Gent OK: #intrab2a1c2b -->
    <div data-role="page" id="intrab2a1c2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical calculous cholecystitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient tolerates penicillin cover with:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 2 g &#40;child: 50 mg/kg up to 2 g&#41; IV, 6-hourly until
                        surgery</span>
                </h4>
                <hr />
                <p class="mrgn20b"><b>Then,</b> after clinical improvement switch to:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg &#40;child: 22.5+3.2 mg/kg up to
                        875+125 mg&#41; orally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>int</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>ONE</b> dose only. infectious diseases
                    must be contacted if IV treatment is to continue past a single post-operative dose. NB/ gentamicin
                    should only be given empirically for the first 48 hours, please check patient has not received any
                    previous doses of gentamicin</div>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </h4>
            <hr />
            <ul class="line30">
                <li>Following successful cholecystectomy all antibiotic therapy should normally be ceased immediately
                    after cholecystectomy as the source of infection has been removed. If surgery was complicated please
                    contact infectious diseases for advice</li>
                <li>Metronidazole is not recommended for acute cholecystitis, and is only recommended in cases of
                    ascending cholangitis with biliary obstruction present</li>
                <li>If surgery is not performed the total treatment duration should not normally exceed 7 days &#40;IV +
                    oral&#41;.</li>
                <li>When available, the results of susceptibility testing should always guide treatment</li>
                <li>If IV therapy is required beyond 72 hours, cease the gentamicin-containing regimen and use
                    ceftriaxone or piperacillin+tazobactam (see the therapeutic guidelines for details)</li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Patients with severe sepsis have higher volumes of distribution and therefore require a higher mg/kg
                    dose</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2a1c2b -->

    <!-- Start of intrab. Pen OK, Cholecystecomy, surgery NO: #intrab2a1c2a -->
    <div data-role="page" id="intrab2a1c2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical calculous cholecystitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient tolerates penicillin but not gentamicin cover with:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17"><span class="color-purple"> Amoxicillin + clavulanate
                            intravenously</span></span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">1 + 0.2 g 8-hourly, &#40;If the patient has an abscess,
                                        use a dose of 1+0.2 g 6-hourly&#41;</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and less than 4kg: &nbsp;</span>
                                </td>
                                <td><span class="color-purple"> 25 + 5 mg/kg 12-hourly,</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and 4kg or more, or 3 months or
                                        older: &nbsp;</span></td>
                                <td><span class="color-purple"> 25 + 5 mg/kg (up to 1 + 0.2g) 8-hourly</span></td>
                            </tr>
                        </table>
                </h4>
            </div>
            <hr />
            <p class="mrgn20b"><b>Then,</b> after clinical improvement:</p>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg &#40;child: 22.5+3.2 mg/kg up to
                        875+125 mg&#41; orally, 12-hourly to make up a maximum of 7 days total treatment &#40;IV and
                        oral&#41;</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for Amoxicillin IV & Clavulanate is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>ina</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Antibiotic therapy should normally be stopped within 24 hours of cholecystectomy as the source of
                    the infection has been removed, if surgery is complicated please contact infectious diseases for
                    advice</li>
                <li>Metronidazole is not recommended for acute cholecystitis, and is only recommended in cases of
                    ascending cholangitis with biliary obstruction present</li>
                <li>If surgery is not performed the total treatment duration should not normally exceed 7 days &#40;IV +
                    oral&#41;.</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
                <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and
                    Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by
                    anaerobic bacteria.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2a1c2a -->
    <!--END of CALCULOUS CHOLECYSTITIS-->

    <!--Start of NOT Calculous cholecystitis-->

    <!-- Start of intrab2b1. ?penicillin: #intrab2b1-->
    <div data-role="page" id="intrab2b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous Cholecystitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2b1c">No penicillin allergy</a></li>
                <li><a href="#intrab2b1a">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#intrab2b1b">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1 -->




    <!-- Start of intrab. Pen MILD, ?GENT: #intrab2b1a -->
    <div data-role="page" id="intrab2b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous Cholecystitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2b1a2">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab2b1a1">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2a1c1 -->


    <!-- Start of intrab. Pen MILD, gent BAD, cholecystectomy ? surgery: #intrab2b1a -->
    <div data-role="page" id="intrab2b1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous Cholecystitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Has a cholecystectomy been performed?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2b1a1a">Yes</a></li>
                <li><a href="#intrab2b1a1b">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1a1 -->

    <!-- Start of intrab. Pen MILD, gent OK, cholecystectomy ? surgery: #intrab2b1a -->
    <div data-role="page" id="intrab2b1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous Cholecystitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Has a cholecystectomy been performed?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2b1a2a">Yes</a></li>
                <li><a href="#intrab2b1a2b">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1a2 -->




    <!-- Start of intrab. Pen MILD, cholecystectomy, surgery NO, Gent NO: #intrab2b1a1b -->
    <div data-role="page" id="intrab2b1a1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical acalculous cholecystitis treatment intolerant of gentamicin and penicillin</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient has a mild penicillin allergy or does not tolerate gentamicin
                    treat empirically with:</span>
            </h3>
            <hr>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g &#40;child 1 month or older: 50 mg/kg up to 2 g&#41; IV,
                        daily until surgery or until clinical improvement then switch to oral</span>
                </h4>
                <div class="font15 mrgn20b"><b>AND</b></div>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child 1 month or older: 12.5 mg/kg up to 500
                        mg&#41; IV, 12-hourly</span>
                </h4>
            </div>
            <p class="mrgn20b">Once the patient's condition has improved, change to:</p>
            <hr>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+sulfamethoxazole 160+800 mg &#40;child 1 month or older:
                        4+20 mg/kg up to 160+800 mg&#41; orally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold">2<script> document.write(getCode())</script>inb</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>The total duration of therapy is 5 days (intravenous + oral) after adequate surgical control of the
                    source of infection has been achieved</li>
                <li>Antibiotic therapy should be ceased after uncomplicated cholecystectomy as the source of the
                    infection has been removed</li>
                <li>If surgery not planned to be performed, please contact ID for long term antibiotic advice.</li>
                <li>Metronidazole is not recommended for acute cholecystitis, and is only recommended in cases of
                    ascending cholangitis with biliary obstruction present</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
                <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and
                    Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by
                    anaerobic bacteria.</li>
                <li>Please see the switch to oral criteria in the Therapeutic Guidelines &#40;below&#41;</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1a1b -->

    <!-- Start of intrab. Pen MILD, cholecystectomy, GENT NO surgery YES: #intrab2b1a1a-->
    <div data-role="page" id="intrab2b1a1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous cholecystitis treatment post surgery</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Treatment post cholecystectomy should normally be ceased within 24 hours. If
                    a further dose of surgical prophylaxis is deemed necessary give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g &#40;child 1 month or older: 50 mg/kg up to 2 g&#41; IV,
                        as a single dose</span>
                </h4>
                <div class="font15 mrgn20b"><b>AND</b></div>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child 1 month or older: 12.5 mg/kg up to 500
                        mg&#41; IV, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 1<script> document.write(getCode())</script>ina</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>ONE</b> day only. Starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 24 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>The total duration of therapy is 5 days (intravenous + oral) after adequate surgical control of the
                    source of infection has been achieved</li>
                <li>If surgery is complicated in some way then please contact infectious diseases for approval of a
                    longer course of IV antibiotics</li>
                <li>If surgery not planned to be performed, please contact ID for long term antibiotic advice.</li>
                <li>Metronidazole is not recommended for acute cholecystitis, and is only recommended in cases of
                    ascending cholangitis with biliary obstruction present</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
                <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and
                    Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by
                    anaerobic bacteria.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1a1a -->

    <!-- Start of intrab. Pen BAD, cholecystectomy, surgery YES, GENT OK: #intrab2b1a2a-->
    <div data-role="page" id="intrab2b1a2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous cholecystitis treatment post surgery</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Following cholecystectomy antibiotic treatment should cease within 24 hours
                    as the source of the infection has been removed. If a further dose of surgical prophylaxis is deemed
                    necessary give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, as a single dose as the per nomogram below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <div class="font15 mrgn20b"><b>AND</b></div>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg &#40;child: 15 mg/kg up to 600 mg&#41; IV, 8-hourly
                        &#40;for up to 24 hours&#41;</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin and clindamycin iv is: </span>
                <span class="font15 bold">1<script> document.write(getCode())</script>ina</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>ONE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 24 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>The total duration of therapy is 5 days (intravenous + oral) after adequate surgical control of the
                    source of infection has been achieved</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
                <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and
                    Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by
                    anaerobic bacteria.</li>
                <li>Metronidazole is not recommended for acute cholecystitis, and is only recommended in cases of
                    ascending cholangitis with biliary obstruction present</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1a2a -->


    <!-- Start of intrab. Pen BAD, cholecystectomy, surgery NO, GENT OK: #intrab2b1a2b-->
    <div data-role="page" id="intrab2b1a2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous cholecystitis treatment post surgery</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Following cholecystectomy antibiotic treatment should cease within 24 hours
                    as the source of the infection has been removed. If a further dose of surgical prophylaxis is deemed
                    necessary give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, as per nomogram below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <div class="font15 mrgn20b"><b>AND</b></div>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg &#40;child: 15 mg/kg up to 600 mg&#41; IV,
                        8-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin and clindamycin iv is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>ina</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>The total duration of therapy is 5 days (intravenous + oral) after adequate surgical control of the
                    source of infection has been achieved</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
                <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and
                    Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by
                    anaerobic bacteria.</li>
                <li>Metronidazole is not recommended for acute cholecystitis, and is only recommended in cases of
                    ascending cholangitis with biliary obstruction present</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1a2b -->




    <!--- PEN BAD -->
    <!-- Start of intrab. Pen BAD, cholecystectomy ? surgery: #intrab2b1b -->
    <div data-role="page" id="intrab2b1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous Cholecystitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Has a cholecystectomy been performed?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2b1b1">Yes</a></li>
                <li><a href="#intrab2b1b2">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1b -->

    <!-- Start of intrab. Pen BAD, cholecystectomy surg YES ?GENT: #intrab2b1b1 -->
    <div data-role="page" id="intrab2b1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous Cholecystitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2b1b1b">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab2b1b2a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1b1 -->

    <!-- Start of intrab. Pen BAD, cholecystectomy surg NO ?GENT: #intrab2b1b2 -->
    <div data-role="page" id="intrab2b1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous Cholecystitis</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2b1b2b">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab2b1b2a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1b2 -->

    <!-- Start of intrab. Pen BAD, cholecystectomy, surgery NO, Gent OK: #intrab2b1b2b -->
    <div data-role="page" id="intrab2b1b2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical acalculous cholecystitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient has a severe penicillin allergy cover with:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <div class="font15 mrgn20b"><b>AND</b></div>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg &#40;child: 15 mg/kg up to 600 mg&#41; IV,
                        8-hourly</span>
                </h4>
                <p class="mrgn20b"><b>Then, after clinical improvement or after 72 hours</b> consider step down to oral:
                </p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+Sulfamethoxazole 160+800 mg &#40;child 1 month or older:
                        4+20 mg/kg up to 160+800 mg&#41; orally, 12-hourly to make up a maximum of 7 days total
                        treatment or until cholecystectomy</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin and clindamycin iv is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>int</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>The total duration of therapy is 5 days (intravenous + oral) after adequate surgical control of the
                    source of infection has been achieved</li>
                <li>Antibiotic therapy should be ceased after uncomplicated cholecystectomy as the source of the
                    infection has been removed</li>
                <li>If surgery not planned to be performed, please contact ID for long term antibiotic advice.</li>
                <li>Metronidazole is not recommended for acute cholecystitis, and is only recommended in cases of
                    ascending cholangitis with biliary obstruction present</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
                <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and
                    Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by
                    anaerobic bacteria.</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1b -->

    <!-- Start of intrab. Pen BAD, cholecystectomy, surgery YES, GENT OK: #intrab2b1b1b-->
    <div data-role="page" id="intrab2b1b1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous cholecystitis treatment post surgery</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Following cholecystectomy antibiotic treatment should cease within 24 hours
                    as the source of the infection has been removed. If a further dose of surgical prophylaxis is deemed
                    necessary give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, as a single dose as the per nomogram below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <div class="font15 mrgn20b"><b>AND</b></div>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg &#40;child: 15 mg/kg up to 600 mg&#41; IV, 8-hourly
                        &#40;for up to 24 hours&#41;</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin and clindamycin iv is: </span>
                <span class="font15 bold">1<script> document.write(getCode())</script>ina</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>ONE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 24 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>The total duration of therapy is 5 days (intravenous + oral) after adequate surgical control of the
                    source of infection has been achieved</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
                <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and
                    Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by
                    anaerobic bacteria.</li>
                <li>Metronidazole is not recommended for acute cholecystitis, and is only recommended in cases of
                    ascending cholangitis with biliary obstruction present</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1b1b -->

    <!-- Start of intrab. Pen BAD, cholecystectomy, surgery YES, Rupture NO: #intrab2b1b2a-->
    <div data-role="page" id="intrab2b1b2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical acalculous cholecystitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient has a contraindication to gentamicin and a severe penicillin
                    allergy:</span>
            </h3>
            <h4 class="color-danger mrgn15b">Please contact infectious diseases for advice</h4>
            <hr />
            <ul class="line30">
                <li>The total duration of therapy is 5 days (intravenous + oral) after adequate surgical control of the
                    source of infection has been achieved</li>
                <li>Please note, following cholecystectomy antibiotic treatment should cease within 24 hours as the
                    source of the infection has been removed.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1b2a -->

    <!-- Start of Intrab 3b pen OK treatment -->
    <!-- Start of intrab. Pen OK, Cholecystecomy ? surgery: #intrab2b1c -->
    <div data-role="page" id="intrab2b1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous Cholecystitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">Has a cholecystectomy been performed?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2b1c1">Yes</a></li>
                <li><a href="#intrab2b1c2">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1c -->

    <!-- Start of intrab. Pen MILD, Chole surg NO ?GENT: #intrab2b1c2 -->
    <div data-role="page" id="intrab2b1c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous Cholecystitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2b1c2b">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab2b1c2a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1c2 -->


    <!-- Start of intrab. Pen MILD, Chole surg NO ?GENT: #intrab2b1c1 -->
    <div data-role="page" id="intrab2b1c1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous Cholecystitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab2b1c1b">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab2b1c1a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1c1 -->

    <!-- Start of intrab. Pen OK, cholec surgery YES, GENT BAD: #intrab2b1c1a-->
    <div data-role="page" id="intrab2b1c1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous cholecystitis treatment post surgery</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Following cholecystectomy antibiotic treatment should cease within 24 hours
                    as the source of the infection has been removed. If a further dose of surgical prophylaxis is deemed
                    necessary give:</span>
            </h3>
            <h4 class="mrgn20b">
                <span class="color-primary">Ongoing antibiotic treatment should normally be continued for a maximum of
                    24 hours only:</span>
            </h4>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple"> Piperacillin+tazobactam 4+0.5 g &#40;child: 100+12.5 mg/kg up to 4+0.5
                        g&#41; IV, 8-hourly for 24 hours</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin is:</span>
                <span class="font15 bold"> 1<script> document.write(getCode())</script>ina</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>ONE</b> day only. Starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 24 hours. NB/ gentamicin should only be given empirically for the first 48 hours,
                    please check patient has not received any previous doses of gentamicin</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>The total duration of therapy is 5 days (intravenous + oral) after adequate surgical control of the
                    source of infection has been achieved</li>
                <li>If surgery was complicated please contact infectious diseases for advice on treatment duration</li>
                <li>Metronidazole is not recommended for acute cholecystitis, and is only recommended in cases of
                    ascending cholangitis with biliary obstruction present</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
                <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and
                    Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by
                    anaerobic bacteria.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1c1a -->


    <!-- Start of intrab. Pen OK, chole surgery YES, Gent OK: #intrab2b1c1b -->
    <div data-role="page" id="intrab2b1c1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous Empirical cholecystitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Following cholecystectomy antibiotic treatment should cease as the source of
                    the infection has been removed. If the surgery was complicated give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin 4-5 mg/kg IV, as a single dose only</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child: 12.5 mg/kg up to 500 mg&#41; IV,
                        12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 2 g &#40;child: 50 mg/kg up to 2 g&#41; IV, 6-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is: </span>
                <span class="font15 bold">1<script> document.write(getCode())</script>ina</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>ONE</b> dose only. infectious diseases
                    must be contacted if IV treatment is to continue past a single post-operative dose. NB/ gentamicin
                    should only be given empirically for the first 48 hours, please check patient has not received any
                    previous doses of gentamicin</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Metronidazole is not recommended for acute cholecystitis, and is only recommended in cases of
                    ascending cholangitis with biliary obstruction present</li>
                <li>When available, the results of susceptibility testing should always guide treatment</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1c1b -->

    <!-- Start of intrab. Pen OK, chole surgery NO, Gent OK: #intrab2b1c2b -->
    <div data-role="page" id="intrab2b1c2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous empirical cholecystitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient tolerates penicillin cover with:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 2 g &#40;child: 50 mg/kg up to 2 g&#41; IV, 6-hourly until
                        surgery</span>
                </h4>
                <hr />
                <p class="mrgn20b"><b>Then,</b> after clinical improvement switch to:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg &#40;child: 22.5+3.2 mg/kg up to
                        875+125 mg&#41; orally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is: </span>
                <span class="font15 bold">2<script> document.write(getCode())</script>int</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>ONE</b> dose only. infectious diseases
                    must be contacted if IV treatment is to continue past a single post-operative dose. NB/ gentamicin
                    should only be given empirically for the first 48 hours, please check patient has not received any
                    previous doses of gentamicin</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Metronidazole is not recommended for acute cholecystitis, and is only recommended in cases of
                    ascending cholangitis with biliary obstruction present</li>
                <li>If surgery not planned to be performed, please contact ID for long term antibiotic advice.</li>
                <li>When available, the results of susceptibility testing should always guide treatment</li>
                <li>If IV therapy is required beyond 72 hours, cease the gentamicin-containing regimen and use
                    ceftriaxone or piperacillin+tazobactam (see the therapeutic guidelines for details)</li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Patients with severe sepsis have higher volumes of distribution and therefore require a higher mg/kg
                    dose</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1c2b -->

    <!-- Start of intrab. Pen OK, Cholecystecomy, surgery NO: #intrab2b1c2a -->
    <div data-role="page" id="intrab2b1c2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Acalculous empirical cholecystitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient tolerates penicillin but not gentamicin cover with:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple"> Piperacillin+tazobactam 4+0.5 g &#40;child: 100+12.5 mg/kg up to 4+0.5
                        g&#41; IV, 8-hourly until surgery or clinically improved then switch to oral</span>
                </h4>
            </div>
            <hr />
            <p class="mrgn20b"><b>Then,</b> after clinical improvement:</p>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg &#40;child: 22.5+3.2 mg/kg up to
                        875+125 mg&#41; orally, 12-hourly to make up a maximum of 7 days total treatment &#40;IV and
                        oral&#41;</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>inb</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Antibiotic therapy should normally be stopped within 24 hours of cholecystectomy as the source of
                    the infection has been removed, if surgery is complicated please contact infectious diseases for
                    advice</li>
                <li>Metronidazole is not recommended for acute cholecystitis, and is only recommended in cases of
                    ascending cholangitis with biliary obstruction present</li>
                <li>If surgery not planned to be performed, please contact ID for long term antibiotic advice.</li>
                <li>When available the results of susceptibility testing should always guide treatment</li>
                <li>Acute cholecystitis is usually caused by enteric Gram-negative bacilli (eg Escherichia coli and
                    Klebsiella species) and, less commonly, Enterococcus faecalis. Infrequently, infection is caused by
                    anaerobic bacteria.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on cholecystitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab2b1c2a -->
    <!--END of NOT CALCULOUS CHOLECYSTITIS-->

    <!-- End of cholecystitis maze -->

    <!-- diverticulitis Maze Begins -->
    <!-- Start of diverticulitis page: #intrab3 -->
    <div data-role="page" id="intrab3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Diverticulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">How would you grade the diverticulitis?</span>
                <span class="font15"> &#40;See below&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab3a">Mild</a></li>
                <li><a href="#intrab3b">Severe</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Patients with mild abdominal pain and tenderness who do not have significant systemic signs or
                    symptoms should be considered to have mild diverticulitis.</li>
                <li>Patients with peritonism, or those who have signs of diverticulitis and significant systemic signs
                    or symptoms (eg fever, elevated white cell count), should be treated as severe or complicated
                    diverticulitis.</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab3 -->

    <!-- Start of diverticulitis MILD page ?systemic: #intrab3a -->
    <div data-role="page" id="intrab3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Diverticulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have any of the following features?</span>
            </h3>
            <ul>
                <li>Immune compromise</li>
                <li>right sided diverticulitis</li>
                <li>failure to improve after 72 hours of conservative treatment &#40;i.e. no antibiotic therapy&#41;
                </li>
            </ul></span>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab3a1">Yes</a></li>
                <li><a href="#intrab3a2">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Antibiotics should only be considered for patients showing systemic symptoms such as fever or
                    elevated white cell count, or patients who have failed to respond to conservative management (IV
                    fluids and bowel rest)</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab3a -->

    <!-- Start of diverticulitis MILD, no systemic symptoms: #intrab3a2 -->
    <div data-role="page" id="intrab3a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Diverticulitis</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For mild diverticulitis with no systemic involvement:</span>
            </h3>
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Antibiotic treatment may not be required.</span>
            </h4>
            <p class="mrgn20b">Recent trials have suggested that antibiotic therapy may not be required for patients
                with mild abdominal pain and tenderness who do not have significant systemic signs or symptoms. If
                antibiotic therapy is deemed necessary then use the link below to continue to treatment:</p>
            <div data-role="content" class="container-fluid">
                <ul data-role="listview" data-inset="true" class="listview">
                    <li><a href="#intrab3a1">Continue to treatment</a></li>
                </ul>
            </div>
            <ul class="line30">
                <li>Antibiotic therapy is appropriate for patients with any of the following features:
                    <ul>
                        <li>immune compromise</li>
                        <li>right-sided diverticulitis</li>
                        <li>failure to improve after 72 hours of conservative treatment (ie no antibiotic therapy).</li>
                    </ul>
                </li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab3a2 -->

    <!-- Start of diverticulitis page: #intrab3b -->
    <div data-role="page" id="intrab3a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Diverticulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab3a1c">No penicillin allergy</a></li>
                <li><a href="#intrab3a1a">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#intrab3a1a">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab3b -->

    <!-- Start of diverticulitis, MILD/SEVERE pen allergy: #intrab3a1a -->
    <div data-role="page" id="intrab3a1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Diverticulitis</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For diverticulitis in a patient with penicillin allergy use:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+sulfamethoxazole 160+800 mg &#40;child 1 month or older:
                        4+20 mg/kg up to 160+800 mg&#41; orally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; orally,
                        12-hourly</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>Total antibiotic therapy should not normally exceed 5 days treatment.</li>
                <li>For patients who have not undergone surgery, the total duration of therapy is 7 to 10 days
                    (intravenous + oral).</li>
                <li>For patients who have undergone surgery, the total duration of therapy is 5 days (intravenous +
                    oral) after adequate surgical control of the source of infection has been achieved.</li>
                <li>Consider alternative diagnoses (eg irritable bowel syndrome). Diagnosis of diverticulitis made by
                    clinical criteria alone has been shown to be incorrect in up to 33% of cases</li>
                <li>Antibiotics should only be considered in patients with signs of diverticulitis who have markers of
                    systemic involvement (eg fever, elevated white cell count), or in patients who have failed to
                    respond to conservative management.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="hhttps://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on diverticulitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->

        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab3a1a -->

    <!-- Start of diverticulitis: #intrab3a1c -->
    <div data-role="page" id="intrab3a1c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Diverticulitis</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For diverticulitis in a patient tolerant of penicillin use as a single
                    agent:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg &#40;child: 22.5+3.2 mg/kg up to
                        875+125 mg&#41; orally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>Total antibiotic therapy should not normally exceed 5 days treatment.</li>
                <li>For patients who have not undergone surgery, the total duration of therapy is 7 to 10 days
                    (intravenous + oral).</li>
                <li>For patients who have undergone surgery, the total duration of therapy is 5 days (intravenous +
                    oral) after adequate surgical control of the source of infection has been achieved.</li>
                <li>Consider alternative diagnoses (eg irritable bowel syndrome). Diagnosis of diverticulitis made by
                    clinical criteria alone has been shown to be incorrect in up to 33% of cases</li>
                <li>Antibiotics should only be considered in patients with signs of diverticulitis who have markers of
                    systemic involvement (eg fever, elevated white cell count), or in patients who have failed to
                    respond to conservative management.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on diverticulitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab3a1c -->

    <!-- Start of diverticulitis page: #intrab3b -->
    <div data-role="page" id="intrab3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Diverticulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab3b3">No penicillin allergy</a></li>
                <li><a href="#intrab3b1">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#intrab3b2">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on diverticulitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab3b -->


    <!-- Start of diverticulitis PEN BAD, Gent Q: #intrab3b2 -->
    <div data-role="page" id="intrab3b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Diverticulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab3b2b">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab3b2a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab3b2 -->

    <!-- Start of diverticulitis PEN OK, Gent Q: #intrab3b3 -->
    <div data-role="page" id="intrab3b3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Diverticulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab3b3b">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab3b3a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab3b3 -->

    <!-- Start of diverticulitis PEN MILD, Gent BAD: #intrab3b1 -->
    <div data-role="page" id="intrab3b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Diverticulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For diverticulitis in a patient with non-life threatening penicillin
                hypersensitivity use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g &#40;child 1 month or older: 50 mg/kg up to 2 g&#41; IV,
                        daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child 1 month or older: 7.5 mg/kg up to 500
                        mg&#41; IV, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>inb</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Consider a switch to oral once patient has been afebrile for 24 hours as with all abdominal
                    infections</li>
                <li>For patients who have not undergone surgery, the total duration of therapy is 7 to 10 days
                    (intravenous + oral).</li>
                <li>For patients who have undergone surgery, the total duration of therapy is 5 days (intravenous +
                    oral) after adequate surgical control of the source of infection has been achieved.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on diverticulitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab3b1 -->

    <!-- Start of diverticulitis PEN BAD, Gent OK: #intrab3b2a -->
    <div data-role="page" id="intrab3b2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Diverticulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For diverticulitis in a patient with life threatening penicillin
                hypersensitivity intolerant of gentamicin:</h3>
            <h4 class="color-danger mrgn15b">Please contact infectious diseases for advice</h4>

            </h4>
            <hr />
            <ul class="line30">
                <li>Consider a switch to oral once patient has been afebrile for 24 hours as with all abdominal
                    infections</li>
                <li>For patients who have not undergone surgery, the total duration of therapy is 7 to 10 days
                    (intravenous + oral).</li>
                <li>For patients who have undergone surgery, the total duration of therapy is 5 days (intravenous +
                    oral) after adequate surgical control of the source of infection has been achieved.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on diverticulitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab3b2a -->

    <!-- Start of diverticulitis PEN BAD, Gent OK: #intrab3b2b -->
    <div data-role="page" id="intrab3b2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Diverticulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For diverticulitis in a patient with life threatening penicillin
                hypersensitivity use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg &#40;child: 15 mg/kg up to 600 mg&#41; IV,
                        8-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for clindamycin and gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>int</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Consider a switch to oral once patient has been afebrile for 24 hours as with all abdominal
                    infections</li>
                <li>Consider alternative diagnoses (eg irritable bowel syndrome). Diagnosis of diverticulitis made by
                    clinical criteria alone has been shown to be incorrect in up to 33% of cases</li>
                <li>Antibiotics should only be considered in patients with signs of diverticulitis who have markers of
                    systemic involvement (eg fever, elevated white cell count), or in patients who have failed to
                    respond to conservative management.</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on diverticulitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab3b2b -->

    <!-- Start of diverticulitis PEN OK, Gent OK: #intrab3b3b -->
    <div data-role="page" id="intrab3b3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Diverticulitis</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For diverticulitis in a patient who can tolerate penicillin and
                gentamicin:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 2 g &#40;child: 50 mg/kg up to 2 g&#41; IV, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child 1 month or older: 12.5 mg/kg up to 500
                        mg&#41; IV, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>int</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Consider a switch to oral once patient has been afebrile for 24 hours as with all abdominal
                    infections</li>
                <li>For patients who have not undergone surgery, the total duration of therapy is 7 to 10 days
                    (intravenous + oral).</li>
                <li>For patients who have undergone surgery, the total duration of therapy is 5 days (intravenous +
                    oral) after adequate surgical control of the source of infection has been achieved.</li>
                <li>Consider alternative diagnoses (eg irritable bowel syndrome). Diagnosis of diverticulitis made by
                    clinical criteria alone has been shown to be incorrect in up to 33% of cases</li>
                <li>Antibiotics should only be considered in patients with signs of diverticulitis who have markers of
                    systemic involvement (eg fever, elevated white cell count), or in patients who have failed to
                    respond to conservative management.</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on diverticulitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab3b3b -->

    <!-- Start of diverticulitis PEN OK, Gent BAD: #intrab3b3a -->
    <div data-role="page" id="intrab3b3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Diverticulitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For diverticulitis in a patient tolerant of penicillin but intolerant of
                gentamicin use:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple"> Amoxicillin + clavulanate intravenously</span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">adult:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">1 + 0.2 g 8-hourly, If the patient has an abscess, use a
                                        dose of 1+0.2 g 6-hourly</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and less than 4kg: &nbsp;</span>
                                </td>
                                <td><span class="color-purple"> 25 + 5 mg/kg 12-hourly,</span></td>
                            </tr>
                            <tr>
                                <td><span class="font17">child younger than 3 months and 4kg or more, or 3 months or
                                        older: &nbsp;</span></td>
                                <td><span class="color-purple"> 25 + 5 mg/kg (up to 1 + 0.2g) 8-hourly</span></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <hr />
                <p class="mrgn20b"><b>Then,</b> after clinical condition improves, step down to oral:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg orally, 12-hourly&#40;child: 22.5+3.2
                        mg/kg up to 875+125 mg&#41; orally, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin+tazobactam is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>inb</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Consider a switch to oral once patient has been afebrile for 24 hours as with all abdominal
                    infections</li>
                <li>For patients who have not undergone surgery, the total duration of therapy is 7 to 10 days
                    (intravenous + oral).</li>
                <li>For patients who have undergone surgery, the total duration of therapy is 5 days (intravenous +
                    oral) after adequate surgical control of the source of infection has been achieved.</li>
                <li>Consider alternative diagnoses (eg irritable bowel syndrome). Diagnosis of diverticulitis made by
                    clinical criteria alone has been shown to be incorrect in up to 33% of cases</li>
                <li>Antibiotics should only be considered in patients with signs of diverticulitis who have markers of
                    systemic involvement (eg fever, elevated white cell count), or in patients who have failed to
                    respond to conservative management.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on diverticulitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab3b3a -->
    <!-- END OF diverticulitis Maze -->

    <!-- Start of Pancreatitis MAZE -->
    <!-- Start of intrab4. ?severe: #intrab4-->
    <div data-role="page" id="intrab4" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pancreatitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">How severe is the pancreatitis?</h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab4a">Mild or Moderate</a></li>
                <li><a href="#intrab4b">Severe &#40;infected pancreatic necrosis/abscess&#41;</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Refer all patients with severe pancreatitis to ICU</li>
                <li>Antibiotics are generally not indicated for acute pancreatitis</li>
                <li>The role of antibiotic therapy in the management of acute pancreatitis is limited to the treatment
                    of infected pancreatic necrosis or pancreatic abscess</li>
                <li>The recognition and treatment of persisting obstruction and/or ascending cholangitis in patients
                    with severe pancreatitis is important</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab4 -->

    <!-- Start of intrab4b. severe, necrosis YES: #intrab4b-->
    <div data-role="page" id="intrab4b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pancreatitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab4b3">No penicillin allergy</a></li>
                <li><a href="#intrab4b1">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#intrab4b2">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab4b -->

    <!-- Start of intrab4. severe, necrosis YES, pen mild: #intrab4b1-->
    <div data-role="page" id="intrab4b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pancreatitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For severe infected/necrotising pancreatitis in a patient with mild
                    penicillin allergy:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Metronidazole 500 mg &#40;child: 12.5
                        mg/kg up to 500 mg&#41; IV, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> either</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Ceftriaxone 2 g &#40;child 1 month or
                        older: 50 mg/kg up to 2 g&#41; IV, daily</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> if child &lt; 2 months old</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Cefotaxime &#40;child: 50 mg/kg up to
                        2 g&#41; IV, 8-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefotaxime or ceftriaxone is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>inp</span>
                <div class="font15 mrgn20b text-left">
                    This code is valid for <b>TWO</b> days only, starting from the first day of treatment for this
                    condition. Infectious diseases must be contacted if IV treatment is to continue past 48 hours.
                    Please annotate this code on the medication chart and document when infectious diseases are to be
                    contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Patients with severe pancreatitis can intermittently appear septic during a prolonged
                    hospitalisation. Before giving antibiotics, every effort should be made to perform image-guided
                    percutaneous aspiration of any pancreatic collection, with Gram stain and cultures of the aspirate
                </li>
                <li>Treatment for infected pancreatic necrosis is a step-up approach using percutaneous drainage,
                    minimally invasive surgery and, if necessary, open surgical debridement. In pancreatic abscess,
                    prompt percutaneous or surgical drainage is important.</li>
                <li>The recognition and treatment of persisting obstruction and/or ascending cholangitis in patients
                    with severe pancreatitis is important</li>
                <li>Data to support the use of carbapenems in empirical treatment are lacking</li>
                <li>This is a guide for empirical therapy only. Modify therapy according to the results of cultures and
                    susceptibility testing. Reserve carbapenems for infections caused by resistant pathogens.</li>
                <li>Antibiotics are not indicated in the management of mild to moderate acute pancreatitis</li>
                <li>The optimal duration of therapy is uncertain. An initial course of 7 days is commonly used. The
                    decision to prolong therapy should be based on careful review of the patient’s clinical status, and
                    radiology and pathology results</li>
                <li>For cases that do not resolve within 7 to 10 days, consider secondary infection with Candida species
                    or multidrug-resistant organisms such as vancomycin-resistant enterococci and carbapenem-resistant
                    Enterobacteriaceae. Antimicrobial therapy should be directed by the results of culture and
                    susceptibility testing of samples taken from a deep site—seek expert surgical, infectious diseases
                    and clinical microbiology advice</li>
                <li>All patients with signs of infective necrotic pancreatitis should have an ICU assessment</li>
                <li>Acute pancreatitis may also be induced by drugs such as azathioprine and antiretroviral and
                    chemotherapeutic drugs. However, when drug-induced pancreatitis is suspected, every drug that the
                    patient is taking should be considered a possible cause</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on pancreatitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab4b1 -->

    <!-- Start of intrab4. severe, necrosis YES, pen BAD: #intrab4b2-->
    <div data-role="page" id="intrab4b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pancreatitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For infected/necrotising pancreatitis in a patient with major penicillin
                    allergy:</span>

            </h3>
            <h4 class="color-danger mrgn15b">Please contact infectious diseases for advice</h4>
            <hr />
            <ul class="line30">
                <li>Patients with severe pancreatitis can intermittently appear septic during a prolonged
                    hospitalisation. Before giving antibiotics, every effort should be made to perform image-guided
                    percutaneous aspiration of any pancreatic collection, with Gram stain and cultures of the aspirate
                </li>
                <li>Treatment for infected pancreatic necrosis is a step-up approach using percutaneous drainage,
                    minimally invasive surgery and, if necessary, open surgical debridement. In pancreatic abscess,
                    prompt percutaneous or surgical drainage is important.</li>
                <li>The recognition and treatment of persisting obstruction and/or ascending cholangitis in patients
                    with severe pancreatitis is important</li>
                <li>Data to support the use of carbapenems in empirical treatment are lacking</li>
                <li>This is a guide for empirical therapy only. Modify therapy according to the results of cultures and
                    susceptibility testing. Reserve carbapenems for infections caused by resistant pathogens.</li>
                <li>Antibiotics are not indicated in the management of mild to moderate acute pancreatitis</li>
                <li>The optimal duration of therapy is uncertain. An initial course of 7 days is commonly used. The
                    decision to prolong therapy should be based on careful review of the patient’s clinical status, and
                    radiology and pathology results</li>
                <li>For cases that do not resolve within 7 to 10 days, consider secondary infection with Candida species
                    or multidrug-resistant organisms such as vancomycin-resistant enterococci and carbapenem-resistant
                    Enterobacteriaceae. Antimicrobial therapy should be directed by the results of culture and
                    susceptibility testing of samples taken from a deep site—seek expert surgical, infectious diseases
                    and clinical microbiology advice</li>
                <li>All patients with signs of infective necrotic pancreatitis should have an ICU assessment</li>
                <li>Acute pancreatitis may also be induced by drugs such as azathioprine and antiretroviral and
                    chemotherapeutic drugs. However, when drug-induced pancreatitis is suspected, every drug that the
                    patient is taking should be considered a possible cause</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on pancreatitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab4b2 -->

    <!-- Start of intrab4b3. severe, necrosis YES, pen OK: #intrab4b3-->
    <div data-role="page" id="intrab4b3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pancreatitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For infected necrotising pancreatitis or pancreatic abscess in a patient
                    with no penicillin allergy:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin+tazobactam 4+0.5 g &#40;child: 100+12.5 mg/kg up to 4+0.5
                        g&#41; IV, 8-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin+tazobactam is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>inp</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul type=circle>
                <li>Patients with severe pancreatitis can intermittently appear septic during a prolonged
                    hospitalisation. Before giving antibiotics, every effort should be made to perform image-guided
                    percutaneous aspiration of any pancreatic collection, with Gram stain and cultures of the aspirate
                </li>
                <li>Treatment for infected pancreatic necrosis is a step-up approach using percutaneous drainage,
                    minimally invasive surgery and, if necessary, open surgical debridement. In pancreatic abscess,
                    prompt percutaneous or surgical drainage is important.</li>
                <li>The recognition and treatment of persisting obstruction and/or ascending cholangitis in patients
                    with severe pancreatitis is important</li>
                <li>Data to support the use of carbapenems in empirical treatment are lacking</li>
                <li>This is a guide for empirical therapy only. Modify therapy according to the results of cultures and
                    susceptibility testing. Reserve carbapenems for infections caused by resistant pathogens.</li>
                <li>Antibiotics are not indicated in the management of mild to moderate acute pancreatitis</li>
                <li>The optimal duration of therapy is uncertain. An initial course of 7 days is commonly used. The
                    decision to prolong therapy should be based on careful review of the patient’s clinical status, and
                    radiology and pathology results</li>
                <li>For cases that do not resolve within 7 to 10 days, consider secondary infection with Candida species
                    or multidrug-resistant organisms such as vancomycin-resistant enterococci and carbapenem-resistant
                    Enterobacteriaceae. Antimicrobial therapy should be directed by the results of culture and
                    susceptibility testing of samples taken from a deep site—seek expert surgical, infectious diseases
                    and clinical microbiology advice</li>
                <li>All patients with signs of infective necrotic pancreatitis should have an ICU assessment</li>
                <li>Acute pancreatitis may also be induced by drugs such as azathioprine and antiretroviral and
                    chemotherapeutic drugs. However, when drug-induced pancreatitis is suspected, every drug that the
                    patient is taking should be considered a possible cause</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on pancreatitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab4b3 -->

    <!-- Start of intrab4. severe, necrosis YES, pen BAD: #intrab4a-->
    <div data-role="page" id="intrab4a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pancreatitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For mild to moderate pancreatitis:</span>
            </h3>
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Antibiotics are not indicated for the management of mild or moderate
                    pancreatitis</span>
            </h4>
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Antibiotics are only indicated if necrosis or systemic signs of infection are
                    observed in severe cases of pancreatitis. These cases should be managed in the ICU/HDU. Gut rest,
                    fluid administration and pain management are the mainstay of treatment for most cases of mild or
                    moderate pancreatitis</span>

            </h4>
            <hr />
            <ul class="line30">
                <li>Refer all patients with severe pancreatitis to ICU</li>
                <li>Antibiotics are generally not indicated for acute pancreatitis</li>
                <li>The role of antibiotic therapy in the management of acute pancreatitis is limited to the treatment
                    of infected pancreatic necrosis or pancreatic abscess</li>
                <li>The recognition and treatment of persisting obstruction and/or ascending cholangitis in patients
                    with severe pancreatitis is important</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on pancreatitis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab4a -->
    <!-- End of Pancreatitis Maze -->

    <!-- Start of Peritonitis Maze -->
    <!-- Start of peritonitis page ?type: #intrab5 -->
    <div data-role="page" id="intrab5" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">What is the cause of the peritonitis?</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab5a">Perforated viscus</a></li>
                <li><a href="#intrab5b">Spontaneous (SBP)</a></li>
                <li><a href="#intrab5c">Peritoneal dialysis</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5 -->

    <!-- Start of peritonitis page, perforated, ?allergy: #intrab5a -->
    <div data-role="page" id="intrab5a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy??</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab5a3">No penicillin allergy</a></li>
                <li><a href="#intrab5a1">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#intrab5a2">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5a -->

    <!-- Start of peritonitis page, spontaneous, ?allergy: #intrab5b -->
    <div data-role="page" id="intrab5b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab5b3">No penicillin allergy</a></li>
                <li><a href="#intrab5b1">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#intrab5b1a">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5b -->

    <!-- Start of peritonitis page, perf, PEN OK ? Gent OK: #intrab5a2 -->
    <div data-role="page" id="intrab5a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab5a2b">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab5a2a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5a2 -->

    <!-- Start of peritonitis page, perf, PEN OK ? Gent OK: #intrab5a3 -->
    <div data-role="page" id="intrab5a3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab5a3b">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab5a3a">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5a3 -->

    <!-- Start of peritonitis page, perf, Pen MILD: #intrab5a1 -->
    <div data-role="page" id="intrab5a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis Treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient has a mild penicillin allergy, until the return of
                    susceptibility results cover with:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g &#40;child 1 month or older: 50 mg/kg up to 2 g&#41; IV,
                        daily</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child: 12.5 mg/kg up to 500 mg&#41; IV,
                        12-hourly</span>
                </h4>
            </div>
            <hr />
            <p class="mrgn20b"><b>Then,</b> after clinical improvement is observed (patient is afebrile for at least 24
                hours) switch to oral:</p>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+Sulfamethoxazole 160+800 mg &#40;child 1 month or older:
                        4+20 mg/kg up to 160+800 mg&#41; orally, 12-hourly. Usually to make up 5 days total treatment
                        &#40;IV &#43; oral&#41; if there are no complications</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; orally,
                        12-hourly. Usually to make up 5 days total treatment &#40;IV &#43; oral&#41; if there are no
                        complications</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>inb</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>As with all intra-abdominal infections, IV therapy can be rapidly switched to oral therapy if
                    patient is improving &#40;generally within the first 48 hours after intiating IV therapy&#41;.</li>
                <li>Empirical antifungal therapy is not normally required, however consider antifungal therapy if yeasts
                    are uncovered from deep surgical site samples</li>
                <li>When available, the results of susceptibility testing should always guide treatment</li>
                <li>Peritonitis is usually a polymicrobial infection with aerobic and anaerobic bowel flora. Peritonitis
                    from a perforated viscus normally requires surgery</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on peritonitis due to perforated viscus</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5a1 -->

    <!-- Start of peritonitis page, perf, Pen BAD, Gent OK: #intrab5a2b -->
    <div data-role="page" id="intrab5a2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical peritonitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient has a severe penicillin allergy cover with:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg &#40;child: 15 mg/kg up to 600 mg&#41; IV,
                        8-hourly</span>
                </h4>
            </div>
            <hr />
            <p class="mrgn20b"><b>Then,</b> after clinical improvement is observed (patient is afebrile for at least 24
                hours) switch to oral:</p>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+Sulfamethoxazole 160+800 mg &#40;child 1 month or older:
                        4+20 mg/kg up to 160+800 mg&#41; orally, 12-hourly to make up 5 days total treatment</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg &#40;child: 10 mg/kg up to 400 mg&#41; orally,
                        12-hourly. Usually to make up 5 days total treatment &#40;IV &#43; oral&#41; if there are no
                        complications</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for clindamycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>int</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>inb</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>As with all intra-abdominal infections, IV therapy can be rapidly switched to oral therapy if
                    patient is improving &#40;generally within the first 48 hours after intiating IV therapy&#41;.</li>
                <li>Empirical antifungal therapy is not normally required, however consider antifungal therapy if yeasts
                    are uncovered from deep surgical site samples</li>
                <li>When available, the results of susceptibility testing should always guide treatment</li>
                <li>Peritonitis is usually a polymicrobial infection with aerobic and anaerobic bowel flora. Peritonitis
                    from a perforated viscus normally requires surgery</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5a2b -->

    <!-- Start of peritonitis page, perf, Pen BAD, Gent BAD: #intrab5a2a -->
    <div data-role="page" id="intrab5a2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical peritonitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient has a severe penicillin allergy and can not tolerate
                    gentamicin:</span>

            </h3>
            <h4 class="color-danger mrgn15b">Please contact infectious diseases there are limited treatment options if a
                patient can not tolerate penicillin or gentamicin</h4>

            </h4>
            <hr />
            <ul class="line30">
                <li>As with all intra-abdominal infections, IV therapy can be rapidly switched to oral therapy if
                    patient is improving &#40;generally within the first 48 hours after intiating IV therapy&#41;.</li>
                <li>Empirical antifungal therapy is not normally required, however consider antifungal therapy if yeasts
                    are uncovered from deep surgical site samples</li>
                <li>When available, the results of susceptibility testing should always guide treatment</li>
                <li>Peritonitis is usually a polymicrobial infection with aerobic and anaerobic bowel flora. Peritonitis
                    from a perforated viscus normally requires surgery</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on peritonitis due to perforated viscus</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5a2a -->

    <!-- Start of peritonitis page, perf, Pen OK, Gent OK: # intrab5a3b -->
    <div data-role="page" id="intrab5a3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical peritonitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient tolerates penicillin cover with:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin IV, dosed as per nomograms below or use the <a
                            href="dosecalcs.html#dose12">gentamicin empiric dose calculator for adults</a></span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 2 g &#40;child: 50 mg/kg up to 2 g&#41; IV, 6-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND,</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg &#40;child: 12.5 mg/kg up to 500 mg&#41; IV,
                        12-hourly</span>
                </h4>
            </div>
            <hr />
            <div id="backcolour">
                <p class="mrgn20b"><b>Then,</b> after clinical improvement is observed (patient is afebrile for at least
                    24 hours) switch to oral:</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg &#40;child: 22.5+3.2 mg/kg up to
                        875+125 mg&#41; orally, 12-hourly. Usually to make up 5 days total treatment &#40;IV &#43;
                        oral&#41; if there are no complications</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>inb</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>If further IV treatment is required after 72 hours of empirical treatment with gentamicin, change
                    patient to piperacillin and tazobactam 4/0.5g &#40;100 mg/kg piperacillin for child&#41; 8-hourly
                    until clinically improved as for patients not tolerant of gentamicin</li>
                <li>As with all intra-abdominal infections, IV therapy can be rapidly switched to oral therapy if
                    patient is improving &#40;generally within the first 48 hours after intiating IV therapy&#41;.</li>
                <li>Empirical antifungal therapy is not normally required, however consider antifungal therapy if yeasts
                    are uncovered from deep surgical site samples</li>
                <li>When available, the results of susceptibility testing should always guide treatment</li>
                <li>Peritonitis is usually a polymicrobial infection with aerobic and anaerobic bowel flora. Peritonitis
                    from a perforated viscus normally requires surgery</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice</li>
                <li>For children with impaired renal function (estimated glomerular filtration rate [eGFR] less than 50
                    mL/min/1.73 m<sup>2</sup>), give a single dose, then seek expert advice for subsequent dosing or
                    selection of alternative drug. Use the modified Schwartz formula to estimate GFR.</li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    (gestational age) plus the time elapsed after birth (postnatal age)</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on peritonitis due to perforated viscus</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5a3b -->

    <!-- Start of peritonitis page, perf, Pen OK, Gent BAD: #intrab5a3a -->
    <div data-role="page" id="intrab5a3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical peritonitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient tolerates penicillin but not gentamicin, prior to release of
                    culture results treat empirically with:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin+tazobactam 4+0.5 g &#40;child: 100+12.5 mg/kg up to 4+0.5
                        g&#41; IV, 8-hourly until clinical condition improves</span>
                </h4>
            </div>
            <hr />
            <p class="mrgn20b"><b>Then,</b> after clinical condition improves, step down to oral:</p>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg &#40;child: 22.5+3.2 mg/kg up to
                        875+125 mg&#41; orally, 12-hourly. Usually to make up 5 days total treatment &#40;IV &#43;
                        oral&#41; if there are no complications</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin+tazobactam is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>inb</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>As with all intra-abdominal infections, IV therapy can be rapidly switched to oral therapy if
                    patient is improving &#40;generally within the first 48 hours after intiating IV therapy&#41;.</li>
                <li>Empirical antifungal therapy is not normally required, however consider antifungal therapy if yeasts
                    are uncovered from deep surgical site samples</li>
                <li>When available, the results of susceptibility testing should always guide treatment</li>
                <li>Peritonitis is usually a polymicrobial infection with aerobic and anaerobic bowel flora. Peritonitis
                    from a perforated viscus normally requires surgery</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on peritonitis due to perforated viscus</a> - Antibiotic Expert
                    Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited;
                    2019. </span>
            </h4>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5a3a -->

    <!-- Start of peritonitis page, SBP, Pen MILD, ?prophylaxis: #intrab5b1 -->
    <div data-role="page" id="intrab5b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Has the patient been on SBP prophylaxis? Or was the peritonitis sourced
                    nosocomially?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab5b1a">Yes</a></li>
                <li><a href="#intrab5b1b">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Answer yes if patient has been on SBP prophylaxis such as trimethoprim and sulphamethoxazole or
                    norfloxacin or if SBP developed during a hospital admission</li>
                <li>Patients who develop SBP while on prophylactic medications are at greater risk of developing
                    <i>Streptococcus</i> or <i>Enterococcus</i> infections which are resistant to cephalosporins</li>
                <li>Nosocomial spontaneous bacterial peritonitis is more likely to be caused by ceftriaxone-resistant
                    Gram-negative bacteria.</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5b1 -->

    <!-- Start of peritonitis page, SBP, PEN OK, ?proph: #intrab5b3 -->
    <div data-role="page" id="intrab5b3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Has the patient been on SBP prophylaxis? Or was the peritonitis sourced
                    nosocomially?</span>

            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab5b3a">Yes</a></li>
                <li><a href="#intrab5b1b">No</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Answer yes if patient has been on SBP prophylaxis such as trimethoprim and sulphamethoxazole or
                    norfloxacin or if SBP developed during a hospital admission</li>
                <li>Patients who develop SBP while on prophylactic medications are at greater risk of developing
                    <i>Streptococcus</i> or <i>Enterococcus</i> infections which are resistant to cephalosporins</li>
                <li>Nosocomial spontaneous bacterial peritonitis is more likely to be caused by ceftriaxone-resistant
                    Gram-negative bacteria.</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5b3 -->

    <!-- Start of peritonitis page, SBP, Pen allergy, need to contact infectious diseases: #intrab5b1a -->
    <div data-role="page" id="intrab5b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <div data-role="header" class="secondpage">
            <h1>Empirical peritonitis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient has a penicillin allergy treatment is complicated:</span>
            </h3>
            <h4 class="color-danger mrgn15b">Please contact infectious diseases for advice</h4>
            <hr />
            <ul class="line30">
                <li>As with all intra-abdominal infections, IV therapy can be rapidly switched to oral therapy if
                    patient is improving &#40;generally within the first 48 hours after intiating IV therapy&#41;.</li>
                <li>The most likely pathogens in SBP are enteric Gram-negative bacilli, such as Escherichia coli and
                    Klebsiella species. Streptococcus pneumoniae, other streptococci, and enterococci occasionally cause
                    infection and are more likely in patients previously on prophylactic treatment. Anaerobic bacteria
                    are uncommon in SBP.</li>
                <li>When available, the results of susceptibility testing should always guide treatment</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on spontaneous bacterial peritonitis</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5b1a -->

    <!-- Start of peritonitis page, SBP, Pen MILD, Proph NO: #intrab5b1b -->
    <div data-role="page" id="intrab5b1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Empirical peritonitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient has not previously been on prophylactic antibiotics treat
                    empirically with:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g &#40;child 1 month or older: 50 mg/kg up to 2 g&#41; IV,
                        daily, until clinical condition improves then switch to oral based on results of culture and
                        susceptibility testing.</span>
                </h4>
                <h4 class="mrgn20b">
                    <span class="color-primary">If signs and symptoms resolve rapidly consider a total treatment length
                        of 5 days &#40;IV &#43; oral&#41;.</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b biteSpecial">
                <span class="font15">Patients with spontaneous bacterial peritonitis and chronic liver disease who have
                    kidney impairment or jaundice are at high risk of developing hepatorenal syndrome. Albumin reduces
                    the rate of acute kidney injury and improves survival. For these adults, use:</span>
                <br>albumin 20% 7.5 mL/kg intravenously, within 6 hours of diagnosis and 5 mL/kg intravenously, as a
                single dose on day 3
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>inb</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>As with all intra-abdominal infections, IV therapy can be rapidly switched to oral therapy if
                    patient is improving &#40;generally within the first 48 hours after intiating IV therapy&#41;.</li>
                <li>The most likely pathogens in SBP are enteric Gram-negative bacilli, such as Escherichia coli and
                    Klebsiella species. Streptococcus pneumoniae, other streptococci, and enterococci occasionally cause
                    infection and are more likely in patients previously on prophylactic treatment. Anaerobic bacteria
                    are uncommon in SBP.</li>
                <li>When available, the results of susceptibility testing should always guide treatment</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on spontaneous bacterial peritonitis</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5b1b -->

    <!-- Start of peritonitis page, SBP, Pen MILD, Proph NO: #intrab5b3a -->
    <div data-role="page" id="intrab5b3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Spontaneous bacterial peritonitis treatment</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">If the patient tolerates penicillin and has previously been on prophylactic
                    antibiotics treat empirically with:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Piperacillin+tazobactam 4+0.5 g &#40;child: 100+12.5 mg/kg up to 4+0.5
                        g&#41; IV, 8-hourly until clinical condition improves or culture results available</span><span
                        class="color-danger mrgn15b"> If the patient has an allergy to piperacillin+tazobactam please
                        contact infectious diseases for advice</span>
                </h4>
                <p class="mrgn20b"><b>Then,</b> after clinical condition improves, step down to oral</p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg &#40;child: 22.5+3.2 mg/kg up to
                        875+125 mg&#41; orally, 12-hourly</span>
                </h4>
            </div>
            <hr>
            <h4 class="mrgn20b biteSpecial">
                <span class="font15">Patients with spontaneous bacterial peritonitis and chronic liver disease who have
                    kidney impairment or jaundice are at high risk of developing hepatorenal syndrome. Albumin reduces
                    the rate of acute kidney injury and improves survival. For these adults, use:</span>
                <br>albumin 20% 7.5 mL/kg intravenously, within 6 hours of diagnosis and 5 mL/kg intravenously, as a
                single dose on day 3
            </h4>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for piperacillin+tazobactam is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>inb</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>As with all intra-abdominal infections, IV therapy can be rapidly switched to oral therapy if
                    patient is improving &#40;generally within the first 48 hours after intiating IV therapy&#41;.</li>
                <li>The most likely pathogens in SBP are enteric Gram-negative bacilli, such as Escherichia coli and
                    Klebsiella species. Streptococcus pneumoniae, other streptococci, and enterococci occasionally cause
                    infection and are more likely in patients previously on prophylactic treatment. Anaerobic bacteria
                    are uncommon in SBP.</li>
                <li>When available, the results of susceptibility testing should always guide treatment</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on spontaneous bacterial peritonitis</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5b3a -->

    <!--PERITONEAL DIALYSIS PERITONITIS MAZE BEGINS -->

    <!-- Start of peritonitis page, peritoneal dialysis -->
    <div data-role="page" id="intrab5c" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab5c1">No penicillin allergy</a></li>
                <li><a href="#intrab5c1">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#intrab5c2">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c -->

    <!-- Start of peritonitis page, peritoneal dialysis, NO or MILD PEN, ?MRSA -->
    <div data-role="page" id="intrab5c1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">Does the patient have a history of previous MRSA colonisation? Or (if unknown) are they at risk of MRSA colonisation? Or otherwise, are they displaying signs of sepsis?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#intrab5c1a">Yes</a></li>
                <li><a href="#intrab5c1b">No</a></li>
            </ul>
            <hr/>
            <ul class="line30">
                <li>Please check the patient's previous admission details. Areas with a high level of MRSA prevalence include detention centres, army barracks, remote communities and gaols</li>
                <li>Patients from the Kimberley, Pilbara, Mid West, Gascoyne and Goldfields-Esperance health regions potentially have higher rates of MRSA carriage</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c1 -->

    <!-- Start of peritonitis page, peritoneal dialysis, NO or MILD PEN, YES MRSA, ?PERF -->
    <div data-role="page" id="intrab5c1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">Is diverticular disease or intestinal perforation suspected?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#intrab5c1a1">Yes</a></li>
                <li><a href="#intrab5c1a2">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c1a -->

    <!-- Start of peritonitis page, peritoneal dialysis, NO or MILD PEN, NO MRSA, ?PERF -->
    <div data-role="page" id="intrab5c1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">Is diverticular disease or intestinal perforation suspected?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#intrab5c1b1">Yes</a></li>
                <li><a href="#intrab5c1b2">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c1b -->

    <!-- Start of peritonitis page, peritoneal dialysis, BAD PEN, ?PERF -->
    <div data-role="page" id="intrab5c2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship"><a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">	
            <h3 class="color-primary mrgn15b">Is diverticular disease or intestinal perforation suspected?</h3>
            <ul data-role="listview"  data-inset="true" class="listview"> 
                <li><a href="#intrab5c2a">Yes</a></li>
                <li><a href="#intrab5c2b">No</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c2 -->

    <!-- Start of peritonitis page, peritoneal dialysis, NO or MILD PEN, YES MRSA, YES PERF -->
    <div data-role="page" id="intrab5c1a1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn20b">Is gentamicin contraindicated in this patient? <span
                class="color-info font15">&#40;See below for contraindications&#41;</span></h3>

        <div data-role="content" class="container-fluid">
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab5c1a1a">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab5c1a1b">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b text-center">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c1a1 -->

    <!-- Start of peritonitis page, peritoneal dialysis, NO or MILD PEN, YES MRSA, NO PERF -->
    <div data-role="page" id="intrab5c1a2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn15b">Is gentamicin contraindicated in this patient? <span
                class="color-info font15">&#40;See below for contraindications&#41;</span></h3>

        <div data-role="content" class="container-fluid">
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab5c1a2a">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab5c1a2b">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b text-center">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c1a2 -->

    <!-- Start of peritonitis page, peritoneal dialysis, NO or MILD PEN, NO MRSA, YES PERF -->
    <div data-role="page" id="intrab5c1b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn15b">Is gentamicin contraindicated in this patient? <span
                class="color-info font15">&#40;See below for contraindications&#41;</span></h3>

        <div data-role="content" class="container-fluid">
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab5c1b1a">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab5c1b1b">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b text-center">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c1b1 -->

    <!-- Start of peritonitis page, peritoneal dialysis, NO or MILD PEN, NO MRSA, NO PERF -->
    <div data-role="page" id="intrab5c1b2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn15b">Is gentamicin contraindicated in this patient? <span
                class="color-info font15">&#40;See below for contraindications&#41;</span></h3>

        <div data-role="content" class="container-fluid">
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab5c1b2a">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab5c1b2b">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b text-center">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c1b2 -->


    <!-- Start of peritonitis page, peritoneal dialysis, BAD PEN, YES PERF -->
    <div data-role="page" id="intrab5c2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn15b">Is gentamicin contraindicated in this patient? <span
                class="color-info font15">&#40;See below for contraindications&#41;</span></h3>

        <div data-role="content" class="container-fluid">
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab5c1a1a">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab5cx">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b text-center">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c2a -->

    <!-- Start of peritonitis page, peritoneal dialysis, BAD PEN, NO PERF -->
    <div data-role="page" id="intrab5c2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <h3 class="color-primary mrgn15b">Is gentamicin contraindicated in this patient? <span
                class="color-info font15">&#40;See below for contraindications&#41;</span></h3>

        <div data-role="content" class="container-fluid">
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#intrab5c1a2a">Gentamicin not contraindicated</a></li>
                <li><a href="#intrab5cx">Gentamicin contraindicated</a></li>
            </ul>
            <h4 class="color-primary mrgn20b text-center">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>
                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>
                    </tr>
                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>
                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>
                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c2b -->

    <!-- Start of peritonitis page, peritoneal dialysis, NO or MILD PEN, YES MRSA, YES PERF, GENT OK -->
    <div data-role="page" id="intrab5c1a1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For peritonitis complicating peritoneal dialysis in a patient at risk of MRSA, with diverticular disease or intestinal perforation who can tolerate gentamicin give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin (adult and child) 0.6 mg/kg up to 50 mg, added to 1 bag of dialysis fluid per day</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin (adult and child) 15 to 30 mg/kg up to 2 g added to 1 bag of dialysis fluid every 3 to 7 days (see when to re-dose below)</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b>, if oral therapy is not possible</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin and gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>pdi</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>All dosing above assumes intermittent dosing with at least a 6 hour dwell time. For continuous intraperitoneal administration please see the Therapeutic Guidelines section on peritonitis complicating peritoneal dialysis</li>
                <li>Modify therapy based on the results of culture and susceptibility testing, if available. After 72 hours of antibiotic therapy, repeat microscopy and culture of dialysate. If results of susceptibility testing are not available by 72 hours and empirical intraperitoneal therapy is still required, stop the gentamicin-containing regimen and seek expert advice. Directed therapy for Gram-positive infections should not include gentamicin.</li>
                <li>If the patient has not improved after 5 days of antibiotic therapy, consider removing the peritoneal dialysis catheter.</li>
                <li>The total duration of therapy is 14 days. For peritonitis caused by S. aureus, Enterococcus species or Gram-negative bacteria, the total duration of therapy is 21 days (irrespective of whether the peritoneal dialysis catheter has been removed).</li>
                <li>The treatment recommendations above apply to both continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD/CCPD)</li>
                <li>To be effective, antibiotics must stay within the peritoneal cavity for at least 6 hours, and this cannot be achieved with automated peritoneal dialysis, which has 1 to 3 hour cycles. To ensure patients undergoing automated peritoneal dialysis are adequately treated, either:
                    <ul>
                        <li>put the antibiotics in a separate 6-hour dwell, which can either be performed by the cycler (called a ‘last fill’) or as a manual continuous ambulatory peritoneal dialysis exchange by the patient, or</li>
                        <li>temporarily switch to continuous ambulatory peritoneal dialysis for the duration of antibiotic treatment</li>
                    </ul>
                </li>
                <li>Indications for removal of the peritoneal dialysis catheter include:
                    <ul>
                        <li>refractory peritonitis (failure to respond to appropriate antibiotics within 5 days)</li>
                        <li>relapsing peritonitis</li>
                        <li>refractory exit-site and tunnel infection</li>
                        <li>fungal or mycobacterial peritonitis</li>
                    </ul>
                </li>
                <li>Clinical monitoring for vestibular and auditory toxicity associated with gentamicin is required. See the Therapeutic Guidelines for signs of vestibular and auditory toxicity</li>
                <li>Monitor trough vancomycin plasma concentration every 3 to 5 days. If the concentration falls below 15 mg/L, repeat the dose of vancomycin, and measure the trough vancomycin plasma concentration in 3 days</li>
                <li>The dosing for vancomycin above assumes intermittent dosing with at least a 6 hour dwell time. If intermittent administration is not possible and continuous vancomycin administration is required please contact infectious diseases for advice</li>
            </ul>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on peritonitis complicating peritoneal dialysis</a> - Antibiotic Expert Groups. Therapeutic
                guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c1a1a -->

    <!-- Start of peritonitis page, peritoneal dialysis, NO or MILD PEN, YES MRSA, YES PERF, GENT BAD -->
    <div data-role="page" id="intrab5c1a1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For peritonitis complicating peritoneal dialysis in a patient with non-severe or no penicillin allergy, at risk of MRSA, with diverticular disease or intestinal perforation who cannot tolerate gentamicin give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefepime 1 g (child: 15 mg/kg up to 1 g) added to 1 bag of dialysis fluid per day</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin (adult and child) 15 to 30 mg/kg up to 2 g added to 1 bag of dialysis fluid every 3 to 7 days (see when to re-dose below)</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b>, if oral therapy is not possible</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>pdi</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>All dosing above assumes intermittent dosing with at least a 6 hour dwell time. For continuous intraperitoneal administration please see the Therapeutic Guidelines section on peritonitis complicating peritoneal dialysis</li>
                <li>Modify therapy based on the results of culture and susceptibility testing, if available. After 72 hours of antibiotic therapy, repeat microscopy and culture of dialysate. If results of susceptibility testing are not available by 72 hours and empirical intraperitoneal therapy is still required seek expert advice.</li>
                <li>If the patient has not improved after 5 days of antibiotic therapy, consider removing the peritoneal dialysis catheter.</li>
                <li>The total duration of therapy is 14 days. For peritonitis caused by S. aureus, Enterococcus species or Gram-negative bacteria, the total duration of therapy is 21 days (irrespective of whether the peritoneal dialysis catheter has been removed).</li>
                <li>The treatment recommendations above apply to both continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD/CCPD)</li>
                <li>To be effective, antibiotics must stay within the peritoneal cavity for at least 6 hours, and this cannot be achieved with automated peritoneal dialysis, which has 1 to 3 hour cycles. To ensure patients undergoing automated peritoneal dialysis are adequately treated, either:
                    <ul>
                        <li>put the antibiotics in a separate 6-hour dwell, which can either be performed by the cycler (called a ‘last fill’) or as a manual continuous ambulatory peritoneal dialysis exchange by the patient, or</li>
                        <li>temporarily switch to continuous ambulatory peritoneal dialysis for the duration of antibiotic treatment</li>
                    </ul>
                </li>
                <li>Indications for removal of the peritoneal dialysis catheter include:
                    <ul>
                        <li>refractory peritonitis (failure to respond to appropriate antibiotics within 5 days)</li>
                        <li>relapsing peritonitis</li>
                        <li>refractory exit-site and tunnel infection</li>
                        <li>fungal or mycobacterial peritonitis</li>
                    </ul>
                </li>
                <li>Monitor trough vancomycin plasma concentration every 3 to 5 days. If the concentration falls below 15 mg/L, repeat the dose of vancomycin, and measure the trough vancomycin plasma concentration in 3 days</li>
                <li>The dosing for vancomycin above assumes intermittent dosing with at least a 6 hour dwell time. If intermittent administration is not possible and continuous vancomycin administration is required please contact infectious diseases for advice</li>
            </ul>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on peritonitis complicating peritoneal dialysis</a> - Antibiotic Expert Groups. Therapeutic
                guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c1a1b -->

<!-- Start of peritonitis page, peritoneal dialysis, NO or MILD PEN OR BAD, YES MRSA, NO PERF, GENT OK -->
<div data-role="page" id="intrab5c1a2a" data-theme="a">
    <div data-role="header" class="frontpage">
        <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
        <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                Stewardship</a></h1>
    </div>
    <!-- /header -->
    <div data-role="header" class="secondpage">
        <h1>Peritonitis complicating peritoneal dialysis</h1>
    </div>
    <!-- /header -->
    <div data-role="content" class="container-fluid">
        <h3 class="color-primary mrgn15b">For peritonitis complicating peritoneal dialysis, at risk of MRSA or with severe penicillin allergy, without diverticular disease or intestinal perforation who can tolerate gentamicin give:</h3>
        <div id="backcolour">
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Gentamicin (adult and child) 0.6 mg/kg up to 50 mg, added to 1 bag of dialysis fluid per day</span>
            </h4>
            <p class="mrgn20b"><b>AND</b></p>
            <h4 class="medicine mrgn20b">
                <span class="color-purple">Vancomycin (adult and child) 15 to 30 mg/kg up to 2 g added to 1 bag of dialysis fluid every 3 to 7 days (see when to re-dose below)</span>
            </h4>
        </div>
        <hr />
        <h4 class="mrgn20b text-center codefor">
            <span class="color-success">Code for vancomycin and gentamicin is:</span>
            <span class="font15 bold"> 2<script> document.write(getCode())</script>pdi</span>
            <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                continue past 48 hours. Please annotate this code on the medication chart and document when
                infectious diseases are to be contacted in the patient notes.</div>
        </h4>
        <hr>
        <ul class="line30">
            <li>All dosing above assumes intermittent dosing with at least a 6 hour dwell time. For continuous intraperitoneal administration please see the Therapeutic Guidelines section on peritonitis complicating peritoneal dialysis</li>
            <li>Modify therapy based on the results of culture and susceptibility testing, if available. After 72 hours of antibiotic therapy, repeat microscopy and culture of dialysate. If results of susceptibility testing are not available by 72 hours and empirical intraperitoneal therapy is still required, stop the gentamicin-containing regimen and seek expert advice. Directed therapy for Gram-positive infections should not include gentamicin.</li>
            <li>If the patient has not improved after 5 days of antibiotic therapy, consider removing the peritoneal dialysis catheter.</li>
            <li>The total duration of therapy is 14 days. For peritonitis caused by S. aureus, Enterococcus species or Gram-negative bacteria, the total duration of therapy is 21 days (irrespective of whether the peritoneal dialysis catheter has been removed).</li>
            <li>The treatment recommendations above apply to both continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD/CCPD)</li>
            <li>To be effective, antibiotics must stay within the peritoneal cavity for at least 6 hours, and this cannot be achieved with automated peritoneal dialysis, which has 1 to 3 hour cycles. To ensure patients undergoing automated peritoneal dialysis are adequately treated, either:
                <ul>
                    <li>put the antibiotics in a separate 6-hour dwell, which can either be performed by the cycler (called a ‘last fill’) or as a manual continuous ambulatory peritoneal dialysis exchange by the patient, or</li>
                    <li>temporarily switch to continuous ambulatory peritoneal dialysis for the duration of antibiotic treatment</li>
                </ul>
            </li>
            <li>Indications for removal of the peritoneal dialysis catheter include:
                <ul>
                    <li>refractory peritonitis (failure to respond to appropriate antibiotics within 5 days)</li>
                    <li>relapsing peritonitis</li>
                    <li>refractory exit-site and tunnel infection</li>
                    <li>fungal or mycobacterial peritonitis</li>
                </ul>
            </li>
            <li>Clinical monitoring for vestibular and auditory toxicity associated with gentamicin is required. See the Therapeutic Guidelines for signs of vestibular and auditory toxicity</li>
            <li>Monitor trough vancomycin plasma concentration every 3 to 5 days. If the concentration falls below 15 mg/L, repeat the dose of vancomycin, and measure the trough vancomycin plasma concentration in 3 days</li>
            <li>The dosing for vancomycin above assumes intermittent dosing with at least a 6 hour dwell time. If intermittent administration is not possible and continuous vancomycin administration is required please contact infectious diseases for advice</li>
        </ul>
    <hr>
    <h4 class="mrgn20b references">
        <span class="color-purple"><b>References: </b></span><br><br>
        <span class="font15"><a
                href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                target="_blank">See section on peritonitis complicating peritoneal dialysis</a> - Antibiotic Expert Groups. Therapeutic
            guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
    </h4>
    </div>
    <!-- /content -->
    <div class="footer">
        <a href="index.html" class="btn btn-lg btn-success"><span
                class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
    </div>
    <!-- /footer -->
</div>
<!-- /intrab5c1a2a -->
    
    <!-- Start of peritonitis page, peritoneal dialysis, NO or MILD PEN, YES MRSA, NO PERF, GENT BAD -->
    <div data-role="page" id="intrab5c1a2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For peritonitis complicating peritoneal dialysis in a patient with non-severe or no penicillin allergy, at risk of MRSA, without diverticular disease or intestinal perforation who cannot tolerate gentamicin give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefepime 1 g (child: 15 mg/kg up to 1 g) added to 1 bag of dialysis fluid per day</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Vancomycin (adult and child) 15 to 30 mg/kg up to 2 g added to 1 bag of dialysis fluid every 3 to 7 days (see when to re-dose below)</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for vancomycin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>pdi</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>All dosing above assumes intermittent dosing with at least a 6 hour dwell time. For continuous intraperitoneal administration please see the Therapeutic Guidelines section on peritonitis complicating peritoneal dialysis</li>
                <li>Modify therapy based on the results of culture and susceptibility testing, if available. After 72 hours of antibiotic therapy, repeat microscopy and culture of dialysate. If results of susceptibility testing are not available by 72 hours and empirical intraperitoneal therapy is still required seek expert advice.</li>
                <li>If the patient has not improved after 5 days of antibiotic therapy, consider removing the peritoneal dialysis catheter.</li>
                <li>The total duration of therapy is 14 days. For peritonitis caused by S. aureus, Enterococcus species or Gram-negative bacteria, the total duration of therapy is 21 days (irrespective of whether the peritoneal dialysis catheter has been removed).</li>
                <li>The treatment recommendations above apply to both continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD/CCPD)</li>
                <li>To be effective, antibiotics must stay within the peritoneal cavity for at least 6 hours, and this cannot be achieved with automated peritoneal dialysis, which has 1 to 3 hour cycles. To ensure patients undergoing automated peritoneal dialysis are adequately treated, either:
                    <ul>
                        <li>put the antibiotics in a separate 6-hour dwell, which can either be performed by the cycler (called a ‘last fill’) or as a manual continuous ambulatory peritoneal dialysis exchange by the patient, or</li>
                        <li>temporarily switch to continuous ambulatory peritoneal dialysis for the duration of antibiotic treatment</li>
                    </ul>
                </li>
                <li>Indications for removal of the peritoneal dialysis catheter include:
                    <ul>
                        <li>refractory peritonitis (failure to respond to appropriate antibiotics within 5 days)</li>
                        <li>relapsing peritonitis</li>
                        <li>refractory exit-site and tunnel infection</li>
                        <li>fungal or mycobacterial peritonitis</li>
                    </ul>
                </li>
                <li>Monitor trough vancomycin plasma concentration every 3 to 5 days. If the concentration falls below 15 mg/L, repeat the dose of vancomycin, and measure the trough vancomycin plasma concentration in 3 days</li>
                <li>The dosing for vancomycin above assumes intermittent dosing with at least a 6 hour dwell time. If intermittent administration is not possible and continuous vancomycin administration is required please contact infectious diseases for advice</li>
            </ul>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on peritonitis complicating peritoneal dialysis</a> - Antibiotic Expert Groups. Therapeutic
                guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c1a2b -->

    <!-- Start of peritonitis page, peritoneal dialysis, NO or MILD PEN, NO MRSA, YES PERF, GENT OK -->
    <div data-role="page" id="intrab5c1b1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For peritonitis complicating peritoneal dialysis in a patient with non-severe or no penicillin allergy, not at risk of MRSA, with diverticular disease or intestinal perforation who can tolerate gentamicin give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin (adult and child) 0.6 mg/kg up to 50 mg, added to 1 bag of dialysis fluid per day</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin (adult and child) 15 mg/kg added to 1 bag of dialysis fluid per day</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b>, if oral therapy is not possible</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>pdi</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>All dosing above assumes intermittent dosing with at least a 6 hour dwell time. For continuous intraperitoneal administration please see the Therapeutic Guidelines section on peritonitis complicating peritoneal dialysis</li>
                <li>Modify therapy based on the results of culture and susceptibility testing, if available. After 72 hours of antibiotic therapy, repeat microscopy and culture of dialysate. If results of susceptibility testing are not available by 72 hours and empirical intraperitoneal therapy is still required, stop the gentamicin-containing regimen and seek expert advice. Directed therapy for Gram-positive infections should not include gentamicin.</li>
                <li>If the patient has not improved after 5 days of antibiotic therapy, consider removing the peritoneal dialysis catheter.</li>
                <li>The total duration of therapy is 14 days. For peritonitis caused by S. aureus, Enterococcus species or Gram-negative bacteria, the total duration of therapy is 21 days (irrespective of whether the peritoneal dialysis catheter has been removed).</li>
                <li>The treatment recommendations above apply to both continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD/CCPD)</li>
                <li>To be effective, antibiotics must stay within the peritoneal cavity for at least 6 hours, and this cannot be achieved with automated peritoneal dialysis, which has 1 to 3 hour cycles. To ensure patients undergoing automated peritoneal dialysis are adequately treated, either:
                    <ul>
                        <li>put the antibiotics in a separate 6-hour dwell, which can either be performed by the cycler (called a ‘last fill’) or as a manual continuous ambulatory peritoneal dialysis exchange by the patient, or</li>
                        <li>temporarily switch to continuous ambulatory peritoneal dialysis for the duration of antibiotic treatment</li>
                    </ul>
                </li>
                <li>Indications for removal of the peritoneal dialysis catheter include:
                    <ul>
                        <li>refractory peritonitis (failure to respond to appropriate antibiotics within 5 days)</li>
                        <li>relapsing peritonitis</li>
                        <li>refractory exit-site and tunnel infection</li>
                        <li>fungal or mycobacterial peritonitis</li>
                    </ul>
                </li>
                <li>Clinical monitoring for vestibular and auditory toxicity associated with gentamicin is required. See the Therapeutic Guidelines for signs of vestibular and auditory toxicity</li>
            </ul>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on peritonitis complicating peritoneal dialysis</a> - Antibiotic Expert Groups. Therapeutic
                guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c1b1a -->

    <!-- Start of peritonitis page, peritoneal dialysis, NO or MILD PEN, NO MRSA, YES PERF, GENT BAD -->
    <div data-role="page" id="intrab5c1b1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For peritonitis complicating peritoneal dialysis in a patient with non-severe or no penicillin allergy, not at risk of MRSA, with diverticular disease or intestinal perforation who cannot tolerate gentamicin give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefepime 1 g (child: 15 mg/kg up to 1 g) added to 1 bag of dialysis fluid per day</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Metronidazole 400 mg (child: 10 mg/kg up to 400 mg) orally, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>OR</b>, if oral therapy is not possible</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefepime is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>pdi</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>All dosing above assumes intermittent dosing with at least a 6 hour dwell time. For continuous intraperitoneal administration please see the Therapeutic Guidelines section on peritonitis complicating peritoneal dialysis</li>
                <li>Modify therapy based on the results of culture and susceptibility testing, if available. After 72 hours of antibiotic therapy, repeat microscopy and culture of dialysate. If results of susceptibility testing are not available by 72 hours and empirical intraperitoneal therapy is still required, seek expert advice.</li>
                <li>If the patient has not improved after 5 days of antibiotic therapy, consider removing the peritoneal dialysis catheter.</li>
                <li>The total duration of therapy is 14 days. For peritonitis caused by S. aureus, Enterococcus species or Gram-negative bacteria, the total duration of therapy is 21 days (irrespective of whether the peritoneal dialysis catheter has been removed).</li>
                <li>The treatment recommendations above apply to both continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD/CCPD)</li>
                <li>To be effective, antibiotics must stay within the peritoneal cavity for at least 6 hours, and this cannot be achieved with automated peritoneal dialysis, which has 1 to 3 hour cycles. To ensure patients undergoing automated peritoneal dialysis are adequately treated, either:
                    <ul>
                        <li>put the antibiotics in a separate 6-hour dwell, which can either be performed by the cycler (called a ‘last fill’) or as a manual continuous ambulatory peritoneal dialysis exchange by the patient, or</li>
                        <li>temporarily switch to continuous ambulatory peritoneal dialysis for the duration of antibiotic treatment</li>
                    </ul>
                </li>
                <li>Indications for removal of the peritoneal dialysis catheter include:
                    <ul>
                        <li>refractory peritonitis (failure to respond to appropriate antibiotics within 5 days)</li>
                        <li>relapsing peritonitis</li>
                        <li>refractory exit-site and tunnel infection</li>
                        <li>fungal or mycobacterial peritonitis</li>
                    </ul>
                </li>
            </ul>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on peritonitis complicating peritoneal dialysis</a> - Antibiotic Expert Groups. Therapeutic
                guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c1b1b -->

    <!-- Start of peritonitis page, peritoneal dialysis, NO or MILD PEN, NO MRSA, NO PERF, GENT OK -->
    <div data-role="page" id="intrab5c1b2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For peritonitis complicating peritoneal dialysis in a patient with non-severe or no penicillin allergy, not at risk of MRSA, with diverticular disease or intestinal perforation who can tolerate gentamicin give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Gentamicin (adult and child) 0.6 mg/kg up to 50 mg, added to 1 bag of dialysis fluid per day</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefazolin (adult and child) 15 mg/kg added to 1 bag of dialysis fluid per day</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>pdi</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>All dosing above assumes intermittent dosing with at least a 6 hour dwell time. For continuous intraperitoneal administration please see the Therapeutic Guidelines section on peritonitis complicating peritoneal dialysis</li>
                <li>Modify therapy based on the results of culture and susceptibility testing, if available. After 72 hours of antibiotic therapy, repeat microscopy and culture of dialysate. If results of susceptibility testing are not available by 72 hours and empirical intraperitoneal therapy is still required, stop the gentamicin-containing regimen and seek expert advice. Directed therapy for Gram-positive infections should not include gentamicin.</li>
                <li>If the patient has not improved after 5 days of antibiotic therapy, consider removing the peritoneal dialysis catheter.</li>
                <li>The total duration of therapy is 14 days. For peritonitis caused by S. aureus, Enterococcus species or Gram-negative bacteria, the total duration of therapy is 21 days (irrespective of whether the peritoneal dialysis catheter has been removed).</li>
                <li>The treatment recommendations above apply to both continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD/CCPD)</li>
                <li>To be effective, antibiotics must stay within the peritoneal cavity for at least 6 hours, and this cannot be achieved with automated peritoneal dialysis, which has 1 to 3 hour cycles. To ensure patients undergoing automated peritoneal dialysis are adequately treated, either:
                    <ul>
                        <li>put the antibiotics in a separate 6-hour dwell, which can either be performed by the cycler (called a ‘last fill’) or as a manual continuous ambulatory peritoneal dialysis exchange by the patient, or</li>
                        <li>temporarily switch to continuous ambulatory peritoneal dialysis for the duration of antibiotic treatment</li>
                    </ul>
                </li>
                <li>Indications for removal of the peritoneal dialysis catheter include:
                    <ul>
                        <li>refractory peritonitis (failure to respond to appropriate antibiotics within 5 days)</li>
                        <li>relapsing peritonitis</li>
                        <li>refractory exit-site and tunnel infection</li>
                        <li>fungal or mycobacterial peritonitis</li>
                    </ul>
                </li>
                <li>Clinical monitoring for vestibular and auditory toxicity associated with gentamicin is required. See the Therapeutic Guidelines for signs of vestibular and auditory toxicity</li>
            </ul>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on peritonitis complicating peritoneal dialysis</a> - Antibiotic Expert Groups. Therapeutic
                guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c1b2a -->

    <!-- Start of peritonitis page, peritoneal dialysis, NO or MILD PEN, NO MRSA, NO PERF, GENT BAD -->
    <div data-role="page" id="intrab5c1b2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="color-primary mrgn15b">For peritonitis complicating peritoneal dialysis in a patient with non-severe or no penicillin allergy, not at risk of MRSA, with no diverticular disease or intestinal perforation who cannot tolerate gentamicin give:</h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Cefepime 1 g (child: 15 mg/kg up to 1 g) added to 1 bag of dialysis fluid per day</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for cefepime is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>pdi</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr>
            <ul class="line30">
                <li>All dosing above assumes intermittent dosing with at least a 6 hour dwell time. For continuous intraperitoneal administration please see the Therapeutic Guidelines section on peritonitis complicating peritoneal dialysis</li>
                <li>Modify therapy based on the results of culture and susceptibility testing, if available. After 72 hours of antibiotic therapy, repeat microscopy and culture of dialysate. If results of susceptibility testing are not available by 72 hours and empirical intraperitoneal therapy is still required, seek expert advice.</li>
                <li>If the patient has not improved after 5 days of antibiotic therapy, consider removing the peritoneal dialysis catheter.</li>
                <li>The total duration of therapy is 14 days. For peritonitis caused by S. aureus, Enterococcus species or Gram-negative bacteria, the total duration of therapy is 21 days (irrespective of whether the peritoneal dialysis catheter has been removed).</li>
                <li>The treatment recommendations above apply to both continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD/CCPD)</li>
                <li>To be effective, antibiotics must stay within the peritoneal cavity for at least 6 hours, and this cannot be achieved with automated peritoneal dialysis, which has 1 to 3 hour cycles. To ensure patients undergoing automated peritoneal dialysis are adequately treated, either:
                    <ul>
                        <li>put the antibiotics in a separate 6-hour dwell, which can either be performed by the cycler (called a ‘last fill’) or as a manual continuous ambulatory peritoneal dialysis exchange by the patient, or</li>
                        <li>temporarily switch to continuous ambulatory peritoneal dialysis for the duration of antibiotic treatment</li>
                    </ul>
                </li>
                <li>Indications for removal of the peritoneal dialysis catheter include:
                    <ul>
                        <li>refractory peritonitis (failure to respond to appropriate antibiotics within 5 days)</li>
                        <li>relapsing peritonitis</li>
                        <li>refractory exit-site and tunnel infection</li>
                        <li>fungal or mycobacterial peritonitis</li>
                    </ul>
                </li>
            </ul>
        <hr>
        <h4 class="mrgn20b references">
            <span class="color-purple"><b>References: </b></span><br><br>
            <span class="font15"><a
                    href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                    target="_blank">See section on peritonitis complicating peritoneal dialysis</a> - Antibiotic Expert Groups. Therapeutic
                guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
        </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5c1b2b -->

    <!-- Start of peritoneal dialysis peritonitis bail out page -->
    <div data-role="page" id="intrab5cx" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship">
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Peritonitis complicating peritoneal dialysis treatment</h1>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h4 class="color-primary mrgn15b">If gentamicin is contraindicated:</h4>
            <h4 class="color-danger mrgn15b">Treatment options are limited. Please contact infectious diseases for advice</h4>
            <hr>
            <ul class="line30">
                <li>Modify therapy based on the results of culture and susceptibility testing, if available. After 72 hours of antibiotic therapy, repeat microscopy and culture of dialysate. If results of susceptibility testing are not available by 72 hours and empirical intraperitoneal therapy is still required, seek expert advice.</li>
                <li>If the patient has not improved after 5 days of antibiotic therapy, consider removing the peritoneal dialysis catheter.</li>
                <li>The total duration of therapy is 14 days. For peritonitis caused by S. aureus, Enterococcus species or Gram-negative bacteria, the total duration of therapy is 21 days (irrespective of whether the peritoneal dialysis catheter has been removed).</li>
                <li>The treatment recommendations above apply to both continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD/CCPD)</li>
                <li>To be effective, antibiotics must stay within the peritoneal cavity for at least 6 hours, and this cannot be achieved with automated peritoneal dialysis, which has 1 to 3 hour cycles. To ensure patients undergoing automated peritoneal dialysis are adequately treated, either:
                    <ul>
                        <li>put the antibiotics in a separate 6-hour dwell, which can either be performed by the cycler (called a ‘last fill’) or as a manual continuous ambulatory peritoneal dialysis exchange by the patient, or</li>
                        <li>temporarily switch to continuous ambulatory peritoneal dialysis for the duration of antibiotic treatment</li>
                    </ul>
                </li>
                <li>Indications for removal of the peritoneal dialysis catheter include:
                    <ul>
                        <li>refractory peritonitis (failure to respond to appropriate antibiotics within 5 days)</li>
                        <li>relapsing peritonitis</li>
                        <li>refractory exit-site and tunnel infection</li>
                        <li>fungal or mycobacterial peritonitis</li>
                    </ul>
                </li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on peritonitis complicating peritoneal dialysis</a> - Antibiotic Expert Groups. Therapeutic
                    guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019. </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /intrab5cx -->

    <!--END OF PERITONITIS MAZES-->

    <!-- start of Pelvic Inflammatory treatment maze -->
    <!-- Start of PID page: #pelvi -->
    <div data-role="page" id="pelvi" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pelvic inflammatory disease</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15">See below for details on penicillin allergy severity</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pelvi1">No penicillin allergy</a></li>
                <li><a href="#pelvi1">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#pelvi3">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pelvi -->

    <!-- Start of pelvic inflammatory disease page, no or mild Pen allergy, ?Severe: #pelvi1 -->
    <div data-role="page" id="pelvi1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pelvic inflammatory disease</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the pelvic inflammatory disease classed as severe?</span>
                <span class="font15"> &#40;See below&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pelvi1a">Non-severe</a></li>
                <li><a href="#pelvi1b">Severe</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Severity includes: severe pain, fever &#40;38°C or higher&#41;, systemic features &#40;eg
                    tachycardia, vomiting&#41;, sepsis or septic shock, or suspected tubo-ovarian abscess, pregnancy.
                </li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pelvi1 -->


    <!-- Start of pelvic inflammatory disease page, no or BAD Pen allergy, ?Severe: #pelvi3 -->
    <div data-role="page" id="pelvi3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pelvic inflammatory disease</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the pelvic inflammatory disease classed as severe?</span>
                <span class="font15"> &#40;See below&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pelvi3a">Non-severe</a></li>
                <li><a href="#pelvi3b">Severe</a></li>
            </ul>
            <hr />
            <ul class="line30">
                <li>Severity includes: severe pain, fever &#40;38°C or higher&#41;, systemic features &#40;eg
                    tachycardia, vomiting&#41;, sepsis or septic shock, or suspected tubo-ovarian abscess, pregnancy.
                </li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pelvi3 -->

    <!-- Start of Pelvic Inflammatory disease Tx PEN BAD, SEVERE ?Gent OK: Gent Q #pelvi3b -->
    <div data-role="page" id="pelvi3b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pelvic inflammatory disease</h1>
            <br>
        </div>
        <!-- /header -->

        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is gentamicin contraindicated in this patient?</span>
                <span class="font15"> &#40;See below for contraindications&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pelvi3b1">Gentamicin not contraindicated</a></li>
                <li><a href="#pelvix">Gentamicin contraindicated</a></li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Aminoglycoside Contraindications and Precautions</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Contraindications</th>
                        <th>Precautions</th>
                    </tr>

                    <tr>
                        <td>History of vestibular or auditory toxicity caused by an aminoglycoside</td>
                        <td>Pre-existing significant auditory impairment &#40;hearing loss or tinnitus&#41;</td>

                    </tr>

                    <tr>
                        <td>History of serious hypersensitivity reaction to an aminoglycoside (rare)</td>
                        <td>Pre-existing vestibular condition (dizziness, vertigo or balance problems)</td>
                    </tr>

                    <tr>
                        <td>Myasthenia gravis</td>
                        <td>Family history (first-degree relative) of auditory toxicity caused by an aminoglycoside</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Chronic renal impairment (creatinine clearance less than 40 mL/min) or rapidly deteriorating
                            renal function</td>

                    </tr>
                    <tr>
                        <td></td>
                        <td>Advanced age (eg 80 years or older), depending on calculated renal function</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If you are unsure whether gentamicin is appropriate for this patient please consult infectious
                    diseases</li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pelvi3b -->

    <!--  PID TREATMENTS BEGIN -->
    <!-- Start of PID page Pen MILD or OK, Non-severe: #pelvi1a -->
    <div data-role="page" id="pelvi1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pelvic inflammatory disease</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For non-severe PID treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 500 mg IM, with 2mL of 1% lignocaine as a single dose</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg orally, 12-hourly for 14 days</span>
                </h4>
                <p class="mrgn20b"><b>PLUS EITHER</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Doxycycline 100mg orally, 12-hourly
                        for 14 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> for women who are pregnant or suspected to be nonadherent to doxycycline
                </p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Azithromycin 1 g orally, as a single
                        dose, repeated 1 week later</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for azithromycin orally is:</span>
                <span class="font15 bold"> 8<script> document.write(getCode())</script>pel</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> doses only. Starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if treatment is to
                    continue past two doses. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 1<script> document.write(getCode())</script>pel</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>ONE</b> dose only. infectious diseases
                    must be contacted if treatment is to continue past 24 hours. Please annotate this code on the
                    medication chart and document when infectious diseases are to be contacted in the patient notes.
                </div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Assess the response to therapy within 72 hours and if the patient has not improved, re-evaluate the
                    diagnosis and consider switching to intravenous antibiotic therapy</li>
                <li>Caution patient not to drink alcohol while taking metronidazole</li>
                <li>Ensure that endocervical swabs are collected for PCR testing for <i>C. trachomatis</i>, <i>M.
                        genitalium</i> and <i>N. gonorrhoeae</i>, and for microscopy, culture and sensitivity testing
                </li>
                <li>Perform a test of cure 1 month after starting treatment for pelvic inflammatory disease if a
                    sexually transmitted pathogen was detected</li>
                <li>If <i>N. gonorrhoeae</i> is identified in the index case, presumptively treat sexual contacts</li>
                <li>f <i>C. trachomatis</i> is identified in the index case, further treatment of sexual contacts is not
                    required. If <i>C. trachomatis</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, undertake contact tracing for that individual</li>
                <li>If <i>M. genitalium</i> is identified in the index case, further treatment of sexual contacts is not
                    required. If <i>M. genitalium</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, perform a test of cure at least 3 weeks after presumptive
                    treatment with azithromycin.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on pelvic inflammatory disease</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pelvi1a -->

    <!-- Start of PID page Pen BAD, Non-severe: #pelvi3a -->
    <div data-role="page" id="pelvi3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pelvic inflammatory disease</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For non-severe PID treatment:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg orally, 12-hourly for 14 days</span>
                </h4>
                <p class="mrgn20b"><b>PLUS EITHER</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Doxycycline 100mg orally, 12-hourly
                        for 14 days</span>
                </h4>
                <p class="mrgn20b"><b>OR</b> for women who are pregnant or suspected to be nonadherent to doxycycline
                </p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9313;</span><span class="color-purple"> Azithromycin 1 g orally, as a single
                        dose, repeated 1 week later</span>
                </h4>
                <p class="color-danger mrgn20b">Note: this regimen will not cover <i>Neisseria gonorrhoeae</i> if
                    <i>Neisseria gonorrhoeae</i> is isolated seek expert advice</p>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for azithromycin orally is:</span>
                <span class="font15 bold"> 8<script> document.write(getCode())</script>pel</span>
            </h4>
            <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> doses only. Starting from the first
                day of treatment for this condition. Infectious diseases must be contacted if treatment is to continue
                past two doses. Please annotate this code on the medication chart and document when infectious diseases
                are to be contacted in the patient notes.</div>
            <hr />
            <ul class="line30">
                <li>Assess the response to therapy within 72 hours and if the patient has not improved, re-evaluate the
                    diagnosis and consider switching to intravenous antibiotic therapy</li>
                <li>Caution patient not to drink alcohol while taking metronidazole</li>
                <li>Ensure that endocervical swabs are collected for PCR testing for <i>C. trachomatis</i>, <i>M.
                        genitalium</i> and <i>N. gonorrhoeae</i>, and for microscopy, culture and sensitivity testing
                </li>
                <li>Perform a test of cure 1 month after starting treatment for pelvic inflammatory disease if a
                    sexually transmitted pathogen was detected</li>
                <li>If <i>N. gonorrhoeae</i> is identified in the index case, presumptively treat sexual contacts</li>
                <li>If <i>C. trachomatis</i> is identified in the index case, further treatment of sexual contacts is
                    not required. If <i>C. trachomatis</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, undertake contact tracing for that individual</li>
                <li>If <i>M. genitalium</i> is identified in the index case, further treatment of sexual contacts is not
                    required. If <i>M. genitalium</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, perform a test of cure at least 3 weeks after presumptive
                    treatment with azithromycin.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on pelvic inflammatory disease</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pelvi3a -->

    <!-- Start of PID page Pen MILD or OK, Severe: #pelvi1b -->
    <div data-role="page" id="pelvi1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe Pelvic inflammatory disease</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For severe or septic PID treatment give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Azithromycin 500 mg IV, daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Ceftriaxone 2 g IV, daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg IV, 12-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for azithromycin iv and ceftriaxone is:</span>
                <span class="font15 bold"> 3<script> document.write(getCode())</script>pev</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>THREE</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 72 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Wherever possible ensure that 2 x blood cultures are taken prior to administration of antibiotics to
                    allow directed therapy</li>
                <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities
                    are available </li>
                <li>If septic, door to needle time must be within <u>ONE HOUR</u> of recognition of septic shock</li>
                <li>If septic, repeat fluid bolus every 15 minutes until patient is normotensive. </li>
                <li>If patient is not normotensive after administration of &gt; 3L of fluid, move the patient to the
                    resuscitation room ASAP if in ED, inform the supervising medical officer &#40;senior emergency
                    doctor or registrar/consultant if on a ward&#41;, refer for urgent ICU assessment . Please see the
                    severe sepsis treatment notes in the Therapeutic Guidelines for more details</li>
                <li>Please contact infectious diseases within 24 hours to rationalise antibiotics once blood culture
                    results return.</li>
                <li>Ensure that endocervical swabs are collected for PCR testing for <i>C. trachomatis</i> and <i>N.
                        gonorrhoeae</i>, and for microscopy, culture and sensitivity testing</li>
                <li>Ensure that endocervical swabs are collected for PCR testing for <i>C. trachomatis</i>, <i>M.
                        genitalium</i> and <i>N. gonorrhoeae</i>, and for microscopy, culture and sensitivity testing
                </li>
                <li>Perform a test of cure 1 month after starting treatment for pelvic inflammatory disease if a
                    sexually transmitted pathogen was detected</li>
                <li>If <i>N. gonorrhoeae</i> is identified in the index case, presumptively treat sexual contacts</li>
                <li>If <i>C. trachomatis</i> is identified in the index case, further treatment of sexual contacts is
                    not required. If <i>C. trachomatis</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, undertake contact tracing for that individual</li>
                <li>If <i>M. genitalium</i> is identified in the index case, further treatment of sexual contacts is not
                    required. If <i>M. genitalium</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, perform a test of cure at least 3 weeks after presumptive
                    treatment with azithromycin.</li>
                <li>Check the Therapeutic Guidelines for details on when to make the switch to oral antibiotics</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on pelvic inflammatory disease</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pelvi1b -->


    <!-- Start of PID page generic contact infectious diseases for most pregnant or non-compliant patients: #pelvix -->
    <div data-role="page" id="pelvix" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Pelvic inflammatory disease in a complex patient:</span>
            </h3>
            <h4 class="color-danger mrgn15b">Please contact infectious diseases for advice</h4>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on pelvic inflammatory disease</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pelvix -->


    <!--Start of PID page Pen BAD, Severe, Gent OK: #pelvi3b1 -->
    <div data-role="page" id="pelvi3b1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Pelvic inflammatory disease</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For severe or septic PID treatment give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Azithromycin 500 mg IV, daily</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17"><span class="color-purple">Gentamicin given over 3-5 minutes intravenously,
                            then dosed as per nomogram below or use the <a href="dosecalcs.html#dose12">gentamicin
                                empiric dose calculator for adults</a></span></span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">Septic shock or requiring intensive care support, but without
                                        known or likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Septic shock or requiring intensive care support, with known or
                                        likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Without septic shock and not requiring intensive care
                                        support:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600mg IV, 8-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for clindamycin, azithromycin iv and gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>pel</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Wherever possible ensure that 2 x blood cultures are taken prior to administration of antibiotics to
                    allow directed therapy</li>
                <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities
                    are available </li>
                <li>If septic, door to needle time must be within <u>ONE HOUR</u> of recognition of septic shock</li>
                <li>If septic, repeat fluid bolus every 15 minutes until patient is normotensive. </li>
                <li>If patient is not normotensive after administration of &gt; 3L of fluid, move the patient to the
                    resuscitation room ASAP if in ED, inform the supervising medical officer &#40;senior emergency
                    doctor or registrar/consultant if on a ward&#41;, refer for urgent ICU assessment. Please see the
                    severe sepsis treatment notes in the Therapeutic Guidelines for more details</li>
                <li>Please contact infectious diseases within 24 hours to rationalise antibiotics once blood culture
                    results return.</li>
                <li>Ensure that endocervical swabs are collected for PCR testing for <i>C. trachomatis</i> and <i>N.
                        gonorrhoeae</i>, and for microscopy, culture and sensitivity testing</li>
                <li>Ensure that endocervical swabs are collected for PCR testing for <i>C. trachomatis</i>, <i>M.
                        genitalium</i> and <i>N. gonorrhoeae</i>, and for microscopy, culture and sensitivity testing
                </li>
                <li>Perform a test of cure 1 month after starting treatment for pelvic inflammatory disease if a
                    sexually transmitted pathogen was detected</li>
                <li>If <i>N. gonorrhoeae</i> is identified in the index case, presumptively treat sexual contacts</li>
                <li>If <i>C. trachomatis</i> is identified in the index case, further treatment of sexual contacts is
                    not required. If <i>C. trachomatis</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, undertake contact tracing for that individual</li>
                <li>If <i>M. genitalium</i> is identified in the index case, further treatment of sexual contacts is not
                    required. If <i>M. genitalium</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, perform a test of cure at least 3 weeks after presumptive
                    treatment with azithromycin.</li>
                <li>Check the Therapeutic Guidelines for details on when to make the switch to oral antibiotics</li>
            </ul>
            <hr>
            <h4 class="color-primary mrgn20b">Initial Paediatric Gentamicin Dosing &#40;Age &lt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th colspan="2">Age</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>
                    <tr>
                        <td rowspan="3">Neonates &lt;30 weeks<br> postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>5 mg/kg</td>
                        <td>48-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 to 28 days</td>
                        <td>4 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 29 days or older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td rowspan="2">neonates 30 to 34 <br>weeks postmenstrual age</td>
                        <td>postnatal age<br> 0 to 7 days</td>
                        <td>4.5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>
                    <tr>
                        <td>postnatal age<br> 8 days and older</td>
                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">neonates 35 weeks<br> postmenstrual age or older </td>

                        <td>4 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                    <tr>
                        <td colspan="2">infants and children</td>
                        <td>7.5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>For dosing in children with cystic fibrosis or those receiving chemotherapy, seek expert advice.
                </li>
                <li>For dosing in children with impaired renal function give a single dose, then seek expert advice.
                </li>
                <li>Postmenstrual age is the time elapsed between the first day of the last menstrual period and birth
                    &#40;gestational age&#41; plus the time elapsed after birth &#40;postnatal age&#41;.</li>
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true">Therapeutic
                        Guidelines - Clinical Monitoring for aminoglycoside toxicity</a> section for more information on
                    monitoring for possible aminoglycoside toxicity</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Pelvic Inflammatory Disease Treatment</a> section for
                    more information on treatment of pelvic inflammatory disease</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pelvi3b1 -->
    <!-- END of PELVIC INFLAMMATORY DISEASE maze -->

    <!-- START OF POSTPROCEDURAL PELVIC INFECTION MAZE -->

    <!-- Start of post procedural pelvic inflammatory disease infection ?Pen allergy -->
    <div data-role="page" id="pospel" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Postprocedural pelvic infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Does the patient have a penicillin allergy?</span>
                <span class="font15"> &#40;See below for details on penicillin allergy severity&#41;</span>
            </h3>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pospel1">No penicillin allergy</a></li>
                <li><a href="#pospel2">Non-severe immediate or delayed penicillin hypersensitivity</a></li>
                <li><a href="#pospel3">Severe immediate or delayed penicillin hypersensitivity</a></li>
            </ul>
            <hr />
            <hr />
            <h4 class="color-primary"> History of penicillin allergy or adverse reaction</h4>
            <p class="bold">No penicillin allergy</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as nausea and limited diarrhoea</li>
                <li>Such reactions are frequently not replicable or generalizable to the whole class. It is safe to
                    prescribe penicillin class antibiotics &#40;with the patient’s knowledge&#41;, and if required, use
                    strategies for symptom control such as metoclopramide</li>
            </ul>
            <p class="bold">Non-severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes non-severe reactions such as isolated rash.</li>
                <li>There is only a 2-3% chance of cephalosporin allergy in a patient with a previous IgE mediated
                    allergy to penicillin, and probably even less for other types of allergies. In most cases it is safe
                    to administer a cephalosporin to a patient who has had a non-life threatening reaction to penicillin
                </li>
            </ul>
            <p class="bold">Severe immediate or delayed penicillin hypersensitivity</p>
            <ul class="line30">
                <li>This includes anaphylaxis &#40;see below&#41; BUT DOES NOT INCLUDE other life-threatening reactions
                    such as Stevens-Johnson Syndrome &#40;SJS&#41;, Toxic epidermal necrolysis &#40;TEN&#41;, Drug
                    reaction with eosinophilia and systemic symptoms &#40;DRESS&#41; or interstitial nephritis. If your
                    patient has a history of these, contact infectious diseases for advice</li>
            </ul>
            <hr>
            <p class="bold">Penicillin anaphylaxis is highly likely if any ONE of the following is fulfilled:</p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>1.</b> Acute onset of an illness (minutes to several hours)
                        involving the skin, mucosal tissue, or both (eg, generalised hives, pruritus or flushing,
                        swollen lips-tongue-uvula) <b>and at least one of:</b></div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze/bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <b>OR</b>
                            <li>Reduced blood pressure &#40;BP&#41; or associated symptoms and signs of end-organ
                                malperfusion &#40;eg, hypotonia [collapse] syncope, incontinence&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>2. TWO OR MORE OF THE FOLLOWING</b> that occur rapidly
                        <i>after exposure</i> to penicillin for that patient &#40;within minutes to several hours&#41;:
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Involvement of the skin-mucosal tissue &#40;eg, generalized hives, itch-flush, swollen
                                lips-tongue-uvula&#41;.</li>
                            <li>Respiratory compromise &#40;eg, dyspnea, wheeze-bronchospasm, stridor, reduced peak
                                expiratory flow, hypoxemia&#41;.</li>
                            <li>Reduced BP or associated symptoms &#40;eg, hypotonia [collapse], syncope,
                                incontinence&#41;.</li>
                            <li>Persistent gastrointestinal symptoms and signs &#40;eg, crampy abdominal pain,
                                vomiting&#41;.</li>
                        </ul>
                    </div>
                </div>
            </div>
            <p class="bold">OR </p>
            <div id="allergycolour">
                <div class="row">
                    <div class="color-purple col-sm-3"><b>3.</b> Reduced BP after exposure to penicillin in a patient
                        with known penicillin allergy &#40;within minutes to several hours&#41;
                    </div>
                    <div class="col-sm-9">
                        <ul class="line30">
                            <li>Reduced BP in adults is defined as a systolic BP of less than 90 mmHg or greater than 30
                                percent decrease from that person's baseline</li>
                            <li>In infants and children, reduced BP is defined as low systolic BP &#40;age-specific&#41;
                                or greater than 30 percent decrease in systolic BP</li>
                            <ul class="circle">
                                <li>i.e. Less than 70 mmHg from 1 month up to 1 year</li>
                                <li>Less than &#40;70 mmHg + [2 x age]&#41; from 1 to 10 years</li>
                                <li>Less than 90 mmHg from 11 to 17 years</li>
                            </ul>
                        </ul>
                    </div>
                </div>
            </div>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pospel -->

    <!-- Start of post procedural pelvic inflammatory disease infection NO Pen allergy ?severe -->
    <div data-role="page" id="pospel1" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Postprocedural pelvic infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the postprocedural pelvic infection severe or non-severe?</span>
            </h3>
            <hr/>
            <ul class="line30">
                <li>Postprocedural pelvic infection is considered non-severe if the patient does not have severe pain, fever (38°C or higher), systemic features (eg tachycardia, vomiting), sepsis or septic shock, or suspected tubo-ovarian abscess</li>
            </ul>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pospel1a">Severe</a></li>
                <li><a href="#pospel1b">Non-Severe</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pospel1 -->

    <!-- Start of post procedural pelvic inflammatory disease infection MILD Pen allergy ?severe -->
    <div data-role="page" id="pospel2" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Postprocedural pelvic infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the postprocedural pelvic infection severe or non-severe?</span>
            </h3>
            <hr/>
            <ul class="line30">
                <li>Postprocedural pelvic infection is considered non-severe if the patient does not have severe pain, fever (38°C or higher), systemic features (eg tachycardia, vomiting), sepsis or septic shock, or suspected tubo-ovarian abscess</li>
            </ul>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pospel2a">Severe</a></li>
                <li><a href="#pospel2b">Non-Severe</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pospel2 -->

    <!-- Start of post procedural pelvic inflammatory disease infection BAD Pen allergy ?severe -->
    <div data-role="page" id="pospel3" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Postprocedural pelvic infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">Is the postprocedural pelvic infection severe or non-severe?</span>
            </h3>
            <hr/>
            <ul class="line30">
                <li>Postprocedural pelvic infection is considered non-severe if the patient does not have severe pain, fever (38°C or higher), systemic features (eg tachycardia, vomiting), sepsis or septic shock, or suspected tubo-ovarian abscess</li>
            </ul>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#pospel3a">Severe</a></li>
                <li><a href="#pospel2b">Non-Severe</a></li>
            </ul>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pospel3 -->

    <!--Post procedural pelvic inflammatory disease infection NO Pen allergy, YES severe -->
    <div data-role="page" id="pospel1a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe postprocedural pelvic infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For severe postprocedural pelvic infection with no penicillin allergy give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17"><span class="color-purple">Gentamicin given over 3-5 minutes intravenously,
                            then dosed as per nomogram below or use the <a href="dosecalcs.html#dose12">gentamicin
                                empiric dose calculator for adults</a></span></span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">Adults with septic shock or requiring intensive care support, but without
                                        known or likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Adults with septic shock or requiring intensive care support, with known or
                                        likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Adults without septic shock and not requiring intensive care
                                        support:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin 2 g intravenously, 6-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for gentamicin is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>pos</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Wherever possible ensure that 2 x blood cultures are taken prior to administration of antibiotics to
                    allow directed therapy</li>
                <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities
                    are available </li>
                <li>If septic, door to needle time must be within <u>ONE HOUR</u> of recognition of septic shock</li>
                <li>If septic, repeat fluid bolus every 15 minutes until patient is normotensive. </li>
                <li>Postprocedural pelvic infection follows a gynaecological procedure and involves similar parts of the female upper genital tract to pelvic inflammatory disease. Postprocedural pelvic infection is polymicrobial and usually caused by vaginal flora</li>
                <li>If speculum examination is not possible, a first-void urine sample or patient-collected vaginal swab can be used</li>
                <li>Please contact infectious diseases within 48 hours to rationalise antibiotics once culture
                    results return.</li>
                <li>Ensure that endocervical swabs are collected for PCR testing for <i>C. trachomatis</i>, <i>M.
                        genitalium</i> and <i>N. gonorrhoeae</i>, and for microscopy, culture and sensitivity testing
                </li>
                <li>Perform a test of cure 1 month after starting treatment if a
                    sexually transmitted pathogen was detected</li>
                <li>If <i>N. gonorrhoeae</i> is identified in the index case, presumptively treat sexual contacts</li>
                <li>If <i>C. trachomatis</i> is identified in the index case, further treatment of sexual contacts is
                    not required. If <i>C. trachomatis</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, undertake contact tracing for that individual</li>
                <li>If <i>M. genitalium</i> is identified in the index case, further treatment of sexual contacts is not
                    required. If <i>M. genitalium</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, perform a test of cure at least 3 weeks after presumptive
                    treatment with azithromycin.</li>
                <li>Switch to oral therapy once the patient is clinically stable. Use oral amoxicillin+clavulanate (as for nonsevere postprocedural pelvic infection) to complete a total treatment duration (intravenous + oral) of at least 2 weeks. Check the Therapeutic Guidelines for details on when to make the switch to oral antibiotics</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Postprocedural pelvic infection</a> section for
                    more information on treatment of pelvic inflammatory disease</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pospel1a -->

    <!--Post procedural pelvic inflammatory disease infection MILD Pen allergy, YES severe -->
    <div data-role="page" id="pospel2a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe postprocedural pelvic infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For severe postprocedural pelvic infection with non-severe penicillin allergy give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 500 mg intravenously, 12-hourly</span>
                </h4>
                <p class="mrgn20b"><b>AND</b> either</p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Ceftriaxone 2 g intravenously, daily (for adults with septic shock or requiring intensive care support, use 1 g intravenously, 12-hourly)</span>
                </h4>
                <p class="mrgn20b"><b>OR</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="font17">&#9312;</span><span class="color-purple"> Cefotaxime 2 g intravenously, 8-hourly (for adults with septic shock or requiring intensive care support, use 2 g intravenously, 6-hourly)</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for ceftriaxone is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>pos</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Wherever possible ensure that 2 x blood cultures are taken prior to administration of antibiotics to
                    allow directed therapy</li>
                <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities
                    are available </li>
                <li>If septic, door to needle time must be within <u>ONE HOUR</u> of recognition of septic shock</li>
                <li>If septic, repeat fluid bolus every 15 minutes until patient is normotensive. </li>
                <li>Postprocedural pelvic infection follows a gynaecological procedure and involves similar parts of the female upper genital tract to pelvic inflammatory disease. Postprocedural pelvic infection is polymicrobial and usually caused by vaginal flora</li>
                <li>If speculum examination is not possible, a first-void urine sample or patient-collected vaginal swab can be used</li>
                <li>Please contact infectious diseases within 48 hours to rationalise antibiotics once culture
                    results return.</li>
                <li>Ensure that endocervical swabs are collected for PCR testing for <i>C. trachomatis</i>, <i>M.
                        genitalium</i> and <i>N. gonorrhoeae</i>, and for microscopy, culture and sensitivity testing
                </li>
                <li>Perform a test of cure 1 month after starting treatment if a
                    sexually transmitted pathogen was detected</li>
                <li>If <i>N. gonorrhoeae</i> is identified in the index case, presumptively treat sexual contacts</li>
                <li>If <i>C. trachomatis</i> is identified in the index case, further treatment of sexual contacts is
                    not required. If <i>C. trachomatis</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, undertake contact tracing for that individual</li>
                <li>If <i>M. genitalium</i> is identified in the index case, further treatment of sexual contacts is not
                    required. If <i>M. genitalium</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, perform a test of cure at least 3 weeks after presumptive
                    treatment with azithromycin.</li>
                <li>Switch to oral therapy once the patient is clinically stable. Use oral trimethoprim+sulfamethoxazole + metronidazole (as for nonsevere postprocedural pelvic infection). Complete a total treatment duration (intravenous + oral) of at least 2 weeks. Check the Therapeutic Guidelines for details on when to make the switch to oral antibiotics</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Postprocedural pelvic infection</a> section for
                    more information on treatment of pelvic inflammatory disease</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pospel2a -->

    <!--Post procedural pelvic inflammatory disease infection BAD Pen allergy, YES severe -->
    <div data-role="page" id="pospel3a" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Severe postprocedural pelvic infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For severe postprocedural pelvic infection with no penicillin allergy give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="font17"><span class="color-purple">Gentamicin given over 3-5 minutes intravenously,
                            then dosed as per nomogram below or use the <a href="dosecalcs.html#dose12">gentamicin
                                empiric dose calculator for adults</a></span></span>
                    <br><br>
                    <div class="table-responsive">
                        <table class="table-blank">
                            <tr>
                                <td><span class="font17">Adults with septic shock or requiring intensive care support, but without
                                        known or likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">7 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Adults with septic shock or requiring intensive care support, with known or
                                        likely pre-existing kidney impairment:&nbsp;&nbsp;<br><br></span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                            <tr>
                                <td><span class="font17">Adults without septic shock and not requiring intensive care
                                        support:&nbsp;&nbsp;</span></td>
                                <td><span class="color-purple">4-5 mg/kg for the first dose, then use the nomogram below
                                        for subsequent dosing or use the <a href="dosecalcs.html#dose12">gentamicin
                                            empiric dose calculator</a></span><br><br></td>
                            </tr>
                        </table>
                    </div>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Clindamycin 600 mg intravenously, 8-hourly</span>
                </h4>
            </div>
            <hr />
            <h4 class="mrgn20b text-center codefor">
                <span class="color-success">Code for clindamycin IV is:</span>
                <span class="font15 bold"> 2<script> document.write(getCode())</script>pos</span>
                <div class="font15 mrgn20b text-left">This code is valid for <b>TWO</b> days only, starting from the
                    first day of treatment for this condition. Infectious diseases must be contacted if IV treatment is
                    to continue past 48 hours. Please annotate this code on the medication chart and document when
                    infectious diseases are to be contacted in the patient notes.</div>
            </h4>
            <hr />
            <ul class="line30">
                <li>Wherever possible ensure that 2 x blood cultures are taken prior to administration of antibiotics to
                    allow directed therapy</li>
                <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities
                    are available </li>
                <li>If septic, door to needle time must be within <u>ONE HOUR</u> of recognition of septic shock</li>
                <li>If septic, repeat fluid bolus every 15 minutes until patient is normotensive. </li>
                <li>Postprocedural pelvic infection follows a gynaecological procedure and involves similar parts of the female upper genital tract to pelvic inflammatory disease. Postprocedural pelvic infection is polymicrobial and usually caused by vaginal flora</li>
                <li>If speculum examination is not possible, a first-void urine sample or patient-collected vaginal swab can be used</li>
                <li>Please contact infectious diseases within 48 hours to rationalise antibiotics once culture
                    results return.</li>
                <li>Ensure that endocervical swabs are collected for PCR testing for <i>C. trachomatis</i>, <i>M.
                        genitalium</i> and <i>N. gonorrhoeae</i>, and for microscopy, culture and sensitivity testing
                </li>
                <li>Perform a test of cure 1 month after starting treatment if a
                    sexually transmitted pathogen was detected</li>
                <li>If <i>N. gonorrhoeae</i> is identified in the index case, presumptively treat sexual contacts</li>
                <li>If <i>C. trachomatis</i> is identified in the index case, further treatment of sexual contacts is
                    not required. If <i>C. trachomatis</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, undertake contact tracing for that individual</li>
                <li>If <i>M. genitalium</i> is identified in the index case, further treatment of sexual contacts is not
                    required. If <i>M. genitalium</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, perform a test of cure at least 3 weeks after presumptive
                    treatment with azithromycin.</li>
                <li>Switch to oral therapy once the patient is clinically stable. Use oral trimethoprim+sulfamethoxazole + metronidazole (as for nonsevere postprocedural pelvic infection). Complete a total treatment duration (intravenous + oral) of at least 2 weeks. Check the Therapeutic Guidelines for details on when to make the switch to oral antibiotics</li>
            </ul>
            <hr />
            <h4 class="color-primary mrgn20b">Initial Gentamicin/Tobramycin Dosing &#40;age &gt; 12 years&#41;</h4>
            <div class="table-responsive">
                <table class="table table-bordered table-striped">
                    <tr>
                        <th>Creatinine clearance<br> (mL/min)</th>
                        <th>Initial<br> dose</th>
                        <th>Dosing<br> frequency</th>
                        <th>Maximum number <br>of empirical doses</th>
                    </tr>

                    <tr>
                        <td>More than<br> 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>24-hourly</td>
                        <td>3 doses <br>&#40;at 0, 24 and 48 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>40 to 60 mL/min</td>
                        <td>4 to 5 mg/kg</td>
                        <td>36-hourly</td>
                        <td>2 doses <br>&#40;at 0 and 36 hours&#41;</td>
                    </tr>

                    <tr>
                        <td>less than <br>40 mL/min</td>
                        <td>4mg/kg</td>
                        <td colspan="2">Single dose, then seek expert advice</td>
                    </tr>
                </table>
            </div>
            <hr />
            <ul class="line30">
                <li>If actual body weight is more than 20% over the ideal body weight, use adjusted body weight to
                    calculate the dose. For morbidly obese patients, seek expert advice.</li>
                <li>Critically ill patients with severe sepsis have higher volumes of distribution. In these patients a
                    dose of 7mg/kg may be appropriate</li>
                <li>Use the <a href="dosecalcs.html#dose7">Cockcroft gault calculator</a> to calculate renal function
                    for adults if using the nomogram, or use the <a href="dosecalcs.html#dose12">adult aminoglycoside
                        dose calculator</a></li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Postprocedural pelvic infection</a> section for
                    more information on treatment of pelvic inflammatory disease</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pospel3a -->


    <!--Post procedural pelvic inflammatory disease infection NO Pen allergy, NOT severe -->
    <div data-role="page" id="pospel1b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Non-severe postprocedural pelvic infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For non-severe postprocedural pelvic infection with no penicillin allergy give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Amoxicillin+clavulanate 875+125 mg orally, 12-hourly for 14 days</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities
                    are available </li>
                <li>Postprocedural pelvic infection follows a gynaecological procedure and involves similar parts of the female upper genital tract to pelvic inflammatory disease. Postprocedural pelvic infection is polymicrobial and usually caused by vaginal flora</li>
                <li>If speculum examination is not possible, a first-void urine sample or patient-collected vaginal swab can be used</li>
                <li>Please contact infectious diseases within 48 hours to rationalise antibiotics once culture
                    results return.</li>
                <li>Ensure that endocervical swabs are collected for PCR testing for <i>C. trachomatis</i>, <i>M.
                        genitalium</i> and <i>N. gonorrhoeae</i>, and for microscopy, culture and sensitivity testing
                </li>
                <li>Perform a test of cure 1 month after starting treatment if a
                    sexually transmitted pathogen was detected</li>
                <li>If <i>N. gonorrhoeae</i> is identified in the index case, presumptively treat sexual contacts</li>
                <li>If <i>C. trachomatis</i> is identified in the index case, further treatment of sexual contacts is
                    not required. If <i>C. trachomatis</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, undertake contact tracing for that individual</li>
                <li>If <i>M. genitalium</i> is identified in the index case, further treatment of sexual contacts is not
                    required. If <i>M. genitalium</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, perform a test of cure at least 3 weeks after presumptive
                    treatment with azithromycin.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Postprocedural pelvic infection</a> section for
                    more information on treatment of pelvic inflammatory disease</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pospel1b -->


    <!--Post procedural pelvic inflammatory disease infection ANY Pen allergy, NOT severe -->
    <div data-role="page" id="pospel2b" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Non-severe postprocedural pelvic infection</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <h3 class="mrgn20b">
                <span class="color-primary">For non-severe postprocedural pelvic infection with a penicillin allergy give:</span>
            </h3>
            <div id="backcolour">
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Trimethoprim+sulfamethoxazole 160+800 mg orally, 12-hourly for 14 days</span>
                </h4>
                <p class="mrgn20b"><b>AND</b></p>
                <h4 class="medicine mrgn20b">
                    <span class="color-purple">Metronidazole 400 mg orally, 12-hourly for 14 days</span>
                </h4>
            </div>
            <hr />
            <ul class="line30">
                <li>This is a guide for empirical therapy only until the results of microbiology and susceptibilities
                    are available </li>
                <li>Postprocedural pelvic infection follows a gynaecological procedure and involves similar parts of the female upper genital tract to pelvic inflammatory disease. Postprocedural pelvic infection is polymicrobial and usually caused by vaginal flora</li>
                <li>If speculum examination is not possible, a first-void urine sample or patient-collected vaginal swab can be used</li>
                <li>Please contact infectious diseases within 48 hours to rationalise antibiotics once culture
                    results return.</li>
                <li>Ensure that endocervical swabs are collected for PCR testing for <i>C. trachomatis</i>, <i>M.
                        genitalium</i> and <i>N. gonorrhoeae</i>, and for microscopy, culture and sensitivity testing
                </li>
                <li>Perform a test of cure 1 month after starting treatment if a
                    sexually transmitted pathogen was detected</li>
                <li>If <i>N. gonorrhoeae</i> is identified in the index case, presumptively treat sexual contacts</li>
                <li>If <i>C. trachomatis</i> is identified in the index case, further treatment of sexual contacts is
                    not required. If <i>C. trachomatis</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, undertake contact tracing for that individual</li>
                <li>If <i>M. genitalium</i> is identified in the index case, further treatment of sexual contacts is not
                    required. If <i>M. genitalium</i> is identified in a sexual contact, further treatment of the
                    contact is not required; however, perform a test of cure at least 3 weeks after presumptive
                    treatment with azithromycin.</li>
            </ul>
            <hr>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15">See the <a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">Therapeutic Guidelines - Postprocedural pelvic infection</a> section for
                    more information on treatment of pelvic inflammatory disease</span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /pospel2b -->

    <!-- POSTPROCEDURAL PELVIC INFECTION MAZE FINISHED -->

    <!-- START OF SEPTIC ABORTION -->

    <!-- Start of SEPTIC ABORTION REDIRECT PAGE -->
    <div data-role="page" id="septor" data-theme="a">
        <div data-role="header" class="frontpage">
            <h1><img src="img/nt-flower.png" alt="WAAMS - Western Australia AntiMicrobial Stewardship" />
            <a href="index.html" STYLE="color: white; text-decoration: none">WAAMS - Western Australia AntiMicrobial
                    Stewardship</a></h1>
        </div>
        <!-- /header -->
        <div data-role="header" class="secondpage">
            <h1>Septic abortion</h1>
        </div>
        <!-- /header -->
        <div data-role="content" class="container-fluid">
            <br/>
            <h4 class="color-danger mrgn15b">Please refer to an obstetrician or gynaecologist for appropriate assessment and management and treat as per postpartum endometritis</h4>
            <hr/>
            <ul data-role="listview" data-inset="true" class="listview">
                <li><a href="#postendo">Postpartum endometritis treatment</a></li>
            </ul>
            <hr/>
            <ul class="line30">
                <li>Septic abortion is an infection of the upper genital tract following either spontaneous abortion (miscarriage) or induced (surgical, unsafe, or rarely, medical) abortion; it is uncommon in developed countries. Infection may spread, causing bacteraemia</li>
                <li>Septic abortion is usually a polymicrobial infection, most commonly involving ascending cervicovaginal organisms, particularly anaerobic bacteria. Patients who are critically ill with sepsis or septic shock may have infection caused by Clostridium species or Streptococcus pyogenes (group A Streptococcus)</li>
                <li>Clinical presentation is variable but usually includes fever (38°C or more) and uterine bleeding. Abdominal pain may be present and the uterus is usually only mildly tender</li>
                <li>Investigate suspected cases of suspected septic abortion with an endocervical swab for:
                    <ul>
                        <li>nucleic acid amplification testing (NAAT) (eg polymerase chain reaction [PCR]) for Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium</li>
                        <li>microscopy, culture and susceptibility testing</li>
                    </ul>
                </li>
                <li>Perform an ultrasound to exclude the presence of retained products of conception</li>
                <li>Collect blood samples for culture and susceptibility testing for patients in hospital</li>
            </ul>
            <h4 class="mrgn20b references">
                <span class="color-purple"><b>References: </b></span><br><br>
                <span class="font15"><a
                        href="https://tgldcdp-tg-org-au.smhslibresources.health.wa.gov.au/topicTeaser?guidelinePage=Antibiotic&etgAccess=true"
                        target="_blank">See section on septic abortion</a> - Antibiotic Expert Groups.
                    Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines Limited; 2019.
                </span>
            </h4>
        </div>
        <!-- /content -->
        <div class="footer">
            <a href="index.html" class="btn btn-lg btn-success"><span
                    class="glyphicon glyphicon-home"></span>&nbsp;Home</a>
        </div>
        <!-- /footer -->
    </div>
    <!-- /septor -->

    <!-- END OF SEPTIC ABORTION -->



</body>
<script src="bootstrap/js/script.js"></script>
<script src="bootstrap/js/test.js"></script>
<script src="bootstrap/js/email.js"></script>

</html>